{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 602,
   "id": "77b1f248-86b4-4471-93f1-aef4a7eabe6a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "from bs4 import BeautifulSoup\n",
    "import os\n",
    "from openai import OpenAI"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bf05d15b-ba80-41b4-a098-1e69c6552cae",
   "metadata": {},
   "source": [
    "# 'https://menet.com.cn"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 603,
   "id": "c9fbb3a6-c060-4f91-8395-72a2a0dcb129",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_list():\n",
    "    host ='https://menet.com.cn'\n",
    "    response = requests.post(url)\n",
    "    soup = BeautifulSoup(response.text, 'html.parser')\n",
    "    news_list = soup.find_all('h3')\n",
    "    return news_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 604,
   "id": "0ad3a20c-35ec-493e-acb7-47fb1bfa51f5",
   "metadata": {},
   "outputs": [],
   "source": [
    "host ='https://menet.com.cn'\n",
    "response = requests.post(url)\n",
    "soup = BeautifulSoup(response.text, 'html.parser')\n",
    "news_list = soup.find_all('h3')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 610,
   "id": "d2bd4529-576c-4f37-8c6e-293be154d46a",
   "metadata": {},
   "outputs": [],
   "source": [
    "news_list = [_ for _ in get_list() if _['class'] == ['item_title']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 612,
   "id": "f099e5a5-638d-4528-9044-c5bc61ec9d66",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_info(item):\n",
    "    host ='https://menet.com.cn'\n",
    "    link = host+item.a['href']\n",
    "    title = item.text\n",
    "    return {\n",
    "    \"title\": title,\n",
    "    'link': link\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 613,
   "id": "f1f599d6-e1dc-4ded-b8f5-454dff99216d",
   "metadata": {},
   "outputs": [],
   "source": [
    "result = list(map(get_info, news_list))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 662,
   "id": "333d123f-ce72-43f8-81cf-995aeaffd12a",
   "metadata": {},
   "outputs": [],
   "source": [
    "for num, item in enumerate(soup.find_all(lambda tag: tag.has_attr('class') and len(tag)==1 and tag['class'] == [\"item_time\"])):\n",
    "    result[num]['date'] = item.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 666,
   "id": "4bcb33bd-ff66-4d33-8858-2cecd18816b4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': '山东新时代爆发了！拿下9个重磅品种，猛攻1100亿市场，11款1类新药、44个新品蓄力',\n",
       "  'link': 'https://menet.com.cn/info/202409/20240905102904294_148064.shtml',\n",
       "  'date': '2024-09-05'},\n",
       " {'title': '492只医药股上半年成绩单！迈瑞净利润首破70亿，5家晋身10亿军团，甘李、海思科……翻倍',\n",
       "  'link': 'https://menet.com.cn/info/202409/202409051027242724_148062.shtml',\n",
       "  'date': '2024-09-05'},\n",
       " {'title': '63个中成药厉害了！独家品种大涨133%，3个超10亿品种亮眼，扬子江、济川、天士力霸屏',\n",
       "  'link': 'https://menet.com.cn/info/202409/202409050941374137_148059.shtml',\n",
       "  'date': '2024-09-05'},\n",
       " {'title': '信立泰厉害了！12款1类新药曝光，猛攻1300亿市场，5款新药上市可期',\n",
       "  'link': 'https://menet.com.cn/info/202409/20240903141804184_148053.shtml',\n",
       "  'date': '2024-09-03'},\n",
       " {'title': '“中药股王”发威！肝病用药狂卖26亿，14个独家中成药热销，8款重磅新药出击',\n",
       "  'link': 'https://menet.com.cn/info/202409/202409031416261626_148051.shtml',\n",
       "  'date': '2024-09-03'},\n",
       " {'title': '第十批集采24个品种备战！千亿市场齐鲁亮了，2大注射剂疯狂连涨，倍特、华海蓄力',\n",
       "  'link': 'https://menet.com.cn/info/202409/20240903141404144_148049.shtml',\n",
       "  'date': '2024-09-03'},\n",
       " {'title': '28款儿科中成药亮眼！葵花、健民、济川领跑实体药店，3大品牌网上药店翻倍',\n",
       "  'link': 'https://menet.com.cn/info/202409/202409031411121112_148047.shtml',\n",
       "  'date': '2024-09-03'},\n",
       " {'title': '翰森制药2024上半年营收大涨！净利润翻番！',\n",
       "  'link': 'https://menet.com.cn/info/202409/202409021433453345_148044.shtml',\n",
       "  'date': '2024-09-02'},\n",
       " {'title': '24个独家妇科中成药亮了！明星产品暴涨186%，千金、步长、恩威上榜，25款新药发力',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408290928112811_148036.shtml',\n",
       "  'date': '2024-08-29'},\n",
       " {'title': '31款凝胶剂火了！院内市场14款独家产品“霸屏”，兴齐3大品牌亮眼，扬子江、亿胜上榜',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408290925592559_148034.shtml',\n",
       "  'date': '2024-08-29'},\n",
       " {'title': '中药龙头发威！2个独家品种涨逾100%，25款1类新药来势汹汹，10款新药冲线在即',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408290923312331_148032.shtml',\n",
       "  'date': '2024-08-29'},\n",
       " {'title': '海思科16款1类新药曝光，猛攻1000亿市场，2款1类新药备战国谈',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408290921442144_148030.shtml',\n",
       "  'date': '2024-08-29'},\n",
       " {'title': '上海医药业绩超预期增长，创新药、中药、大健康、商业板块等成绩斐然',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408281645204520_148029.shtml',\n",
       "  'date': '2024-08-28'},\n",
       " {'title': '科伦爆发了！今年28个产品获批过评，39个产品申报',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408271625382538_148023.shtml',\n",
       "  'date': '2024-08-27'},\n",
       " {'title': '关于心血管疾病，这篇宝藏论文一定要看！',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408231358535853_148018.shtml',\n",
       "  'date': '2024-08-23'},\n",
       " {'title': '第十批国采65个注射剂备战！人福惊现“11连涨”，倍特、科伦、扬子江蓄势待发',\n",
       "  'link': 'https://menet.com.cn/info/202408/202408230941334133_148016.shtml',\n",
       "  'date': '2024-08-23'}]"
      ]
     },
     "execution_count": 666,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4daa5d3-5499-4881-8b6c-59e91a9e3f55",
   "metadata": {},
   "source": [
    "# https://www.pharnexcloud.com/zixun"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 976,
   "id": "ddf53b70-1ac6-4a25-8110-7a49b0aba876",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get('https://www.pharnexcloud.com/zixun')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 977,
   "id": "d1ebba6c-fe16-456f-9e75-097e808a6c4c",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup = BeautifulSoup(r.text, 'html.parser')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 978,
   "id": "1299695a-ddd9-415a-a367-e676922de203",
   "metadata": {},
   "outputs": [],
   "source": [
    "dates = soup.find_all(lambda tag:tag.has_attr('class') and tag['class']==['date'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1002,
   "id": "7996cd9d-d46f-4f64-a2ac-cdad4d315a16",
   "metadata": {},
   "outputs": [],
   "source": [
    "dates = [_.text for _ in dates]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 986,
   "id": "48d6ccce-d85a-4b4f-b8ef-e5fd0357f1b3",
   "metadata": {},
   "outputs": [],
   "source": [
    "result = soup.find_all('a', class_ = 'img-content')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 992,
   "id": "f5771842-7db8-4ab8-b22e-4440d415a7bc",
   "metadata": {},
   "outputs": [],
   "source": [
    "def query_tilte_url(item):\n",
    "    title = item.find_next()['alt']\n",
    "    url = 'https://www.pharnexcloud.com' + item['href']\n",
    "    return {\n",
    "        'title': title,\n",
    "        'url': url\n",
    "    }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1004,
   "id": "b323460c-c439-4f1b-9b51-f7e209b31ffa",
   "metadata": {},
   "outputs": [],
   "source": [
    "res = list(map(query_tilte_url, result))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1016,
   "id": "589e63b5-f4cf-4ff5-98fa-7254a2caeff3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 {'title': '齐鲁制药再添利器！美罗培南普莱巴坦获临床试验许可，专攻复杂性腹腔感染', 'url': 'https://www.pharnexcloud.com/zixun/sx_8459'}\n",
      "1 {'title': '科伦博泰SKB571双抗ADC药物IND申请获NMPA受理，肿瘤治疗迎新突破', 'url': 'https://www.pharnexcloud.com/zixun/sx_8458'}\n",
      "2 {'title': '华润九新：头孢唑林钠水合物日本成功上市！质量卓越引领市场', 'url': 'https://www.pharnexcloud.com/zixun/sx_8457'}\n",
      "3 {'title': '百奥泰度普利尤单抗BAT2406获NMPA临床试验批准，助力特应性皮炎等疾病治疗', 'url': 'https://www.pharnexcloud.com/zixun/sx_8456'}\n",
      "4 {'title': '康方生物依沃西：全球首创PD-1/VEGF双抗，III期临床力压帕博利珠单抗！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8455'}\n",
      "5 {'title': '恒瑞医药SHR-1918注射液拟获突破性治疗认定，降脂新利器亮相ESC！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8454'}\n",
      "6 {'title': 'AI赋能药物革命：礼来与Genetic Leap合作开发RNA靶向疗法', 'url': 'https://www.pharnexcloud.com/zixun/sx_8453'}\n",
      "7 {'title': '全球监管合作加速基因疗法普及：FDA专家展望五年蓝图', 'url': 'https://www.pharnexcloud.com/zixun/sx_8452'}\n",
      "8 {'title': '医疗耗材集采新动向：深圳15+12省联盟聚焦超声刀头与预充式导管冲洗器', 'url': 'https://www.pharnexcloud.com/zixun/sx_8451'}\n",
      "9 {'title': '人福医药创新药物HW071021片获批临床，抗肿瘤药市场再添利器', 'url': 'https://www.pharnexcloud.com/zixun/sx_8450'}\n",
      "10 {'title': '齐鲁制药：达肝素钠注射液通过一致性评价，领跑抗凝药市场！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8449'}\n",
      "11 {'title': '先声再明携手塔吉瑞，独揽TGRX-326抗肿瘤神药中国大陆商业化权益', 'url': 'https://www.pharnexcloud.com/zixun/sx_8448'}\n",
      "12 {'title': '2024年第34周08.26-09.01全球创新药研发概览', 'url': 'https://www.pharnexcloud.com/zixun/bg_8447'}\n",
      "13 {'title': '2024年第34周08.26-09.01全球医药大健康行业投融资数据', 'url': 'https://www.pharnexcloud.com/zixun/bg_8446'}\n",
      "14 {'title': '2024年第34周08.26-09.01国内医药大健康行业政策法规汇总', 'url': 'https://www.pharnexcloud.com/zixun/bg_8445'}\n",
      "15 {'title': '2024年第34周08.26-09.01国内仿制药/生物类似物申报/审批数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8444'}\n",
      "16 {'title': '2024年第34周08.26-09.01国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8443'}\n",
      "17 {'title': '60种药品主动降价！石家庄四药24亿+品种大降，神经系统药居首', 'url': 'https://www.pharnexcloud.com/zixun/sx_8442'}\n",
      "18 {'title': '神州细胞1类新药SCT520FF注射液获批临床！专攻湿性AMD视力危机', 'url': 'https://www.pharnexcloud.com/zixun/sx_8441'}\n",
      "19 {'title': '信达生物：IBI363双抗融合蛋白，黑色素瘤治疗获FDA快速通道', 'url': 'https://www.pharnexcloud.com/zixun/sx_8440'}\n",
      "20 {'title': '安帝康生物获超2亿元A轮融资，加速抗流感新药玛氘诺沙韦的研发与商业化', 'url': 'https://www.pharnexcloud.com/zixun/trz_8029'}\n",
      "21 {'title': '国内核药再现大笔融资，是值得押注的赛道吗？', 'url': 'https://www.pharnexcloud.com/zixun/trz_7794'}\n",
      "22 {'title': '日本大财团三井物产和乐敦制药，47亿收购百年中医药品牌余仁生', 'url': 'https://www.pharnexcloud.com/zixun/trz_7795'}\n",
      "23 {'title': '2024Q1季度：6家CGT公司上市', 'url': 'https://www.pharnexcloud.com/zixun/trz_7762'}\n",
      "24 {'title': '2024年4月国内CGT投融资盘点', 'url': 'https://www.pharnexcloud.com/zixun/trz_7747'}\n",
      "25 {'title': '英伟达投资5000万美金，“押注”AI制药：Recursion！', 'url': 'https://www.pharnexcloud.com/zixun/trz_7716'}\n",
      "26 {'title': 'TORL BioTherapeutics完成1.58亿美元融资，用于推进其ADC药物研发', 'url': 'https://www.pharnexcloud.com/zixun/trz_7720'}\n",
      "27 {'title': 'Avenzo完成1.5亿美元A轮融资！', 'url': 'https://www.pharnexcloud.com/zixun/trz_7707'}\n",
      "28 {'title': 'Obsidian 完成C轮融资1.6亿美元！以推进TIL疗法OBX-115开发', 'url': 'https://www.pharnexcloud.com/zixun/trz_7703'}\n",
      "29 {'title': '科研新突破！DNA纳米实现精准血栓治疗，药物递送技术新型解码…', 'url': 'https://www.pharnexcloud.com/zixun/trz_7668'}\n",
      "30 {'title': '基金取代创始人，成为这家国内biotech大股东', 'url': 'https://www.pharnexcloud.com/zixun/trz_7638'}\n",
      "31 {'title': '伯瑞替尼肠溶胶囊定价出炉；完成巨额融资，这家小分子企业有何特色？', 'url': 'https://www.pharnexcloud.com/zixun/trz_7453'}\n",
      "32 {'title': '融资2.5亿美元！蓝鸟生物“找钱”新模式', 'url': 'https://www.pharnexcloud.com/zixun/trz_7382'}\n",
      "33 {'title': '融资3700万美元！免疫新锐开发癌症新靶点T细胞接合器', 'url': 'https://www.pharnexcloud.com/zixun/trz_7364'}\n",
      "34 {'title': '融资3.7亿元！推进CAR iPS-T细胞疗法', 'url': 'https://www.pharnexcloud.com/zixun/trz_7356'}\n",
      "35 {'title': '1600万美元！CGT CDMO领域又一起并购', 'url': 'https://www.pharnexcloud.com/zixun/trz_7318'}\n",
      "36 {'title': '冬天不冷，20家CXO获超1亿元融资', 'url': 'https://www.pharnexcloud.com/zixun/trz_7319'}\n",
      "37 {'title': '肿瘤疫苗biotech获得C轮融资，5.3亿元！', 'url': 'https://www.pharnexcloud.com/zixun/trz_7253'}\n",
      "38 {'title': 'CAR-T细胞疗法本年度最大规模IPO之一！融资20亿元', 'url': 'https://www.pharnexcloud.com/zixun/trz_7245'}\n",
      "39 {'title': '抗肿瘤药物热度不减！今年最大一笔创新药融资，江苏药企拿下！', 'url': 'https://www.pharnexcloud.com/zixun/trz_7217'}\n",
      "40 {'title': 'FDA观点：利多卡因/丙胺卡因外用制剂的物理和结构特性（Q3）与产品体内外性质的相关性', 'url': 'https://www.pharnexcloud.com/zixun/sd_8435'}\n",
      "41 {'title': '2024年中药上市公司中报，六巨头净利超10亿，云南白药领跑！', 'url': 'https://www.pharnexcloud.com/zixun/sd_8434'}\n",
      "42 {'title': '集采预测：多治疗领域药品或将被列入名单', 'url': 'https://www.pharnexcloud.com/zixun/sd_8427'}\n",
      "43 {'title': '既是API也是辅料！详解这款可能是处方组成最简单的外用制剂', 'url': 'https://www.pharnexcloud.com/zixun/sd_8426'}\n",
      "44 {'title': '2024盘点丨银屑病治疗新突破！生物制剂与小分子靶向药最新梳理', 'url': 'https://www.pharnexcloud.com/zixun/sd_8424'}\n",
      "45 {'title': '全球畅销孤儿药TOP10预测，两款国产药在榜！', 'url': 'https://www.pharnexcloud.com/zixun/sd_8423'}\n",
      "46 {'title': '从复星凯特到传奇生物：中国CAR-T细胞治疗市场六强争霸，商业化前景展望', 'url': 'https://www.pharnexcloud.com/zixun/sd_8397'}\n",
      "47 {'title': '一文了解德曲妥珠单抗（DS-8201）：上市进展、适应症、价格、市场表现...', 'url': 'https://www.pharnexcloud.com/zixun/sd_8392'}\n",
      "48 {'title': '从2000到2024：FDA批准局部皮肤用凝胶剂25年大盘点', 'url': 'https://www.pharnexcloud.com/zixun/sd_8376'}\n",
      "49 {'title': '潜力黑马IDEAYA：TOP药企争相携手，独家获百奥赛图首创ADC项目全球许可权', 'url': 'https://www.pharnexcloud.com/zixun/sd_8360'}\n",
      "50 {'title': '中药创新热潮：政策与市场双轮驱动，经典名方制剂注册申请激增', 'url': 'https://www.pharnexcloud.com/zixun/sd_8354'}\n",
      "51 {'title': '浅析不同定量方法中积分方法的玄机妙设', 'url': 'https://www.pharnexcloud.com/zixun/sd_8347'}\n",
      "52 {'title': '2024盘点丨24款创新药获批上市！超40个品种优先审评，中药亮眼！', 'url': 'https://www.pharnexcloud.com/zixun/sd_8345'}\n",
      "53 {'title': '制药人的健康警钟：揭秘行业背后的健康风险与应对措施', 'url': 'https://www.pharnexcloud.com/zixun/sd_8325'}\n",
      "54 {'title': '阿伐曲泊帕：国内首款治疗血小板减少症口服药物！慢性肝病患者福音！', 'url': 'https://www.pharnexcloud.com/zixun/sd_8313'}\n",
      "55 {'title': '集采时代的悲歌，阳光下的仿制药', 'url': 'https://www.pharnexcloud.com/zixun/sd_8299'}\n",
      "56 {'title': '托莱西单抗：PCSK9抑制剂中的“国货之光”！心血管疾病治疗福音', 'url': 'https://www.pharnexcloud.com/zixun/sd_8281'}\n",
      "57 {'title': '鞍石生物科技：MET抑制剂伯瑞替尼快速供药，价格亲民助力肺癌治疗', 'url': 'https://www.pharnexcloud.com/zixun/sd_8277'}\n",
      "58 {'title': '反腐整风运动下医疗及药企产业变局分析', 'url': 'https://www.pharnexcloud.com/zixun/sd_8265'}\n",
      "59 {'title': '2024年医药整风运动对医院全面影响解析', 'url': 'https://www.pharnexcloud.com/zixun/sd_8264'}\n",
      "60 {'title': '药品反垄断指南出炉：全领域覆盖，力促公平竞争新生态', 'url': 'https://www.pharnexcloud.com/zixun/zc_8341'}\n",
      "61 {'title': '下月起执行！九大类耗材品种开始降价，平均降价83.46%……', 'url': 'https://www.pharnexcloud.com/zixun/zc_8020'}\n",
      "62 {'title': '国家新规出台，全面彻查公立医院欠款问题！', 'url': 'https://www.pharnexcloud.com/zixun/zc_7970'}\n",
      "63 {'title': '国家医保局最新指令，全国严查大型医疗设备！', 'url': 'https://www.pharnexcloud.com/zixun/zc_7904'}\n",
      "64 {'title': '新政策！北京发文支持CGT药物等快速形成产业增量', 'url': 'https://www.pharnexcloud.com/zixun/zc_7885'}\n",
      "65 {'title': '注射剂用覆膜胶塞的缺陷与对策', 'url': 'https://www.pharnexcloud.com/zixun/zc_7567'}\n",
      "66 {'title': '重磅！第三批鼓励仿制药品目录出炉！39品种纳入，帕替司兰、伏环孢素等', 'url': 'https://www.pharnexcloud.com/zixun/zc_7395'}\n",
      "67 {'title': '福建第四批化药集采拟中选结果，间苯三酚降价92%！30+药企扎堆申报', 'url': 'https://www.pharnexcloud.com/zixun/zc_7345'}\n",
      "68 {'title': '国家药监局发文，GLP认证新《办法》7月1日执行！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6660'}\n",
      "69 {'title': '注射剂注意！《中国药典》通则（0102）注射剂修订！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6640'}\n",
      "70 {'title': '最新！CDE更新11条一般技术性问题！涉及审评审批、MAH变更等', 'url': 'https://www.pharnexcloud.com/zixun/zc_6618'}\n",
      "71 {'title': 'GLP-1必备SNAC！原辅料全产业链平台完整打造，天吉生物未来可期！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6612'}\n",
      "72 {'title': '重磅！医保目录调整方案公开征求意见！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6597'}\n",
      "73 {'title': '2023年中国科学院院士增选79名，药剂学方向优先！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6590'}\n",
      "74 {'title': 'CDE最新发布通知，公开征求GCP指导原则！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6506'}\n",
      "75 {'title': '鼓励研发！卫健委开出29个临床急需儿童用药，均未在国内上市！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6498'}\n",
      "76 {'title': '医美新势力！CMDE发布2项重磅指导原则，涉及重组胶原蛋白！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6497'}\n",
      "77 {'title': '重磅！《关于加强委托生产药品上市许可持有人监管工作的通知》公开征求意见！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6477'}\n",
      "78 {'title': 'CDE重磅！《关于无参比制剂品种仿制研究的公告（征求意见稿）》征求意见！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6476'}\n",
      "79 {'title': '重磅！全国中成药集采正式文件公布！', 'url': 'https://www.pharnexcloud.com/zixun/zc_6453'}\n",
      "80 {'title': '2024年第34周08.26-09.01全球创新药研发概览', 'url': 'https://www.pharnexcloud.com/zixun/bg_8447'}\n",
      "81 {'title': '2024年第34周08.26-09.01全球医药大健康行业投融资数据', 'url': 'https://www.pharnexcloud.com/zixun/bg_8446'}\n",
      "82 {'title': '2024年第34周08.26-09.01国内医药大健康行业政策法规汇总', 'url': 'https://www.pharnexcloud.com/zixun/bg_8445'}\n",
      "83 {'title': '2024年第34周08.26-09.01国内仿制药/生物类似物申报/审批数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8444'}\n",
      "84 {'title': '2024年第34周08.26-09.01国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8443'}\n",
      "85 {'title': '2024年8月共有183个品种过评！齐鲁制药、汇宇制药、恒瑞医药三足鼎立…', 'url': 'https://www.pharnexcloud.com/zixun/bg_8433'}\n",
      "86 {'title': '2024年第33周08.19-08.25全球创新药研发概览', 'url': 'https://www.pharnexcloud.com/zixun/bg_8406'}\n",
      "87 {'title': '2024年第33周08.19-08.25全球医药大健康行业投融资数据', 'url': 'https://www.pharnexcloud.com/zixun/bg_8405'}\n",
      "88 {'title': '2024年第33周08.19-08.25国内医药大健康行业政策法规汇总', 'url': 'https://www.pharnexcloud.com/zixun/bg_8404'}\n",
      "89 {'title': '2024年第33周08.19-08.25国内仿制药/生物类似物申报/审批数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8403'}\n",
      "90 {'title': '2024年第33周08.19-08.25国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8402'}\n",
      "91 {'title': '2024年第32周08.12-08.18全球创新药研发概览', 'url': 'https://www.pharnexcloud.com/zixun/bg_8359'}\n",
      "92 {'title': '2024年第32周08.12-08.18全球医药大健康行业投融资数据', 'url': 'https://www.pharnexcloud.com/zixun/bg_8358'}\n",
      "93 {'title': '2024年第32周08.12-08.18国内医药大健康行业政策法规汇总', 'url': 'https://www.pharnexcloud.com/zixun/bg_8357'}\n",
      "94 {'title': '2024年第32周08.12-08.18国内仿制药/生物类似物申报/审批数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8356'}\n",
      "95 {'title': '2024年第32周08.12-08.18国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析', 'url': 'https://www.pharnexcloud.com/zixun/bg_8355'}\n",
      "96 {'title': '252个品种过评，首家过评品种增至38个！7月仿制药一致性评价及获批上市亮点频现', 'url': 'https://www.pharnexcloud.com/zixun/bg_8333'}\n",
      "97 {'title': '2024年7月140款新药获批临床！5款创新药获批上市，涉及信立泰、药华医药……', 'url': 'https://www.pharnexcloud.com/zixun/bg_8319'}\n",
      "98 {'title': '2024年第31周08.05-08.11全球创新药研发概览', 'url': 'https://www.pharnexcloud.com/zixun/bg_8318'}\n",
      "99 {'title': '2024年第31周08.05-08.11全球医药大健康行业投融资数据', 'url': 'https://www.pharnexcloud.com/zixun/bg_8317'}\n",
      "100 {'title': '群贤共聚，论道医药！第五届CMC-China中国国际生物&化学制药博览会圆满结束！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6793'}\n",
      "101 {'title': '深耕代谢疾病：君圣泰递交IPO申请，海普瑞为大股东之一（附招股书）', 'url': 'https://www.pharnexcloud.com/zixun/hy_6611'}\n",
      "102 {'title': '千位药企掌门聚苏州！第四届中国API Summit开始报名！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6553'}\n",
      "103 {'title': '新环境下企业拓展OTC赛道新思路！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6568'}\n",
      "104 {'title': '10个一致性评价受理号获批！一品种集齐36家过评！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6559'}\n",
      "105 {'title': '制药人，不懂点合成生物学，就有点落后了！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6558'}\n",
      "106 {'title': '就在成都！沉浸式交流：小分子工艺开发和质量分析科学，一文速览议程！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6554'}\n",
      "107 {'title': '266亿！浅析黏膜给药制剂销售趋势及市场格局', 'url': 'https://www.pharnexcloud.com/zixun/hy_6544'}\n",
      "108 {'title': '报名开始！8月苏州，中国绿色制药技术大会', 'url': 'https://www.pharnexcloud.com/zixun/hy_6534'}\n",
      "109 {'title': '基因治疗，国内药企该如何布局并弯道超车？', 'url': 'https://www.pharnexcloud.com/zixun/hy_6524'}\n",
      "110 {'title': '改良新药已开卷，企业的求生法则', 'url': 'https://www.pharnexcloud.com/zixun/hy_6502'}\n",
      "111 {'title': '溯源而上！这场大会，体现抗体、小分子、细胞基因疗法、核酸等差异化竞争与合作', 'url': 'https://www.pharnexcloud.com/zixun/hy_6461'}\n",
      "112 {'title': '就在这周五：相约泰州，纳米抗体新药论坛！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6441'}\n",
      "113 {'title': '倒计时3天！免报名费！来石家庄，听外用制剂、高端注射剂、改良新药与复杂制剂内容！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6369'}\n",
      "114 {'title': '药物工艺开发及质量控制要点峰会，6月14-15日，成都开幕！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6362'}\n",
      "115 {'title': '以药为融 | 万人圈友大聚会@第五届CMC-China制药博览会', 'url': 'https://www.pharnexcloud.com/zixun/hy_6351'}\n",
      "116 {'title': '院士领衔，专家齐聚，群贤毕至，待您加入！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6341'}\n",
      "117 {'title': '纳米抗体30周年：行业新生赛道的机遇与挑战', 'url': 'https://www.pharnexcloud.com/zixun/hy_6305'}\n",
      "118 {'title': '限时免费报名！石家庄MAH&DDS制剂合作大会，各路专家带你飞！', 'url': 'https://www.pharnexcloud.com/zixun/hy_6242'}\n",
      "119 {'title': '下一站再聚 | 改良型新药趋势与合作交流大会圆满落幕', 'url': 'https://www.pharnexcloud.com/zixun/hy_6213'}\n",
      "120 {'title': '齐鲁制药再添利器！美罗培南普莱巴坦获临床试验许可，专攻复杂性腹腔感染', 'url': 'https://www.pharnexcloud.com/zixun/sx_8459'}\n",
      "121 {'title': '科伦博泰SKB571双抗ADC药物IND申请获NMPA受理，肿瘤治疗迎新突破', 'url': 'https://www.pharnexcloud.com/zixun/sx_8458'}\n",
      "122 {'title': '华润九新：头孢唑林钠水合物日本成功上市！质量卓越引领市场', 'url': 'https://www.pharnexcloud.com/zixun/sx_8457'}\n",
      "123 {'title': '百奥泰度普利尤单抗BAT2406获NMPA临床试验批准，助力特应性皮炎等疾病治疗', 'url': 'https://www.pharnexcloud.com/zixun/sx_8456'}\n",
      "124 {'title': '康方生物依沃西：全球首创PD-1/VEGF双抗，III期临床力压帕博利珠单抗！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8455'}\n",
      "125 {'title': '恒瑞医药SHR-1918注射液拟获突破性治疗认定，降脂新利器亮相ESC！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8454'}\n",
      "126 {'title': 'AI赋能药物革命：礼来与Genetic Leap合作开发RNA靶向疗法', 'url': 'https://www.pharnexcloud.com/zixun/sx_8453'}\n",
      "127 {'title': '全球监管合作加速基因疗法普及：FDA专家展望五年蓝图', 'url': 'https://www.pharnexcloud.com/zixun/sx_8452'}\n",
      "128 {'title': '医疗耗材集采新动向：深圳15+12省联盟聚焦超声刀头与预充式导管冲洗器', 'url': 'https://www.pharnexcloud.com/zixun/sx_8451'}\n",
      "129 {'title': '人福医药创新药物HW071021片获批临床，抗肿瘤药市场再添利器', 'url': 'https://www.pharnexcloud.com/zixun/sx_8450'}\n",
      "130 {'title': '齐鲁制药：达肝素钠注射液通过一致性评价，领跑抗凝药市场！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8449'}\n",
      "131 {'title': '先声再明携手塔吉瑞，独揽TGRX-326抗肿瘤神药中国大陆商业化权益', 'url': 'https://www.pharnexcloud.com/zixun/sx_8448'}\n",
      "132 {'title': '60种药品主动降价！石家庄四药24亿+品种大降，神经系统药居首', 'url': 'https://www.pharnexcloud.com/zixun/sx_8442'}\n",
      "133 {'title': '神州细胞1类新药SCT520FF注射液获批临床！专攻湿性AMD视力危机', 'url': 'https://www.pharnexcloud.com/zixun/sx_8441'}\n",
      "134 {'title': '信达生物：IBI363双抗融合蛋白，黑色素瘤治疗获FDA快速通道', 'url': 'https://www.pharnexcloud.com/zixun/sx_8440'}\n",
      "135 {'title': '融资3.25亿美元！CAR-T新锐开发实体瘤可编程细胞疗法', 'url': 'https://www.pharnexcloud.com/zixun/sx_8439'}\n",
      "136 {'title': 'BioAge Labs冲刺纳斯达克！肥胖治疗新星azelaprag引领IPO热潮', 'url': 'https://www.pharnexcloud.com/zixun/sx_8438'}\n",
      "137 {'title': '岸迈生物BCMA×CD3双抗成功出海，剑指全球自身免疫疾病市场', 'url': 'https://www.pharnexcloud.com/zixun/sx_8437'}\n",
      "138 {'title': '《柳叶刀》揭秘：司美格鲁肽显著降低心衰恶化风险31%！', 'url': 'https://www.pharnexcloud.com/zixun/sx_8436'}\n",
      "139 {'title': '福元医药业绩连续多年双增，4亿+抗癫痫药丙戊酸钠缓释片(Ⅰ)斩获首家过评', 'url': 'https://www.pharnexcloud.com/zixun/sx_8432'}\n",
      "140 {'title': '国际疾病分类编码在线查询（ICD-10&ICD-11）', 'url': 'https://www.pharnexcloud.com/zixun/kp_8168'}\n",
      "141 {'title': '5万+全国各省市中药饮片炮制规范-在线免费查询啦！', 'url': 'https://www.pharnexcloud.com/zixun/kp_8142'}\n",
      "142 {'title': '2020《中国药典》电子版官网在线查询入口|中国药典检索🔍', 'url': 'https://www.pharnexcloud.com/zixun/kp_8097'}\n",
      "143 {'title': '【调研必看】中国慢性疾病统计数据查询方法-28个权威网站', 'url': 'https://www.pharnexcloud.com/zixun/kp_8081'}\n",
      "144 {'title': '分享两种印度仿制药品信息查询方法', 'url': 'https://www.pharnexcloud.com/zixun/kp_8063'}\n",
      "145 {'title': '国谈药品是什么意思？与集采药品有什么区别？', 'url': 'https://www.pharnexcloud.com/zixun/kp_8053'}\n",
      "146 {'title': '<一文看懂>保健食品备案和注册的区别', 'url': 'https://www.pharnexcloud.com/zixun/kp_7981'}\n",
      "147 {'title': '特殊医学用途配方食品有哪些?如何查询？', 'url': 'https://www.pharnexcloud.com/zixun/kp_7982'}\n",
      "148 {'title': '保健食品注册信息在线查询平台', 'url': 'https://www.pharnexcloud.com/zixun/kp_7946'}\n",
      "149 {'title': '原研药-创新药-全球药品研发进度在线查询平台', 'url': 'https://www.pharnexcloud.com/zixun/kp_7930'}\n",
      "150 {'title': 'ICH指导原则中英文版下载', 'url': 'https://www.pharnexcloud.com/zixun/kp_7912'}\n",
      "151 {'title': '全国快速预审通道发明专利1-6个月授权', 'url': 'https://www.pharnexcloud.com/zixun/kp_7840'}\n",
      "152 {'title': '我国药品定价政策及所需考虑的市场因素', 'url': 'https://www.pharnexcloud.com/zixun/kp_7831'}\n",
      "153 {'title': '中药保护品种：官网目录信息收载数据4000+', 'url': 'https://www.pharnexcloud.com/zixun/kp_7838'}\n",
      "154 {'title': '化学药品注册分类标准及申报资料要求(新版原文)', 'url': 'https://www.pharnexcloud.com/zixun/kp_7784'}\n",
      "155 {'title': '请查收！《中药注册分类及申报材料要求》', 'url': 'https://www.pharnexcloud.com/zixun/kp_7791'}\n",
      "156 {'title': '中医诊疗方案数据库:收载历史多版本400多个治疗方案', 'url': 'https://www.pharnexcloud.com/zixun/kp_7741'}\n",
      "157 {'title': '中医临床诊疗术语一览表(收载官网全部术语4705个)', 'url': 'https://www.pharnexcloud.com/zixun/kp_7735'}\n",
      "158 {'title': '法国药品数据库-药品查询方法详细讲解<实操案列>', 'url': 'https://www.pharnexcloud.com/zixun/kp_7628'}\n",
      "159 {'title': 'Sumitomo Pharma日本百年Top10药企简史——住友制药', 'url': 'https://www.pharnexcloud.com/zixun/kp_7606'}\n"
     ]
    }
   ],
   "source": [
    "for no, item in enumerate(res):\n",
    "    \n",
    "    item['date'] = dates[no]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1022,
   "id": "ef54e783-8114-490c-9ec4-84508dfd5c31",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': '齐鲁制药再添利器！美罗培南普莱巴坦获临床试验许可，专攻复杂性腹腔感染',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8459',\n",
       "  'date': '2024-09-09 11:56:32'},\n",
       " {'title': '科伦博泰SKB571双抗ADC药物IND申请获NMPA受理，肿瘤治疗迎新突破',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8458',\n",
       "  'date': '2024-09-09 11:46:09'},\n",
       " {'title': '华润九新：头孢唑林钠水合物日本成功上市！质量卓越引领市场',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8457',\n",
       "  'date': '2024-09-09 11:28:58'},\n",
       " {'title': '百奥泰度普利尤单抗BAT2406获NMPA临床试验批准，助力特应性皮炎等疾病治疗',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8456',\n",
       "  'date': '2024-09-09 11:16:12'},\n",
       " {'title': '康方生物依沃西：全球首创PD-1/VEGF双抗，III期临床力压帕博利珠单抗！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8455',\n",
       "  'date': '2024-09-09 10:59:31'},\n",
       " {'title': '恒瑞医药SHR-1918注射液拟获突破性治疗认定，降脂新利器亮相ESC！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8454',\n",
       "  'date': '2024-09-09 10:51:50'},\n",
       " {'title': 'AI赋能药物革命：礼来与Genetic Leap合作开发RNA靶向疗法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8453',\n",
       "  'date': '2024-09-09 10:41:53'},\n",
       " {'title': '全球监管合作加速基因疗法普及：FDA专家展望五年蓝图',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8452',\n",
       "  'date': '2024-09-09 10:23:50'},\n",
       " {'title': '医疗耗材集采新动向：深圳15+12省联盟聚焦超声刀头与预充式导管冲洗器',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8451',\n",
       "  'date': '2024-09-09 10:02:16'},\n",
       " {'title': '人福医药创新药物HW071021片获批临床，抗肿瘤药市场再添利器',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8450',\n",
       "  'date': '2024-09-06 11:43:15'},\n",
       " {'title': '齐鲁制药：达肝素钠注射液通过一致性评价，领跑抗凝药市场！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8449',\n",
       "  'date': '2024-09-06 11:34:52'},\n",
       " {'title': '先声再明携手塔吉瑞，独揽TGRX-326抗肿瘤神药中国大陆商业化权益',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8448',\n",
       "  'date': '2024-09-06 11:20:50'},\n",
       " {'title': '2024年第34周08.26-09.01全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8447',\n",
       "  'date': '2024-09-06 11:03:33'},\n",
       " {'title': '2024年第34周08.26-09.01全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8446',\n",
       "  'date': '2024-09-06 10:55:52'},\n",
       " {'title': '2024年第34周08.26-09.01国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8445',\n",
       "  'date': '2024-09-06 10:45:08'},\n",
       " {'title': '2024年第34周08.26-09.01国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8444',\n",
       "  'date': '2024-09-06 10:34:44'},\n",
       " {'title': '2024年第34周08.26-09.01国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8443',\n",
       "  'date': '2024-09-06 10:18:19'},\n",
       " {'title': '60种药品主动降价！石家庄四药24亿+品种大降，神经系统药居首',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8442',\n",
       "  'date': '2024-09-05 11:55:51'},\n",
       " {'title': '神州细胞1类新药SCT520FF注射液获批临床！专攻湿性AMD视力危机',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8441',\n",
       "  'date': '2024-09-05 11:45:52'},\n",
       " {'title': '信达生物：IBI363双抗融合蛋白，黑色素瘤治疗获FDA快速通道',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8440',\n",
       "  'date': '2024-09-05 11:37:41'},\n",
       " {'title': '安帝康生物获超2亿元A轮融资，加速抗流感新药玛氘诺沙韦的研发与商业化',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_8029',\n",
       "  'date': '2024-06-26 10:21:23'},\n",
       " {'title': '国内核药再现大笔融资，是值得押注的赛道吗？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7794',\n",
       "  'date': '2024-04-28 12:00:00'},\n",
       " {'title': '日本大财团三井物产和乐敦制药，47亿收购百年中医药品牌余仁生',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7795',\n",
       "  'date': '2024-04-28 12:00:00'},\n",
       " {'title': '2024Q1季度：6家CGT公司上市',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7762',\n",
       "  'date': '2024-04-23 12:00:00'},\n",
       " {'title': '2024年4月国内CGT投融资盘点',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7747',\n",
       "  'date': '2024-04-18 12:00:00'},\n",
       " {'title': '英伟达投资5000万美金，“押注”AI制药：Recursion！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7716',\n",
       "  'date': '2024-04-11 12:00:00'},\n",
       " {'title': 'TORL BioTherapeutics完成1.58亿美元融资，用于推进其ADC药物研发',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7720',\n",
       "  'date': '2024-04-11 12:00:00'},\n",
       " {'title': 'Avenzo完成1.5亿美元A轮融资！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7707',\n",
       "  'date': '2024-04-09 12:00:00'},\n",
       " {'title': 'Obsidian 完成C轮融资1.6亿美元！以推进TIL疗法OBX-115开发',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7703',\n",
       "  'date': '2024-04-07 15:00:00'},\n",
       " {'title': '科研新突破！DNA纳米实现精准血栓治疗，药物递送技术新型解码…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7668',\n",
       "  'date': '2024-03-27 12:00:00'},\n",
       " {'title': '基金取代创始人，成为这家国内biotech大股东',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7638',\n",
       "  'date': '2024-03-19 12:00:00'},\n",
       " {'title': '伯瑞替尼肠溶胶囊定价出炉；完成巨额融资，这家小分子企业有何特色？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7453',\n",
       "  'date': '2024-01-15 17:00:00'},\n",
       " {'title': '融资2.5亿美元！蓝鸟生物“找钱”新模式',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7382',\n",
       "  'date': '2023-12-21 12:00:00'},\n",
       " {'title': '融资3700万美元！免疫新锐开发癌症新靶点T细胞接合器',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7364',\n",
       "  'date': '2023-12-15 12:00:00'},\n",
       " {'title': '融资3.7亿元！推进CAR iPS-T细胞疗法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7356',\n",
       "  'date': '2023-12-14 12:00:00'},\n",
       " {'title': '1600万美元！CGT CDMO领域又一起并购',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7318',\n",
       "  'date': '2023-12-05 12:00:00'},\n",
       " {'title': '冬天不冷，20家CXO获超1亿元融资',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7319',\n",
       "  'date': '2023-12-05 12:00:00'},\n",
       " {'title': '肿瘤疫苗biotech获得C轮融资，5.3亿元！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7253',\n",
       "  'date': '2023-11-15 12:00:00'},\n",
       " {'title': 'CAR-T细胞疗法本年度最大规模IPO之一！融资20亿元',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7245',\n",
       "  'date': '2023-11-14 11:28:09'},\n",
       " {'title': '抗肿瘤药物热度不减！今年最大一笔创新药融资，江苏药企拿下！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7217',\n",
       "  'date': '2023-11-07 12:00:00'},\n",
       " {'title': 'FDA观点：利多卡因/丙胺卡因外用制剂的物理和结构特性（Q3）与产品体内外性质的相关性',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8435',\n",
       "  'date': '2024-09-05 09:52:43'},\n",
       " {'title': '2024年中药上市公司中报，六巨头净利超10亿，云南白药领跑！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8434',\n",
       "  'date': '2024-09-04 14:17:29'},\n",
       " {'title': '集采预测：多治疗领域药品或将被列入名单',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8427',\n",
       "  'date': '2024-09-04 10:20:33'},\n",
       " {'title': '既是API也是辅料！详解这款可能是处方组成最简单的外用制剂',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8426',\n",
       "  'date': '2024-09-04 09:50:00'},\n",
       " {'title': '2024盘点丨银屑病治疗新突破！生物制剂与小分子靶向药最新梳理',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8424',\n",
       "  'date': '2024-09-03 11:26:03'},\n",
       " {'title': '全球畅销孤儿药TOP10预测，两款国产药在榜！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8423',\n",
       "  'date': '2024-09-03 10:55:54'},\n",
       " {'title': '从复星凯特到传奇生物：中国CAR-T细胞治疗市场六强争霸，商业化前景展望',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8397',\n",
       "  'date': '2024-08-29 11:02:48'},\n",
       " {'title': '一文了解德曲妥珠单抗（DS-8201）：上市进展、适应症、价格、市场表现...',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8392',\n",
       "  'date': '2024-08-28 11:46:01'},\n",
       " {'title': '从2000到2024：FDA批准局部皮肤用凝胶剂25年大盘点',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8376',\n",
       "  'date': '2024-08-27 10:25:28'},\n",
       " {'title': '潜力黑马IDEAYA：TOP药企争相携手，独家获百奥赛图首创ADC项目全球许可权',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8360',\n",
       "  'date': '2024-08-23 10:36:36'},\n",
       " {'title': '中药创新热潮：政策与市场双轮驱动，经典名方制剂注册申请激增',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8354',\n",
       "  'date': '2024-08-22 11:50:43'},\n",
       " {'title': '浅析不同定量方法中积分方法的玄机妙设',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8347',\n",
       "  'date': '2024-08-22 10:34:24'},\n",
       " {'title': '2024盘点丨24款创新药获批上市！超40个品种优先审评，中药亮眼！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8345',\n",
       "  'date': '2024-08-21 16:28:34'},\n",
       " {'title': '制药人的健康警钟：揭秘行业背后的健康风险与应对措施',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8325',\n",
       "  'date': '2024-08-19 10:15:20'},\n",
       " {'title': '阿伐曲泊帕：国内首款治疗血小板减少症口服药物！慢性肝病患者福音！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8313',\n",
       "  'date': '2024-08-15 12:15:07'},\n",
       " {'title': '集采时代的悲歌，阳光下的仿制药',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8299',\n",
       "  'date': '2024-08-14 11:38:53'},\n",
       " {'title': '托莱西单抗：PCSK9抑制剂中的“国货之光”！心血管疾病治疗福音',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8281',\n",
       "  'date': '2024-08-09 11:44:15'},\n",
       " {'title': '鞍石生物科技：MET抑制剂伯瑞替尼快速供药，价格亲民助力肺癌治疗',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8277',\n",
       "  'date': '2024-08-09 10:35:36'},\n",
       " {'title': '反腐整风运动下医疗及药企产业变局分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8265',\n",
       "  'date': '2024-08-07 14:16:11'},\n",
       " {'title': '2024年医药整风运动对医院全面影响解析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8264',\n",
       "  'date': '2024-08-07 11:44:58'},\n",
       " {'title': '药品反垄断指南出炉：全领域覆盖，力促公平竞争新生态',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_8341',\n",
       "  'date': '2024-08-21 13:48:57'},\n",
       " {'title': '下月起执行！九大类耗材品种开始降价，平均降价83.46%……',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_8020',\n",
       "  'date': '2024-06-24 11:20:58'},\n",
       " {'title': '国家新规出台，全面彻查公立医院欠款问题！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7970',\n",
       "  'date': '2024-06-13 10:59:20'},\n",
       " {'title': '国家医保局最新指令，全国严查大型医疗设备！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7904',\n",
       "  'date': '2024-05-30 10:46:58'},\n",
       " {'title': '新政策！北京发文支持CGT药物等快速形成产业增量',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7885',\n",
       "  'date': '2024-05-27 12:04:09'},\n",
       " {'title': '注射剂用覆膜胶塞的缺陷与对策',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7567',\n",
       "  'date': '2024-02-28 12:00:00'},\n",
       " {'title': '重磅！第三批鼓励仿制药品目录出炉！39品种纳入，帕替司兰、伏环孢素等',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7395',\n",
       "  'date': '2023-12-26 15:00:00'},\n",
       " {'title': '福建第四批化药集采拟中选结果，间苯三酚降价92%！30+药企扎堆申报',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7345',\n",
       "  'date': '2023-12-13 12:00:00'},\n",
       " {'title': '国家药监局发文，GLP认证新《办法》7月1日执行！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6660',\n",
       "  'date': '2023-06-25 11:21:09'},\n",
       " {'title': '注射剂注意！《中国药典》通则（0102）注射剂修订！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6640',\n",
       "  'date': '2023-06-20 11:20:46'},\n",
       " {'title': '最新！CDE更新11条一般技术性问题！涉及审评审批、MAH变更等',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6618',\n",
       "  'date': '2023-06-15 11:38:20'},\n",
       " {'title': 'GLP-1必备SNAC！原辅料全产业链平台完整打造，天吉生物未来可期！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6612',\n",
       "  'date': '2023-06-14 11:26:16'},\n",
       " {'title': '重磅！医保目录调整方案公开征求意见！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6597',\n",
       "  'date': '2023-06-13 09:57:26'},\n",
       " {'title': '2023年中国科学院院士增选79名，药剂学方向优先！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6590',\n",
       "  'date': '2023-06-12 11:12:03'},\n",
       " {'title': 'CDE最新发布通知，公开征求GCP指导原则！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6506',\n",
       "  'date': '2023-05-30 10:35:14'},\n",
       " {'title': '鼓励研发！卫健委开出29个临床急需儿童用药，均未在国内上市！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6498',\n",
       "  'date': '2023-05-29 11:03:47'},\n",
       " {'title': '医美新势力！CMDE发布2项重磅指导原则，涉及重组胶原蛋白！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6497',\n",
       "  'date': '2023-05-29 11:00:19'},\n",
       " {'title': '重磅！《关于加强委托生产药品上市许可持有人监管工作的通知》公开征求意见！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6477',\n",
       "  'date': '2023-05-25 09:59:51'},\n",
       " {'title': 'CDE重磅！《关于无参比制剂品种仿制研究的公告（征求意见稿）》征求意见！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6476',\n",
       "  'date': '2023-05-25 09:52:47'},\n",
       " {'title': '重磅！全国中成药集采正式文件公布！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6453',\n",
       "  'date': '2023-05-22 11:50:22'},\n",
       " {'title': '2024年第34周08.26-09.01全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8447',\n",
       "  'date': '2024-09-06 11:03:33'},\n",
       " {'title': '2024年第34周08.26-09.01全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8446',\n",
       "  'date': '2024-09-06 10:55:52'},\n",
       " {'title': '2024年第34周08.26-09.01国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8445',\n",
       "  'date': '2024-09-06 10:45:08'},\n",
       " {'title': '2024年第34周08.26-09.01国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8444',\n",
       "  'date': '2024-09-06 10:34:44'},\n",
       " {'title': '2024年第34周08.26-09.01国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8443',\n",
       "  'date': '2024-09-06 10:18:19'},\n",
       " {'title': '2024年8月共有183个品种过评！齐鲁制药、汇宇制药、恒瑞医药三足鼎立…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8433',\n",
       "  'date': '2024-09-04 12:14:45'},\n",
       " {'title': '2024年第33周08.19-08.25全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8406',\n",
       "  'date': '2024-08-30 10:10:56'},\n",
       " {'title': '2024年第33周08.19-08.25全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8405',\n",
       "  'date': '2024-08-30 10:04:06'},\n",
       " {'title': '2024年第33周08.19-08.25国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8404',\n",
       "  'date': '2024-08-30 09:58:56'},\n",
       " {'title': '2024年第33周08.19-08.25国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8403',\n",
       "  'date': '2024-08-30 09:53:17'},\n",
       " {'title': '2024年第33周08.19-08.25国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8402',\n",
       "  'date': '2024-08-30 09:44:35'},\n",
       " {'title': '2024年第32周08.12-08.18全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8359',\n",
       "  'date': '2024-08-23 10:14:23'},\n",
       " {'title': '2024年第32周08.12-08.18全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8358',\n",
       "  'date': '2024-08-23 10:09:34'},\n",
       " {'title': '2024年第32周08.12-08.18国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8357',\n",
       "  'date': '2024-08-23 10:02:55'},\n",
       " {'title': '2024年第32周08.12-08.18国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8356',\n",
       "  'date': '2024-08-23 09:57:35'},\n",
       " {'title': '2024年第32周08.12-08.18国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8355',\n",
       "  'date': '2024-08-23 09:45:47'},\n",
       " {'title': '252个品种过评，首家过评品种增至38个！7月仿制药一致性评价及获批上市亮点频现',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8333',\n",
       "  'date': '2024-08-19 12:15:43'},\n",
       " {'title': '2024年7月140款新药获批临床！5款创新药获批上市，涉及信立泰、药华医药……',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8319',\n",
       "  'date': '2024-08-16 10:40:37'},\n",
       " {'title': '2024年第31周08.05-08.11全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8318',\n",
       "  'date': '2024-08-16 10:26:49'},\n",
       " {'title': '2024年第31周08.05-08.11全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8317',\n",
       "  'date': '2024-08-16 10:19:52'},\n",
       " {'title': '群贤共聚，论道医药！第五届CMC-China中国国际生物&化学制药博览会圆满结束！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6793',\n",
       "  'date': '2023-08-10 12:00:00'},\n",
       " {'title': '深耕代谢疾病：君圣泰递交IPO申请，海普瑞为大股东之一（附招股书）',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6611',\n",
       "  'date': '2023-06-14 11:13:41'},\n",
       " {'title': '千位药企掌门聚苏州！第四届中国API Summit开始报名！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6553',\n",
       "  'date': '2023-06-12 11:59:16'},\n",
       " {'title': '新环境下企业拓展OTC赛道新思路！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6568',\n",
       "  'date': '2023-06-08 10:45:14'},\n",
       " {'title': '10个一致性评价受理号获批！一品种集齐36家过评！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6559',\n",
       "  'date': '2023-06-07 10:00:19'},\n",
       " {'title': '制药人，不懂点合成生物学，就有点落后了！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6558',\n",
       "  'date': '2023-06-07 09:51:28'},\n",
       " {'title': '就在成都！沉浸式交流：小分子工艺开发和质量分析科学，一文速览议程！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6554',\n",
       "  'date': '2023-06-06 10:53:55'},\n",
       " {'title': '266亿！浅析黏膜给药制剂销售趋势及市场格局',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6544',\n",
       "  'date': '2023-06-05 11:51:14'},\n",
       " {'title': '报名开始！8月苏州，中国绿色制药技术大会',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6534',\n",
       "  'date': '2023-06-02 11:16:16'},\n",
       " {'title': '基因治疗，国内药企该如何布局并弯道超车？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6524',\n",
       "  'date': '2023-06-01 11:25:37'},\n",
       " {'title': '改良新药已开卷，企业的求生法则',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6502',\n",
       "  'date': '2023-05-29 11:55:20'},\n",
       " {'title': '溯源而上！这场大会，体现抗体、小分子、细胞基因疗法、核酸等差异化竞争与合作',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6461',\n",
       "  'date': '2023-05-23 11:30:36'},\n",
       " {'title': '就在这周五：相约泰州，纳米抗体新药论坛！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6441',\n",
       "  'date': '2023-05-19 10:28:41'},\n",
       " {'title': '倒计时3天！免报名费！来石家庄，听外用制剂、高端注射剂、改良新药与复杂制剂内容！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6369',\n",
       "  'date': '2023-05-09 10:51:08'},\n",
       " {'title': '药物工艺开发及质量控制要点峰会，6月14-15日，成都开幕！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6362',\n",
       "  'date': '2023-05-08 12:49:28'},\n",
       " {'title': '以药为融 | 万人圈友大聚会@第五届CMC-China制药博览会',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6351',\n",
       "  'date': '2023-05-06 10:56:59'},\n",
       " {'title': '院士领衔，专家齐聚，群贤毕至，待您加入！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6341',\n",
       "  'date': '2023-05-05 11:00:00'},\n",
       " {'title': '纳米抗体30周年：行业新生赛道的机遇与挑战',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6305',\n",
       "  'date': '2023-04-26 11:18:13'},\n",
       " {'title': '限时免费报名！石家庄MAH&DDS制剂合作大会，各路专家带你飞！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6242',\n",
       "  'date': '2023-04-18 11:23:08'},\n",
       " {'title': '下一站再聚 | 改良型新药趋势与合作交流大会圆满落幕',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6213',\n",
       "  'date': '2023-04-13 11:25:59'},\n",
       " {'title': '齐鲁制药再添利器！美罗培南普莱巴坦获临床试验许可，专攻复杂性腹腔感染',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8459',\n",
       "  'date': '2024-09-09 11:56:32'},\n",
       " {'title': '科伦博泰SKB571双抗ADC药物IND申请获NMPA受理，肿瘤治疗迎新突破',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8458',\n",
       "  'date': '2024-09-09 11:46:09'},\n",
       " {'title': '华润九新：头孢唑林钠水合物日本成功上市！质量卓越引领市场',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8457',\n",
       "  'date': '2024-09-09 11:28:58'},\n",
       " {'title': '百奥泰度普利尤单抗BAT2406获NMPA临床试验批准，助力特应性皮炎等疾病治疗',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8456',\n",
       "  'date': '2024-09-09 11:16:12'},\n",
       " {'title': '康方生物依沃西：全球首创PD-1/VEGF双抗，III期临床力压帕博利珠单抗！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8455',\n",
       "  'date': '2024-09-09 10:59:31'},\n",
       " {'title': '恒瑞医药SHR-1918注射液拟获突破性治疗认定，降脂新利器亮相ESC！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8454',\n",
       "  'date': '2024-09-09 10:51:50'},\n",
       " {'title': 'AI赋能药物革命：礼来与Genetic Leap合作开发RNA靶向疗法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8453',\n",
       "  'date': '2024-09-09 10:41:53'},\n",
       " {'title': '全球监管合作加速基因疗法普及：FDA专家展望五年蓝图',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8452',\n",
       "  'date': '2024-09-09 10:23:50'},\n",
       " {'title': '医疗耗材集采新动向：深圳15+12省联盟聚焦超声刀头与预充式导管冲洗器',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8451',\n",
       "  'date': '2024-09-09 10:02:16'},\n",
       " {'title': '人福医药创新药物HW071021片获批临床，抗肿瘤药市场再添利器',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8450',\n",
       "  'date': '2024-09-06 11:43:15'},\n",
       " {'title': '齐鲁制药：达肝素钠注射液通过一致性评价，领跑抗凝药市场！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8449',\n",
       "  'date': '2024-09-06 11:34:52'},\n",
       " {'title': '先声再明携手塔吉瑞，独揽TGRX-326抗肿瘤神药中国大陆商业化权益',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8448',\n",
       "  'date': '2024-09-06 11:20:50'},\n",
       " {'title': '60种药品主动降价！石家庄四药24亿+品种大降，神经系统药居首',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8442',\n",
       "  'date': '2024-09-05 11:55:51'},\n",
       " {'title': '神州细胞1类新药SCT520FF注射液获批临床！专攻湿性AMD视力危机',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8441',\n",
       "  'date': '2024-09-05 11:45:52'},\n",
       " {'title': '信达生物：IBI363双抗融合蛋白，黑色素瘤治疗获FDA快速通道',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8440',\n",
       "  'date': '2024-09-05 11:37:41'},\n",
       " {'title': '融资3.25亿美元！CAR-T新锐开发实体瘤可编程细胞疗法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8439',\n",
       "  'date': '2024-09-05 11:20:19'},\n",
       " {'title': 'BioAge Labs冲刺纳斯达克！肥胖治疗新星azelaprag引领IPO热潮',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8438',\n",
       "  'date': '2024-09-05 11:10:55'},\n",
       " {'title': '岸迈生物BCMA×CD3双抗成功出海，剑指全球自身免疫疾病市场',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8437',\n",
       "  'date': '2024-09-05 10:56:39'},\n",
       " {'title': '《柳叶刀》揭秘：司美格鲁肽显著降低心衰恶化风险31%！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8436',\n",
       "  'date': '2024-09-05 10:39:44'},\n",
       " {'title': '福元医药业绩连续多年双增，4亿+抗癫痫药丙戊酸钠缓释片(Ⅰ)斩获首家过评',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8432',\n",
       "  'date': '2024-09-04 12:03:17'},\n",
       " {'title': '国际疾病分类编码在线查询（ICD-10&ICD-11）',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8168',\n",
       "  'date': '2024-07-22 09:00:42'},\n",
       " {'title': '5万+全国各省市中药饮片炮制规范-在线免费查询啦！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8142',\n",
       "  'date': '2024-07-15 18:39:56'},\n",
       " {'title': '2020《中国药典》电子版官网在线查询入口|中国药典检索🔍',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8097',\n",
       "  'date': '2024-07-10 10:12:38'},\n",
       " {'title': '【调研必看】中国慢性疾病统计数据查询方法-28个权威网站',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8081',\n",
       "  'date': '2024-07-04 06:24:02'},\n",
       " {'title': '分享两种印度仿制药品信息查询方法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8063',\n",
       "  'date': '2024-07-01 09:09:19'},\n",
       " {'title': '国谈药品是什么意思？与集采药品有什么区别？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8053',\n",
       "  'date': '2024-06-26 16:31:58'},\n",
       " {'title': '<一文看懂>保健食品备案和注册的区别',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7981',\n",
       "  'date': '2024-06-13 08:43:16'},\n",
       " {'title': '特殊医学用途配方食品有哪些?如何查询？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7982',\n",
       "  'date': '2024-06-12 00:00:00'},\n",
       " {'title': '保健食品注册信息在线查询平台',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7946',\n",
       "  'date': '2024-06-03 20:34:51'},\n",
       " {'title': '原研药-创新药-全球药品研发进度在线查询平台',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7930',\n",
       "  'date': '2024-06-01 19:19:09'},\n",
       " {'title': 'ICH指导原则中英文版下载',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7912',\n",
       "  'date': '2024-05-30 09:36:58'},\n",
       " {'title': '全国快速预审通道发明专利1-6个月授权',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7840',\n",
       "  'date': '2024-05-14 10:17:29'},\n",
       " {'title': '我国药品定价政策及所需考虑的市场因素',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7831',\n",
       "  'date': '2024-05-10 11:09:39'},\n",
       " {'title': '中药保护品种：官网目录信息收载数据4000+',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7838',\n",
       "  'date': '2024-05-10 10:00:00'},\n",
       " {'title': '化学药品注册分类标准及申报资料要求(新版原文)',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7784',\n",
       "  'date': '2024-04-26 11:01:57'},\n",
       " {'title': '请查收！《中药注册分类及申报材料要求》',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7791',\n",
       "  'date': '2024-04-25 19:03:14'},\n",
       " {'title': '中医诊疗方案数据库:收载历史多版本400多个治疗方案',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7741',\n",
       "  'date': '2024-04-17 11:07:52'},\n",
       " {'title': '中医临床诊疗术语一览表(收载官网全部术语4705个)',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7735',\n",
       "  'date': '2024-04-16 12:00:00'},\n",
       " {'title': '法国药品数据库-药品查询方法详细讲解<实操案列>',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7628',\n",
       "  'date': '2024-03-14 09:00:43'},\n",
       " {'title': 'Sumitomo Pharma日本百年Top10药企简史——住友制药',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7606',\n",
       "  'date': '2024-03-07 09:25:33'}]"
      ]
     },
     "execution_count": 1022,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "db641522-6823-457c-a703-1b35fd071f5d",
   "metadata": {},
   "source": [
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f80bd62b-b271-437a-b610-259a36f5edc7",
   "metadata": {},
   "source": [
    "# https://bydrug.pharmcube.com/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1026,
   "id": "abc1cc1c-74ed-4d3c-8a4c-ebaf5fe7320f",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get('https://bydrug.pharmcube.com/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1028,
   "id": "4f842457-9616-4896-8109-28e284f0dfd8",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup = BeautifulSoup(r.text, 'html.parser')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1030,
   "id": "7f7e8b1e-40d6-4d59-b87f-a14eef75069b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<!DOCTYPE html>\n",
       "\n",
       "<html data-n-head=\"%7B%22lang%22:%7B%22ssr%22:%22zh%22%7D%7D\" data-n-head-ssr=\"\" lang=\"zh\">\n",
       "<head>\n",
       "<meta charset=\"utf-8\" data-n-head=\"ssr\"/><meta content=\"width=device-width, initial-scale=1.0, minimum-scale=1, maximum-scale=1, user-scalable=no\" data-n-head=\"ssr\" name=\"viewport\"/><meta content=\"telephone=no\" data-n-head=\"ssr\" name=\"format-detection\"/><meta content=\"codeva-eL5dxvvOkL\" data-n-head=\"ssr\" name=\"baidu-site-verification\"/><meta content=\"strict-origin-when-cross-origin\" data-n-head=\"ssr\" name=\"referrer\"/><meta content=\"研究报告，医药魔方独家研究报告，海外研究报告，药企演讲ppt，药企财报，招股书，招股说明书，CDE培训咨询会议，FDA咨询会议，医药行业会议，药品获批新闻，医药新闻，医药魔方深度分析，热点研究，中国医疗器械，医疗器械上市数据，医疗器械注册数据，医疗器械注册审批信息，获批新药，license out，国家集采中标，医保谈判结果，ByDrug，掰药\" data-n-head=\"ssr\" name=\"keywords\"/><meta content=\"ByDrug掰药是一个专业的、覆盖医药行业药械相关信息资源和媒体资讯服务的共享中心。聚焦于药物和器械研发信息，面向医药行业从业人员提供医药行业优质研究报告、新闻报道、医药类专利和中国及海外医疗器械数据等。\" data-hid=\"description\" data-n-head=\"ssr\" name=\"description\"/><title>ByDrug-一站式医药资源共享中心-医药魔方</title><link data-n-head=\"ssr\" href=\"https://vcdn.pharmcube.com/1672301164623_logo-2.svg\" rel=\"icon\" type=\"image/x-icon\"/><script data-n-head=\"ssr\" src=\"https://hm.baidu.com/hm.js?aedff73bc4f02be835e11695a0b2066e\"></script><script data-n-head=\"ssr\" src=\"https://cdn.beschannels.com/js-sdk/collect-0.0.5.min.js\"></script><link as=\"script\" href=\"/_nuxt/906d100.js\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/b325f63.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/27bf4da.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/21c0bce.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/5c39864.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/0ffb51c.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/af88994.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/bc02015.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/c0b72af.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/adf5c0e.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/9fee54f.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/899bd2d.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/d26a049.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/d766ac1.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/64c1edb.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/f5958aa.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/5528309.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/0e8d870.js\" rel=\"preload\"/><link href=\"/_nuxt/css/27bf4da.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/5c39864.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/af88994.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/c0b72af.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/9fee54f.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/d26a049.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/64c1edb.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/5528309.css\" rel=\"stylesheet\"/>\n",
       "</head>\n",
       "<body>\n",
       "<div data-server-rendered=\"true\" id=\"__nuxt\"><!-- --><div id=\"__layout\"><div class=\"nuxt-layout\"><img alt=\"\" src=\"https://vcdn.pharmcube.com/1672301164623_logo-2.svg\" style=\"width:64px;height:64px;visibility:hidden;position:fixed;\"/> <div class=\"cube-layout\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"cube-layout__nav web\" data-v-5c8b65e4=\"\"><div class=\"cube-nav\" data-v-3b232041=\"\" data-v-5c8b65e4=\"\" style=\"z-index:900;\"><div class=\"mf-gw-container mf-flex mf-justify-between mf-items-center\" data-v-3b232041=\"\"><a class=\"mf-flex mf-items-center\" data-v-3b232041=\"\" href=\"https://www.pharmcube.com\"><i class=\"iconfont icon-left\" data-v-3b232041=\"\"></i> <span data-v-3b232041=\"\">返回医药魔方首页</span></a> <a data-v-3b232041=\"\" href=\"https://www.pharmcube.com/product/about/index\" target=\"_blank\">关于医药魔方</a></div> <div class=\"cube-nav-inner cube-nav-inner__showdow\" data-v-3b232041=\"\"><div class=\"logo\" data-v-3b232041=\"\"><a data-v-3b232041=\"\" href=\"https://www.pharmcube.com\"><img alt=\"\" class=\"mofang\" data-v-3b232041=\"\" src=\"https://vcdn.pharmcube.com/drawbed/1710833114943_mofang.svg\"/></a> <div class=\"divider\" data-v-3b232041=\"\"></div> <a data-v-3b232041=\"\" href=\"/\"><img alt=\"\" class=\"bydrug\" data-v-3b232041=\"\" src=\"https://vcdn.pharmcube.com/drawbed/1710833114942_drug.svg\"/></a></div> <div class=\"menu\" data-v-3b232041=\"\"><ul class=\"cube-nav-menu\" data-v-3b232041=\"\" data-v-c534db4c=\"\"><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(0,146,188);--color-hover:rgb(0,146,188);\"><span class=\"menu-item menu-item--active\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(0,146,188);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">首页</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/report\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药报告</span> <!-- --> <!-- --></span></a> <span class=\"icon-arrow\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);\"><svg class=\"cube-slot-nav__nav-menu__svg\" data-v-c534db4c=\"\" height=\"16\" viewbox=\"0 0 1024 1024\" width=\"16\"><path d=\"M792.137143 338.139429a36.571429 36.571429 0 0 0-51.565714 3.584L513.462857 603.062857 283.282286 341.577143a36.425143 36.425143 0 1 0-54.784 48.201143L485.668571 683.300571l0.438858 0.292572a36.132571 36.132571 0 0 0 26.331428 11.264l0.512-0.146286 0.585143 0.146286a36.352 36.352 0 0 0 13.897143-2.925714 65.389714 65.389714 0 0 0 10.24-6.217143 36.571429 36.571429 0 0 0 3.364571-3.364572l254.537143-292.717714a36.571429 36.571429 0 0 0-3.510857-51.492571\" fill=\"currentColor\"></path></svg></span> <!-- --></span> <ul class=\"sub-menus\" data-v-c534db4c=\"\"><li data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/report\" style=\"width:100%;\"><span data-v-c534db4c=\"\">研究报告</span> <!-- --> <!-- --></a></li><li data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/report-device\" style=\"width:100%;\"><span data-v-c534db4c=\"\">医疗器械</span> <!-- --> <!-- --></a></li><li data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/chart\" style=\"width:100%;\"><span data-v-c534db4c=\"\">图表数据</span> <!-- --> <!-- --></a></li></ul></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/news\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药新闻</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/topic\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药专题</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">数据查询</span> <!-- --> <!-- --></span></a> <!-- --> <span class=\"icon-arrow icon-no-rotate\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);\"><svg class=\"cube-slot-nav__nav-menu__svg\" data-v-c534db4c=\"\" height=\"16\" viewbox=\"0 0 1024 1024\" width=\"16\"><path d=\"M792.137143 338.139429a36.571429 36.571429 0 0 0-51.565714 3.584L513.462857 603.062857 283.282286 341.577143a36.425143 36.425143 0 1 0-54.784 48.201143L485.668571 683.300571l0.438858 0.292572a36.132571 36.132571 0 0 0 26.331428 11.264l0.512-0.146286 0.585143 0.146286a36.352 36.352 0 0 0 13.897143-2.925714 65.389714 65.389714 0 0 0 10.24-6.217143 36.571429 36.571429 0 0 0 3.364571-3.364572l254.537143-292.717714a36.571429 36.571429 0 0 0-3.510857-51.492571\" fill=\"currentColor\"></path></svg></span></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://go.pharmcube.com/medical_policy\" target=\"_blank\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药政策</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li> <div class=\"databox-popover mf-flex mf-pl-200px\" data-v-c534db4c=\"\" style=\"display:none;\"><div data-v-c534db4c=\"\" style=\"width: 1200px; margin: 0 auto\"><div class=\"ant-row\" data-v-c534db4c=\"\"><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">药物研发</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/freePat\">医药专利</a></li></ul></div></div><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">中国器械</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceCNImported\">中国大陆上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceCNEvaluation\">中国大陆审评</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceHK\">中国香港上市</a></li></ul></div></div><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">全球器械</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceUS\">美国上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceJP\">日本上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceUK\">英国上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceSG\">新加坡上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/devicePT\">葡萄牙上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceRO\">罗马尼亚上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceSA\">沙特上市</a></li></ul></div></div><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">专题数据</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectNewdrug\">全球获批新药</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectLicenseout\">License out</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectVbp\">国家集采结果</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectHealthcare\">医保谈判结果</a></li></ul></div></div></div></div></div></ul></div> <div class=\"right\" data-v-3b232041=\"\" style=\"color:rgb(52,55,56);\"> <!-- --> <div class=\"lang-text importantHover\" data-v-3b232041=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);display:none;\"><svg class=\"cube-slot-nav__nav-menu__svg\" data-v-3b232041=\"\" height=\"24\" version=\"1.1\" viewbox=\"0 0 1024 1024\" width=\"24\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M512 85.333333c235.648 0 426.666667 191.018667 426.666667 426.666667s-191.018667 426.666667-426.666667 426.666667S85.333333 747.648 85.333333 512 276.352 85.333333 512 85.333333z m0 42.666667a384 384 0 1 0 0 768 384 384 0 0 0 0-768z\" fill=\"currentColor\" p-id=\"4923\"></path> <path d=\"M469.333333 349.866667a25.6 25.6 0 1 1 0 51.2H332.757333v85.333333H469.333333a25.6 25.6 0 1 1 0 51.2H332.757333v85.333333H469.333333a25.6 25.6 0 0 1 0 51.2H307.2a25.6 25.6 0 0 1-25.6-25.6l0.085333-2.133333a25.941333 25.941333 0 0 1-0.085333-2.133333V375.466667a25.6 25.6 0 0 1 25.6-25.6H469.333333z m247.466667 0a25.6 25.6 0 0 1 25.6 25.6v273.066666a25.6 25.6 0 0 1-51.114667 1.877334l-0.085333 0.128-85.333333-171.690667V648.533333a25.6 25.6 0 0 1-51.2 0V375.466667a25.6 25.6 0 0 1 51.029333-2.944l0.170667-0.085334 85.290666 161.621334L691.2 375.466667a25.6 25.6 0 0 1 25.6-25.6z\" fill=\"currentColor\" p-id=\"4924\"></path></svg></div> <!-- --> <div data-v-3b232041=\"\"><span class=\"exit-text mf-relative\" data-v-3b232041=\"\">登录</span> <!-- --></div></div></div></div></div> <div class=\"cube-layout__nav h5\" data-v-5c8b65e4=\"\"><div class=\"h5-header mf-flex mf-items-center mf-justify-between\" data-v-5c8b65e4=\"\"><a data-v-5c8b65e4=\"\" href=\"https://pharmcube.com\"><i class=\"iconfont icon-logo-dantuxing\" data-v-5c8b65e4=\"\" style=\"color: #0092bc; font-size: 24px\"></i></a> <div class=\"title\" data-v-5c8b65e4=\"\">医药魔方ByDrug</div> <div class=\"mf-flex mf-items-center\" data-v-5c8b65e4=\"\"><i class=\"iconfont icon-menu\" data-v-5c8b65e4=\"\" style=\"color: #0092bc; font-size: 24px\"></i> <!-- --></div></div></div> <div class=\"cube-layout__content mf-relative\" data-v-5c8b65e4=\"\"><div class=\"nuxt-content-container\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"overflow-x:hidden;padding-top:36px;\"><div class=\"top-banner mf-relative mf-h-514px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"width:100vw;\"><div class=\"coverbg\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></div> <div class=\"home-center-layout mf-pt-24px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div class=\"bg\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></div> <div class=\"top-mfreport-container ant-row\" data-v-65ceef8e=\"\"><div class=\"ant-col ant-col-12 ant-col-xs-24 ant-col-md-24 ant-col-lg-12 ant-col-xl-12\" data-v-65ceef8e=\"\"><div class=\"title-container\" data-v-65ceef8e=\"\"><div class=\"mfreport-tags\" data-v-65ceef8e=\"\" style=\"margin-top:38px;height:26px;\"><!-- --></div> <h1 class=\"mfreport-fileName mf-line-clamp-3 mf-mt-16px\" data-v-65ceef8e=\"\">\n",
       "                DeepMed临床指南-2024非小细胞肺癌临床指南洞察报告\n",
       "              </h1> <button class=\"mfreport-btn ant-btn ant-btn-primary\" data-v-65ceef8e=\"\" type=\"button\"><span>立即查看</span></button></div></div> <div class=\"ant-col ant-col-12 ant-col-xs-24 ant-col-md-24 ant-col-lg-12 ant-col-xl-12\" data-v-65ceef8e=\"\"></div></div> <div class=\"hot-reports-layout hot-reports-container mf-flex mf-items-center mf-justify-start\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"left mf-w-120px mf-flex mf-items-center mf-justify-center mofangtuijian\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><img alt=\"魔方推荐报告\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683868574791_形状结合@2x.png\" style=\"width:64px;height:70px;\"/></div> <div class=\"right reports-swiper mf-relative\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"indicator\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><span class=\"active\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span> <span data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span></div> <div class=\"round left disable\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-left\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"round right\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"reports-container ant-row\" data-v-65ceef8e=\"\" style=\"overflow:hidden;width:1080px;padding:0px 20px;\"><div class=\"mf-w-2080px slider\" data-v-65ceef8e=\"\"><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        新药研发\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/fc2e735bb74d477cb5e50b6fb44df2ce\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        中国新药月报-第24期-2024年7月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">PharmaGO</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-08-15</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        医药交易\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/f291fe66050346c08ae3d0d0ca71e15c\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        全球医药交易月报-2024年7月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-08-14</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        新药研发\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/9ce903ee817040e799110394eabcf239\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        全球新药研发进展月报-第40期-2024年7月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-08-12</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        医药交易\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/7ff2d59d38944fddb6a23418fc42ca2b\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        2024年H1 中国医药交易分析报告\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-07-18</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        专利洞察\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/2bba9764b5ad464aabf8c186e6fe09f7\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        专利调研报告——PARP抑制剂尼拉帕利（Niraparib）\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPat</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-07-17</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        医药交易\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/33b2d49875604b24b23eca62681ee9bd\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        全球医药交易月报-2024年6月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-07-16</span></div></div></div></div></div></div></div></div></div> <div class=\"home-center-layout mf-mt-26px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div class=\"mf-flex flex-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"left-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"report-container mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title-container mf-flex mf-items-end\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h2 data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"z-index:2;position:relative;\">研究报告</h2> <img alt=\"\" class=\"shape\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683869649817_形状结合@2x (1).png\"/></div> <div class=\"app-underline-switcher mf-ml-32px\" data-v-12f9d2f3=\"\" data-v-65ceef8e=\"\"><ul class=\"tabs\" data-v-12f9d2f3=\"\"><li class=\"tab active\" data-v-12f9d2f3=\"\">\n",
       "      最新\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li><li class=\"tab mf-ml-12px\" data-v-12f9d2f3=\"\">\n",
       "      药企PPT\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li><li class=\"tab mf-ml-12px\" data-v-12f9d2f3=\"\">\n",
       "      财报/招股书\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li></ul></div> <a class=\"lg-more alink mf-flex mf-items-center\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report\" target=\"_blank\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">更多</div> <i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></a></div> <div class=\"ant-spin-nested-loading\" data-v-65ceef8e=\"\"><div class=\"ant-spin-container\"><div class=\"reportCommon-container\" data-v-65ceef8e=\"\"><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/bbd1d34c596d4ece9403a1b1e3c3ff0a\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：武田1类创新药拟纳入突破性治疗品种\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%A4%AA%E5%B9%B3%E6%B4%8B\" target=\"_blank\">太平洋</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">0.36M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">3页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/99938f6dd0c34db385840a0b00ac0834\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：创新催化、政策鼓励支持，医药基本面持续向上复苏\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E6%B0%91%E7%94%9F%E8%AF%81%E5%88%B8\" target=\"_blank\">民生证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.13M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">20页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/61a06f9a125c4882a461c9c5975432ec\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：安进1类新药在华再获批临床\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%A4%AA%E5%B9%B3%E6%B4%8B\" target=\"_blank\">太平洋</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">0.37M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">3页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/ad8d10f28c934acd9a3c87c460cbfe18\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          WCLC 2024 摘要集\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/WCLC\" target=\"_blank\">WCLC</a></span><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/WCLC%202024\" target=\"_blank\">WCLC 2024</a></span></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/WCLC\" target=\"_blank\">WCLC</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">35.68M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">1627页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/95d65b44db8d475f8006495485005d37\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          新药周观点：Biotech 2024中报总结，商业化放量步入正轨、亏损持续改善\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%9B%BD%E6%8A%95%E8%AF%81%E5%88%B8\" target=\"_blank\">国投证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">0.93M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">15页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/1b0c24e8a9444dadaa37ee7793d5724c\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药魔方核心行业数据监测周报-09月09日\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/%E9%AD%94%E6%96%B9%E5%91%A8%E6%8A%A5\" target=\"_blank\">魔方周报</a></span></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\">医药魔方</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">3.36M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">23页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/3bb9f1c2c9484d07aca443c140648feb\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：Pharma创新成果显著，迈入商业化收获阶段\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8D%8E%E6%BA%90%E8%AF%81%E5%88%B8\" target=\"_blank\">华源证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.39M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">14页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/b65b7f0a0ed5475483fb2ef38048fc03\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药生物行业周报：中药及商业板块整体略显承压，部分个股表现亮眼\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%BC%80%E6%BA%90%E8%AF%81%E5%88%B8\" target=\"_blank\">开源证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.46M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">12页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/356e990eb32e484196e5ff9fd1dc6ab0\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药生物：关注ODAC，PD1双抗或将改变晚期胃癌免疫治疗认识\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8D%8E%E7%A6%8F%E8%AF%81%E5%88%B8\" target=\"_blank\">华福证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.93M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">15页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/05f71a4840604c3baa6d7c259e96e48a\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药魔方核心行业数据监测周报EN-09月09日\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/%E9%AD%94%E6%96%B9%E5%91%A8%E6%8A%A5\" target=\"_blank\">魔方周报</a></span></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\">医药魔方</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2.54M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">33页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:0;width:calc(100% - 32px);\"></div></div></div> <!-- --></div></div></div></div></div> <div class=\"right-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"box mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container zmjg\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">知名机构</h3> <i class=\"icon iconfont icon-zhimingjigou\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ant-row\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" style=\"white-space:nowrap;\" target=\"_blank\">医药魔方</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%A5%BF%E5%8D%97%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">西南证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%9B%BD%E9%87%91%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">国金证券</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E6%B5%99%E5%95%86%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">浙商证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%8D%8E%E5%AE%89%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">华安证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%AE%89%E4%BF%A1%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">安信证券</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E6%B9%98%E8%B4%A2%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">湘财证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E4%B8%9C%E5%90%B4%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">东吴证券</a></div></div></div></div> <div class=\"box mf-bg-white mf-rounded-8px mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container hyhy\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">行业会议</h3> <i class=\"icon iconfont icon-hangyehuiyi1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ant-row\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/ESMO\" style=\"white-space:nowrap;\" target=\"_blank\">ESMO</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/ASCO\" style=\"white-space:nowrap;\" target=\"_blank\">ASCO</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/AACR\" style=\"white-space:nowrap;\" target=\"_blank\">AACR</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/CSCO\" style=\"white-space:nowrap;\" target=\"_blank\">CSCO</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/SABCS\" style=\"white-space:nowrap;\" target=\"_blank\">SABCS</a></div></div></div></div> <div class=\"box mf-bg-white mf-rounded-8px mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container rmgs\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">热门公司</h3> <i class=\"icon iconfont icon-remengongsi1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ant-row\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E7%BD%97%E6%B0%8F\" style=\"white-space:nowrap;\" target=\"_blank\">罗氏</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%AF%BA%E5%8D%8E\" style=\"white-space:nowrap;\" target=\"_blank\">诺华</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%BE%89%E7%91%9E\" style=\"white-space:nowrap;\" target=\"_blank\">辉瑞</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E9%BB%98%E6%B2%99%E4%B8%9C\" style=\"white-space:nowrap;\" target=\"_blank\">默沙东</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E9%98%BF%E6%96%AF%E5%88%A9%E5%BA%B7\" style=\"white-space:nowrap;\" target=\"_blank\">阿斯利康</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%BC%BA%E7%94%9F\" style=\"white-space:nowrap;\" target=\"_blank\">强生</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%B5%9B%E8%AF%BA%E8%8F%B2\" style=\"white-space:nowrap;\" target=\"_blank\">赛诺菲</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/BMS\" style=\"white-space:nowrap;\" target=\"_blank\">BMS</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/GSK\" style=\"white-space:nowrap;\" target=\"_blank\">GSK</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%90%89%E5%88%A9%E5%BE%B7\" style=\"white-space:nowrap;\" target=\"_blank\">吉利德</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E7%A4%BC%E6%9D%A5\" style=\"white-space:nowrap;\" target=\"_blank\">礼来</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E7%99%BE%E6%B5%8E%E7%A5%9E%E5%B7%9E\" style=\"white-space:nowrap;\" target=\"_blank\">百济神州</a></div></div></div></div> <div class=\"box mf-bg-white mf-rounded-8px mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container xzph mf-flex mf-items-center mf-justify-between\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">热门报告</h3> <i class=\"icon iconfont icon-xiazaipaihangbang\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i> <div class=\"app-tab-switcher mf- mf-mr-8px\" data-v-65ceef8e=\"\" data-v-874a1162=\"\" style=\"z-index:2;\"><div class=\"mf-flex mf-justify-start\" data-v-874a1162=\"\"><div class=\"mf-flex mf-justify-start mf-items-center mf-cursor-pointer tab active\" data-v-874a1162=\"\"><span data-v-874a1162=\"\">周榜</span></div><div class=\"mf-flex mf-justify-start mf-items-center mf-cursor-pointer tab mf-ml-8px\" data-v-874a1162=\"\"><span data-v-874a1162=\"\">月榜</span></div></div></div></div> <div class=\"mf-pt-8px mf-pb-20px ant-spin-nested-loading\" data-v-65ceef8e=\"\" style=\"padding-top:8px;\"><div class=\"ant-spin-container\"><div class=\"rankingList-container\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center mf-justify-between item-ranking mf-px-16px mf-pl-20px\" data-v-65ceef8e=\"\" style=\"position:relative;line-height:20px;\"><div class=\"left mf-flex mf-items-center mf-justify-start\" data-v-65ceef8e=\"\"><div class=\"rank-index\" data-v-65ceef8e=\"\" style=\"color:#999999;font-size:12px;position:relative;left:-3px;\">\n",
       "                      排行\n",
       "                    </div> <div data-v-65ceef8e=\"\" style=\"color:#999999;font-size:12px;margin-left:4px;\">\n",
       "                      名称\n",
       "                    </div></div> <div data-v-65ceef8e=\"\" style=\"color:#999999;font-size:12px;\">热度</div></div> <div class=\"empty-container mf-flex mf-justify-center mf-items-center\" data-v-65ceef8e=\"\" style=\"padding:16px;\"><div class=\"ui-empty mf-text-center small\" data-v-65ceef8e=\"\"><div class=\"mf-text-center\"><img alt=\"\" src=\"https://vcdn.pharmcube.com/1684832692952_空数据.png\"/></div> <div class=\"text cover-text\">\n",
       "    暂无数据\n",
       "  </div></div></div></div></div></div></div></div></div></div> <div class=\"home-center-layout mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div class=\"news-container mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title-container mf-flex mf-items-end\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h2 data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"z-index:2;position:relative;\">医药专题</h2> <img alt=\"\" class=\"shape\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683869649817_形状结合@2x (1).png\"/></div> <a class=\"lg-more alink mf-flex mf-items-center\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/topic\" target=\"_blank\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">更多</div> <i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></a></div> <div class=\"topic-reports-container mf-relative\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"indicator\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><span class=\"active\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span><span data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span></div> <div class=\"round left disable\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-left\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"round right\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"overflow:hidden;width:1200px;\"><div class=\"mf-flex mf-justify-start slider\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"width:2249px;transform:translateX(8.5px);transition:transform 0.5s ease-in-out;\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/d07e7e8477de48b68c9db80f6817fe0e\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">医保支付方式（DRG/DIP）改革培训资料</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/054e1039a58b478fa0230794ffb2acc7\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">WCLC 2024 研究报告及临床研究资讯合集</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/a9d9db0e79ad458380ed9a66e048be7d\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-ICH Q2(R2)/Q14指导原则</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/1bba492189144db9a987c26527d37636\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-抗肿瘤药物技术审评常见问题</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/88905fb06453440e956af3b2914897bf\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024年热门医药企业半年报合集</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/22e95bbdbf364f678820d43e47159c4a\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-药物临床研究基本考虑、试验设计</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/9c2b1ffe196c44a4bc62f5a9c78d819c\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年35份医药行业 IPO 招股书汇总</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/dbc58be8a1af43a185235777f7d59814\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年50份医药行业精选报告汇总</div></a></div></div></div></div> <div class=\"topic-reports-h5-container\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/d07e7e8477de48b68c9db80f6817fe0e\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">医保支付方式（DRG/DIP）改革培训资料</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/054e1039a58b478fa0230794ffb2acc7\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">WCLC 2024 研究报告及临床研究资讯合集</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/a9d9db0e79ad458380ed9a66e048be7d\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-ICH Q2(R2)/Q14指导原则</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/1bba492189144db9a987c26527d37636\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-抗肿瘤药物技术审评常见问题</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/88905fb06453440e956af3b2914897bf\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024年热门医药企业半年报合集</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/22e95bbdbf364f678820d43e47159c4a\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-药物临床研究基本考虑、试验设计</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/9c2b1ffe196c44a4bc62f5a9c78d819c\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年35份医药行业 IPO 招股书汇总</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/dbc58be8a1af43a185235777f7d59814\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年50份医药行业精选报告汇总</div></a></div></div></div></div> <div class=\"home-center-layout mf-mt-20px mf-mb-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" id=\"news\" style=\"position:relative;top:-92px;\"></div> <div class=\"mf-flex flex-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"left-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"news-container mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title-container mf-flex mf-items-end\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h2 data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"z-index:2;position:relative;\">医药新闻</h2> <img alt=\"\" class=\"shape\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683869649817_形状结合@2x (1).png\"/></div> <div class=\"app-underline-switcher mf-ml-32px\" data-v-12f9d2f3=\"\" data-v-65ceef8e=\"\"><ul class=\"tabs\" data-v-12f9d2f3=\"\"><li class=\"tab active\" data-v-12f9d2f3=\"\">\n",
       "      魔方原创\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li><li class=\"tab mf-ml-12px\" data-v-12f9d2f3=\"\">\n",
       "      1w+阅读\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li></ul></div> <a class=\"lg-more alink mf-flex mf-items-center\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?tab=%E9%AD%94%E6%96%B9%E5%8E%9F%E5%88%9B\" target=\"_blank\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">更多</div> <i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></a></div> <div class=\"ant-spin-nested-loading\" data-v-65ceef8e=\"\"><div class=\"ant-spin-container\"><div class=\"reportCommon-container\" data-v-65ceef8e=\"\"><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/51841ff780bf7f422270e48ea7213332\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">融资建厂锐减超6成！创新药过剩产能加速出清</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">过去一年，尤其是2024年初产业里出现的一些变动，让业内感觉国产创新药正在出清，且有所加速了。 一方面，国内Biotech出现了破产清算的案例，随之而来的还有各类重组；另一方面， 具体到产品管线和产能建设上，来自CDE和医药魔方的数据显示，自2021年开始都出现了数量下滑趋势 。 产业出清：从管线到公司。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Invest\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/21e09891ba976e69ffc0613a5e5e9eed.png\"/></div>\n",
       "\n",
       "          医药魔方Invest\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">7小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/d7f14a9a1ea214c54c0b90a81d976002\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>华泰创新药技术研究院</span></a></span></span></div> <!-- --></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/c478b5698fcf7306423ef70059f962aa\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">全球首个！依沃西单抗挑战K药III期研究取得积极结果</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">9月8日，康方生物在2024世界肺癌大会（WCLC）上发布了PD-1/VEGF双抗依沃西单抗单药对比帕博利珠单抗（K药）单药一线治疗PD-L1表达阳性（PD-L1 TPS≥1%）的局部晚期或转移性非小细胞肺癌（NSCLC）的注册性III期临床研究（HARMONi-2/AK112-303）的重磅研究数据。 该 研究试验组与对照组入组人群基线均衡，其中 PD-L1 TPS≥50%患者的占比为42.2%，与真实世界人群分布一致。 结果显示，在意向治疗人群（ITT）中，依沃西单抗单药相较于K药单药显著延长了患者的无进展生存期（PFS），显著降低了患者的疾病进展或死亡风险（11.14 vs. 5.82个月，HR=0.51，P&lt;0.0001）。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">7小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <div class=\"similar\" data-v-12a4774d=\"\">\n",
       "      1篇相似报道\n",
       "    </div></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/46775102224fc8bc48665c8f6b400f00\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>依沃西单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/d0c46969a188e3d57621570bf3570ec3\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">联合用药能否出爆款？从贝伐珠单抗说起</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">一个略冷的知识：公认的明星重磅炸弹药物贝伐珠单抗（anti-VEGF单抗），获批的适应症绝大多数都是联合用药，而并非广泛认为的单药。 根据医药魔方NextPharma®数据库，贝伐珠单抗自2004年首次以联用FOLFIR治疗结直肠癌获批在美国上市后，近20年间全球市场（美、欧、日、中）共获批9大癌种47项适应症。 还真未必，至少还有两款明星重磅炸弹也是联合用药的适应症作为主导。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">7小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/7deca95e5f8930c89e46a68331c88ead\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>贝伐珠单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/141fe4725cbb14c02162c103b03a0967\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">科伦博泰Trop2 ADC芦康沙妥珠单抗宫颈癌临床数据亮相ESMO 2024！ADC+肿瘤免疫有望重新定义宫颈癌治疗标准</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">2024年欧洲肿瘤内科学会（ESMO）年会将于2024年9月13日至17日在西班牙巴塞罗那举行，科伦博泰生物（6990.HK）TROP2 ADC芦康沙妥珠单抗（sac-TMT）联合帕博利珠单抗（可瑞达®）用于复发或转移性宫颈癌（CC）患者的疗效及安全性数据摘要已在ESMO官网披露。 宫颈癌发病率居全球妇科三大恶性肿瘤之首，是导致女性癌症死亡的第四大原因。 据世界卫生组织（WHO）统计，2022年全球女性宫颈癌新发病例约66.2万例，占所有肿瘤的3.3%，位居第八，死亡人数约34.9万例，占所有肿瘤的3.6%，位居第九 。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">7小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <div class=\"similar\" data-v-12a4774d=\"\">\n",
       "      1篇相似报道\n",
       "    </div></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/9f44ad9e386cd6d9206802b5bbdc9961\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>科伦博泰生物</span></a></span></span></div> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/cf3f7121a8d0d5fbd82e427640170cd2\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>帕博利珠单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/fe7f731d6e5fa8e2fcce51db150fc4ea\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">信永中和被书面警示，涉及赛克赛斯IPO项目</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">近日，深交所发出一份《关于对信永中和会计师事务所（特殊普通合伙）、毕强、燕进的监管函》。 招股说明书（申报稿）显示，发行人聘请CSO推广服务商开展调研与咨询、学术推广、展览与宣传及会议会务等推 广活动，2020-2022年各期业务推广费分别为12,933.78万元、20,426.98万元、17,409.30万元，占营业收入比例分别为44.62%、46.72%、39.95%。 中国证监会现场检查发现，发行人业务推广相关内部控制存在薄弱环节，部分推广活动验收存在瑕疵。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Invest\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/21e09891ba976e69ffc0613a5e5e9eed.png\"/></div>\n",
       "\n",
       "          医药魔方Invest\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">昨天 10:06</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div data-v-12a4774d=\"\" data-v-299cff7f=\"\" style=\"height:4px;\"></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/0949ab354c20a4431e71a71d6dabd769\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">纳微科技终止再融资，原计划募资6.7亿元</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">近日，上交所官网显示， 纳微科技 和 保荐人中信证券股份有限公司申请撤回向不特定对象发行可转换公司债券，审核终止。 纳微科技原计划募集资金总额不超过6.7亿元，拟用于以下项目：。 纳微科技专门从事高性能纳米微球材料研发、规模化生产、销售及应用服务，为生物医药、平板显示、分析检测及体外诊断等领域客户提供核心微球材料及相关技术解决方案。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Invest\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/21e09891ba976e69ffc0613a5e5e9eed.png\"/></div>\n",
       "\n",
       "          医药魔方Invest\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">前天 10:09</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div data-v-12a4774d=\"\" data-v-299cff7f=\"\" style=\"height:4px;\"></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/4c6c75b36db7964885619f744e353663\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">新药获批上市，如何对其赛道进行竞争格局调研，确定产品价值 | 新药调研指南01</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">2024 年 8 月 27 日，传奇生物自主研发的 BCMA 靶向 CAR-T 细胞治疗产品卡卫荻®（西达基奥 仑 赛注射液）获得国家药品监督管理局批准上市，用于治疗复发或难治性多发性骨髓瘤成人患者，既往接受过至少三线治疗后进展（至少使用过一种蛋白酶体抑制剂及免疫调节剂）。 NextPharma全球新药数据库提供以下策略来帮助您解决这些问题。 策略1： 对目标所处赛道进行全面透视，纵览全球竞争格局。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Info\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/6ad25aa68a7f2d9979385ef99131cad0.png\"/></div>\n",
       "\n",
       "          医药魔方Info\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">前天 08:55</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/d5482ac5ca989e2c3eb6830f8729a12b\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>传奇生物</span></a></span></span></div> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/0e9b81af3af7abcd1627b87e41f2eb24\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>西达基奥仑赛</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/a5d65db083b31901c57f6caa2adffded\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">慢阻肺病再现突破！GSK美泊利珠单抗III期研究成功</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">9月6日，葛兰素史克（GSK）宣布 Nucala（ 美泊利珠单抗 ）治疗 慢性阻塞性肺病 （简称慢阻肺病， COPD）的III期 MATINEE研究取得了积极结果。 该研究是一项为期52-104周的多中心、随机、双盲、安慰剂对照临床试验（n=806），评估了 美泊利珠单抗（100mg，每4周1次，皮下注射）对比安慰剂作为疾病频繁恶化且血嗜酸性粒细胞水平升高的中度至重度COPD患者在维持治疗之外的附加治疗方案的有效性和安全性 。 结果显示， 治疗104周后， 美泊利珠单抗组患者的年恶化率低于安慰剂组，数据 具有统计学意义和临床意义 。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">前天 08:29</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/f10a428fe5594a04fc9a1438e51144c3\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>葛兰素史克</span></a></span></span></div> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/07169db6e896dc8d8970fb59289e6508\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>美泊利珠单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/dac03cf5730f16692bb830fe4f71b665\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">Science：阿尔茨海默病新靶点——IDO1</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病。 脑糖代谢受损是AD的一个病理特征。 有神经科学家认为，阿尔茨海默病可能会通过破坏葡萄糖代谢来剥夺大脑功能。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Pro\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/84fad3f676ebd639a89e7abb94b92856.png\"/></div>\n",
       "\n",
       "          医药魔方Pro\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">09-06 21:51</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/e11eae5f4a0b03980e385cb3b2dec43d\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>葡萄糖</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/38ddeef684ef405b68246a240cb6927e\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">信达前总裁入职石药！刘勇军担任石药执行总裁和全球研发总裁</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">9月5日，石药聘任刘勇军为公司执行总裁和全球研发总裁。 据公开资料，今年8月，刘勇军从信达生物离职并退休。 他于2020年10月加入信达生物，被任命为公司总裁，负责信达生物全球研发、管线战略、商务合作及国际业务等工作。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Info\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/6ad25aa68a7f2d9979385ef99131cad0.png\"/></div>\n",
       "\n",
       "          医药魔方Info\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">09-06 14:38</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/bd289c614873d90bf7607b7770487ca6\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>石药集团</span></a></span></span></div> <!-- --></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:0;width:calc(100% - 48px);\"></div></div></div> <!-- --></div></div></div> <div class=\"mf-pt-8px mf-pb-20px mf-text-center load-more-container\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ui-load-more mf-flex mf-items-center mf-justify-center\" data-v-65ceef8e=\"\"><div><button class=\"load-more ant-btn\" data-v-65ceef8e=\"\" type=\"button\"><span>加载更多</span></button></div></div></div></div></div> <div class=\"right-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"box mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container rmbq\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">热门标签</h3> <i class=\"icon iconfont icon-remenbiaoqian\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"padding-bottom:0.1px;\"><div class=\"mf-mb-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=FDA\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">FDA</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=%E6%81%92%E7%91%9E%E5%8C%BB%E8%8D%AF\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">恒瑞医药</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=%E8%82%BF%E7%98%A4\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">肿瘤</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=PD1\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">PD1</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">流感疫苗</a> <!-- --></div></div></div></div></div></div></div> <!-- --> <div class=\"mffooter\" data-v-5c8b65e4=\"\" data-v-a97d78d2=\"\"><div class=\"inner\" data-v-a97d78d2=\"\"><div class=\"left\" data-v-a97d78d2=\"\"><div class=\"ltop\" data-v-a97d78d2=\"\"><p data-v-a97d78d2=\"\">Copyright©2015-2024</p> <p data-v-a97d78d2=\"\">\n",
       "          备案号:\n",
       "          <a data-v-a97d78d2=\"\" href=\"https://beian.miit.gov.cn\" target=\"_blank\">沪ICP备2024080838号-7</a> <span data-v-a97d78d2=\"\"><img alt=\"备案图标\" data-v-a97d78d2=\"\" src=\"https://vcdn.pharmcube.com/images/common/ico_gongan.png\" style=\"\\n                display: inline-block;\\n                vertical-align: middle;\\n                margin: -1px 2px 0px 17px;\\n              \"/> <a data-v-a97d78d2=\"\" href=\"https://www.beian.gov.cn/portal/registerSystemInfo?recordcode=11010502052237\" target=\"_blank\">沪公网安备31011502401367号</a></span></p> <p data-v-a97d78d2=\"\">\n",
       "          互联网药品信息服务资格证书编号：(沪)-经营性-2024-0212\n",
       "        </p></div> <div class=\"ldown\" data-v-a97d78d2=\"\"><span class=\"iconf iconfont icon-weixin\" data-v-a97d78d2=\"\"><!-- --></span> <a class=\"iconf iconfont icon-weibo\" data-v-a97d78d2=\"\" href=\"https://weibo.com/yiyaomofang\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-zhihu\" data-v-a97d78d2=\"\" href=\"https://www.zhihu.com/org/yi-yao-mo-fang-6 \" target=\"_blank\"></a> <a class=\"iconf iconfont icon-linkedin-fill\" data-v-a97d78d2=\"\" href=\"https://www.linkedin.com/company/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9/?viewAsMember=true\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-twitter-fill\" data-v-a97d78d2=\"\" href=\"https://twitter.com/pharmcube\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-facebook-fill\" data-v-a97d78d2=\"\" href=\"https://www.facebook.com/PharmCubeGlobal\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-youtubeyoutube7\" data-v-a97d78d2=\"\" href=\"https://www.youtube.com/channel/UCQReNOQAXp1tmg-YCkrMhfg\" target=\"_blank\"></a></div></div> <div class=\"right\" data-v-a97d78d2=\"\"><svg class=\"icon\" data-v-a97d78d2=\"\" p-id=\"4457\" t=\"1658893879302\" version=\"1.1\" viewbox=\"0 0 2925 1024\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M876.251429 377.173333l-248.685715 115.321905c-17.554286 8.289524-29.013333 25.84381-29.013333 45.348572v306.468571c0 18.529524 19.260952 30.96381 36.083809 23.161905l248.685715-115.321905c17.554286-8.289524 29.013333-25.84381 29.013333-45.348571V400.335238c0-18.529524-19.260952-30.96381-36.083809-23.161905z m-114.834286 291.596191c20.48-9.99619 33.401905-35.352381 33.401905-35.352381l8.045714 4.388571c1.462857 0.731429 1.706667 3.169524 0.487619 5.36381-10.24 18.041905-24.868571 33.401905-41.20381 40.96-30.47619 14.140952-55.344762-3.657143-55.344761-39.984762 0-36.08381 24.868571-77.04381 55.344761-91.184762 16.335238-7.558095 30.96381-5.851429 41.20381 2.681905 1.219048 0.975238 0.975238 3.657143-0.487619 5.851428l-7.070476 10.24s-9.264762-12.190476-31.451429-2.194285c-19.748571 9.020952-41.691429 40.472381-42.422857 67.535238-0.487619 26.331429 17.798095 42.422857 39.497143 31.695238zM633.660952 288.182857l-30.963809-14.628571-52.419048 24.624762 30.476191 14.140952c9.020952 4.144762 32.670476 6.826667 49.980952-1.219048 20.48-9.508571 10.48381-19.260952 2.925714-22.918095z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4458\"></path> <path d=\"M872.838095 333.04381c21.455238-9.99619 21.455238-40.472381 0-50.468572L616.594286 162.620952a90.209524 90.209524 0 0 0-76.068572 0l-256.243809 119.954286c-21.455238 9.99619-21.455238 40.472381 0 50.468572l256.243809 119.954285a90.209524 90.209524 0 0 0 76.068572 0l256.243809-119.954285z m-306.224762-14.140953l-30.47619-14.140952-44.617143 20.967619-19.748571-9.264762 120.685714-56.32a12.190476 12.190476 0 0 1 9.264762 0l45.348571 21.211428c11.946667 5.607619 34.864762 21.942857-0.975238 38.521905-28.038095 13.165714-64.853333 5.851429-79.481905-0.975238zM528.822857 492.495238l-248.685714-116.297143c-16.822857-8.045714-36.327619 4.388571-36.327619 22.918095v306.468572c0 19.504762 11.215238 37.059048 28.769524 45.348571l248.685714 116.297143c16.822857 7.801905 36.327619-4.388571 36.327619-23.161905V537.84381c0-19.504762-11.215238-37.302857-28.769524-45.348572z m-73.142857 218.209524l-16.579048-7.801905v-92.891428l-38.521904 40.228571-38.521905-76.312381v88.259048c0 2.438095-1.706667 3.657143-3.657143 2.681904l-12.921905-6.095238V536.380952c0-2.681905 1.706667-3.900952 3.900953-2.925714l10.483809 4.876191 40.472381 81.188571 39.740952-41.691429c0.731429-0.731429 1.950476-0.975238 3.169524-0.243809l12.434286 5.851428v127.268572z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4459\"></path> <path d=\"M2122.361905 289.889524h153.843809v-22.430476c0-3.169524-2.681905-5.851429-5.851428-5.851429h-147.992381v-9.264762a7.070476 7.070476 0 0 0-7.070476-7.070476h-41.691429v16.335238h-147.992381c-3.169524 0-5.851429 2.681905-5.851429 5.851429v225.523809c0 28.038095-5.851429 45.104762-24.868571 50.712381-2.438095 0.731429-4.144762 2.925714-4.144762 5.607619v27.550476c51.687619 0 72.167619-39.740952 72.167619-83.626666V290.133333H2122.361905z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4460\"></path> <path d=\"M1986.31619 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851429 5.851428h27.062857v-24.380952c0-3.169524-2.681905-5.851429-5.851428-5.851429h-27.062858zM2084.08381 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851428 5.851428h27.062857v-24.380952c0-3.169524-2.681905-5.851429-5.851428-5.851429h-27.062857z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4461\"></path> <path d=\"M2121.142857 310.857143c0-3.169524-2.681905-5.851429-5.851428-5.851429H2072.380952a7.68 7.68 0 0 0-7.558095-7.070476h-35.59619v7.070476h-42.910477c-3.169524 0-5.851429 2.681905-5.851428 5.851429v22.430476h48.761905V365.714286c0 3.413333 2.925714 6.339048 6.339047 6.339047H2072.380952v-39.009523h48.761905v-22.186667zM2274.255238 310.857143c0-3.169524-2.681905-5.851429-5.851428-5.851429h-42.910477a7.68 7.68 0 0 0-7.558095-7.070476h-35.59619v7.070476H2140.647619a7.070476 7.070476 0 0 0-7.070476 7.070476v21.211429h48.761905V365.714286c0 3.413333 2.925714 6.339048 6.339047 6.339047h37.059048v-39.009523h48.761905v-22.186667z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4462\"></path> <path d=\"M2137.478095 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851429 5.851428h27.062857v-24.380952c0-3.169524-2.681905-5.851429-5.851429-5.851429h-27.062857zM2236.464762 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851428 5.851428h27.062858v-24.380952c0-3.169524-2.681905-5.851429-5.851429-5.851429h-27.062857zM2087.984762 498.834286h30.72v62.902857c0 8.045714 6.582857 14.628571 14.628571 14.628571h135.801905c8.045714 0 14.628571-6.582857 14.628572-14.628571v-36.571429H2250.361905c-3.413333 0-6.095238 2.681905-6.095238 6.095238v11.702858h-76.556191c-3.169524 0-5.851429-2.681905-5.851428-5.851429v-38.278095h93.379047c8.045714 0 14.628571-6.582857 14.628572-14.628572v-88.259047c0-3.169524-2.681905-5.851429-5.851429-5.851429h-161.401905v-6.095238a7.070476 7.070476 0 0 0-7.070476-7.070476h-41.691428V390.095238h-62.415239c-3.169524 0-5.851429 2.681905-5.851428 5.851429v102.887619h57.051428c-3.657143 27.550476-39.009524 45.83619-64.365714 49.005714-2.681905 0.24381-4.87619 2.925714-4.87619 5.851429v24.137142c59.733333 2.194286 101.668571-31.207619 114.590476-78.994285z m61.19619-41.691429h80.944762v13.409524h-80.944762v-13.409524z m80.944762-24.868571h-80.944762v-14.140953h80.944762v14.140953z m-124.342857-13.897143v14.140952h-81.432381v-14.140952h81.432381z m-81.188571 52.175238v-13.409524h81.432381v13.409524h-81.432381z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4463\"></path> <path d=\"M2188.190476 506.148571c-5.851429 0-10.727619 3.900952-11.946666 9.508572l-0.975239 4.144762-3.900952 16.091428h62.171429c1.950476 0 3.413333-1.706667 3.169523-3.657143l-3.169523-17.554285h-22.674286l0.975238 5.12h-12.190476l3.900952-13.653334h-15.36zM1108.601905 576.609524h349.135238V551.009524c0-3.169524-2.681905-5.851429-5.851429-5.851429H1148.586667c-3.169524 0-5.851429-2.681905-5.851429-5.851428V288.914286h309.881905V263.314286c0-3.169524-2.681905-5.851429-5.851429-5.851429H1100.068571c-3.169524 0-5.851429 2.681905-5.851428 5.851429v298.910476c0 7.801905 6.339048 14.384762 14.384762 14.384762z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4464\"></path> <path d=\"M1438.72 403.504762c0-3.169524-2.681905-5.851429-5.851429-5.851429h-104.350476v-37.546666h102.64381v-25.84381c0-3.169524-2.681905-5.851429-5.851429-5.851428h-164.083809l8.289523-13.897143h-56.563809l-14.140952 23.405714c-3.169524 5.36381-9.020952 8.533333-15.116191 8.533333h-0.975238c-3.169524 0-5.851429 2.681905-5.851429 5.851429v22.430476h28.281905c13.409524 0 26.087619-5.36381 35.352381-14.628571h39.009524v37.546666H1175.161905c-3.169524 0-5.851429 2.681905-5.851429 5.851429v25.843809h108.251429c-6.339048 27.794286-30.232381 59.977143-102.4 61.68381-3.169524 0-5.851429 2.681905-5.851429 5.851429v23.161904c69.973333 0 111.420952-18.773333 134.339048-43.885714 22.918095 25.112381 64.609524 43.885714 134.339047 43.885714v-23.405714c0-3.169524-2.438095-5.607619-5.607619-5.607619-72.411429-1.706667-96.304762-33.889524-102.643809-61.68381h108.251428v-25.843809zM1503.329524 550.765714v26.575238l130.438095-13.897142c2.925714-0.24381 5.12-2.925714 5.12-5.851429v-26.575238l-130.438095 13.897143c-2.925714 0.24381-5.12 2.681905-5.12 5.851428zM1845.638095 562.224762v-214.796191c0-3.169524-2.681905-5.851429-5.851428-5.851428h-106.544762l7.558095-12.921905h-56.56381l-12.434285 20.72381c-3.169524 5.36381-9.020952 8.533333-15.116191 8.533333h-0.975238c-3.169524 0-5.851429 2.681905-5.851428 5.851429v22.430476h28.281904c12.678095 0 24.380952-4.87619 33.401905-12.921905h85.089524v172.129524h-101.668571c-3.169524 0-5.607619 2.438095-5.60762 5.607619v25.843809h141.409524c8.289524-0.24381 14.872381-6.826667 14.872381-14.628571z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4465\"></path> <path d=\"M1720.07619 501.76h41.935239L1731.047619 420.08381a5.827048 5.827048 0 0 0-5.363809-3.657143h-41.935239l30.96381 81.67619c0.731429 2.194286 2.925714 3.657143 5.363809 3.657143zM1545.020952 301.348571v8.777143c0 3.169524 2.681905 5.851429 5.851429 5.851429h42.910476v-14.628572h161.401905v8.777143c0 3.169524 2.681905 5.851429 5.851428 5.851429h42.910477v-14.628572h52.419047V275.504762c0-3.169524-2.681905-5.851429-5.851428-5.851429h-46.567619v-18.529523c0-3.169524-2.681905-5.851429-5.851429-5.851429h-42.910476v24.624762h-161.401905v-18.773333c0-3.169524-2.681905-5.851429-5.851428-5.851429h-42.910477v24.624762h-46.811428c-3.169524 0-5.607619 2.438095-5.607619 5.607619v25.843809h52.419047zM1634.742857 328.655238h-65.340952l-63.878095 70.948572c-1.462857 1.706667-2.194286 3.657143-2.194286 5.851428v24.868572h65.340952l-63.878095 71.19238c-0.975238 0.975238-1.462857 2.438095-1.462857 3.900953v16.335238l130.681905-13.897143c2.925714-0.24381 5.12-2.925714 5.12-5.851428V475.428571l-50.468572 5.36381 49.005714-54.369524c0.975238-0.975238 1.462857-2.438095 1.462858-3.900952v-20.48h-70.217143l65.828571-73.386667zM2674.834286 269.897143h-150.430476v-17.310476a7.070476 7.070476 0 0 0-7.070477-7.070477h-41.691428v24.624762h-150.430476a7.070476 7.070476 0 0 0-7.070477 7.070477v24.380952h100.205715l-39.497143 191.634286c-5.607619 27.550476-28.281905 47.542857-49.249524 50.224762-2.925714 0.487619-5.12 2.925714-5.12 5.607619v27.550476c51.687619 0 91.91619-26.575238 101.180952-70.460953l23.405715-113.127619h155.062857l-15.847619 151.893334h-63.634286c-3.169524 0-5.607619 2.438095-5.607619 5.607619l-0.24381 25.843809h104.594286c7.558095 0 13.897143-5.851429 14.384762-13.165714l16.822857-185.782857a14.482286 14.482286 0 0 0-14.384762-15.847619H2455.893333l12.434286-60.220953H2681.904762v-24.380952a7.070476 7.070476 0 0 0-7.070476-7.070476zM1139.809524 662.918095h-41.447619c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h17.798095V736.304762h27.794286c13.409524 0 37.302857-9.752381 37.302857-35.352381 0-32.670476-26.575238-38.034286-37.302857-38.034286z m0 60.708572h-27.794286v-47.786667h28.281905c6.826667 0 20.967619 4.87619 20.967619 23.893333 0 15.60381-13.409524 23.893333-21.455238 23.893334zM1337.539048 667.062857v43.885714h-50.956191v-48.274285h-13.897143c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h17.798096v-53.638095h50.95619v53.638095h17.798095v-114.102857h-13.653333c-2.194286 0.24381-3.900952 2.194286-3.900952 4.388571zM1509.424762 662.918095h-12.434286c-1.706667 0-3.169524 0.975238-3.900952 2.438095l-46.32381 111.664762h18.773334l12.921904-31.939047h46.567619l12.921905 31.939047h18.773334l-46.32381-111.664762-0.975238-2.438095z m-25.84381 69.485715l18.285715-45.836191 18.285714 45.592381-36.571429 0.24381zM1929.99619 664.624762l-42.910476 53.881905-43.885714-55.588572h-11.459048c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h13.897143c2.194286 0 4.144762-1.706667 4.144762-4.144762v-78.994285l41.691429 52.175238 41.447619-52.175238v83.139047h17.798095v-114.102857h-13.165714c-1.462857 0-2.681905 0.487619-3.413334 1.706667zM2313.020952 730.940952c0 8.533333-5.607619 31.695238-30.232381 31.695238-21.942857 0-30.232381-22.918095-30.232381-31.695238V663.161905h-18.041904V731.428571c0 12.921905 4.632381 24.137143 14.140952 33.401905 9.264762 9.264762 20.72381 13.897143 34.133333 13.897143 13.409524 0 24.624762-4.632381 34.133334-13.897143 9.264762-9.264762 14.140952-20.23619 14.140952-33.401905v-68.510476h-18.041905v68.022857zM2502.217143 725.820952c-1.462857-1.950476-3.169524-3.900952-5.12-5.607619-1.950476-1.706667-3.413333-2.681905-4.144762-3.169523a6.680381 6.680381 0 0 0-1.706667-0.975239l2.925715-2.194285c1.950476-1.462857 3.657143-4.144762 5.607619-8.045715 1.950476-3.900952 2.925714-8.045714 2.925714-12.678095 0-7.801905-5.851429-30.232381-33.401905-30.232381h-42.179047c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h48.761904c10.48381 0 19.260952-3.169524 26.087619-9.752381 7.070476-6.826667 10.727619-14.872381 10.48381-24.137142 0-3.900952-0.975238-7.558095-2.438095-10.971429-1.462857-2.681905-2.438095-4.632381-3.657143-6.339048z m-61.68381-50.224762h28.525715c4.388571 0 15.60381 2.438095 15.603809 17.310477 0 13.653333-10.971429 17.310476-15.603809 17.310476h-28.525715v-34.620953z m30.96381 88.746667h-28.525714a2.438095 2.438095 0 0 1-2.438096-2.438095V724.114286h30.96381c5.36381 0 18.773333 5.36381 18.773333 19.504762 0 16.335238-13.653333 20.72381-18.773333 20.723809zM2677.76 764.342857h-60.220952v-38.521905h57.051428v-9.020952c0-2.438095-1.950476-4.144762-4.144762-4.144762h-52.662857v-36.815238h62.902857v-8.533333c0-2.438095-1.950476-4.144762-4.144762-4.144762h-72.167619c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095H2681.904762v-8.533333c0-2.438095-1.950476-4.388571-4.144762-4.388572zM1731.291429 696.07619c-0.975238-25.112381-20.72381-33.158095-34.864762-33.158095h-43.885715c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h17.798096V731.428571h26.087619l25.35619 45.592381h18.773334L1710.08 731.428571s22.186667-7.801905 21.211429-35.352381z m-35.108572 22.674286h-30.232381v-43.154286h29.013334c7.801905 0 19.748571 4.87619 19.748571 20.48 0.24381 15.36-9.752381 22.674286-18.529524 22.674286zM2133.577143 747.27619s-12.678095 17.310476-35.596191 17.310477c-23.893333 0-43.154286-20.967619-43.154285-44.373334 0-23.405714 19.260952-44.373333 43.154285-44.373333 22.918095 0 35.59619 17.310476 35.596191 17.310476l9.020952-7.558095c1.462857-1.219048 1.706667-3.657143 0.487619-5.12-10.971429-11.946667-27.550476-19.017143-45.104762-19.017143-32.914286 0-59.733333 26.331429-59.733333 58.758095s26.819048 58.758095 59.733333 58.758096c17.798095 0 34.133333-7.070476 45.104762-19.017143 1.219048-1.462857 0.975238-3.657143-0.487619-5.12l-9.020952-7.558096z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4466\"></path></svg></div> <!-- --></div></div></div> <!-- --> <div data-v-03c3c235=\"\" data-v-5c8b65e4=\"\"><div class=\"subscribe-float toggle-default\" data-v-03c3c235=\"\"><div class=\"ui-subscribe\" data-v-03c3c235=\"\">魔方智选</div> <div class=\"ui-subscribe-expand\" data-v-03c3c235=\"\"><img alt=\"\" class=\"mail\" data-v-03c3c235=\"\" src=\"https://vcdn.pharmcube.com/drawbed/1702970312257_邮件素材.png\"/> <div class=\"bg\" data-v-03c3c235=\"\"><div class=\"left\" data-v-03c3c235=\"\"><div class=\"l1\" data-v-03c3c235=\"\" style=\"white-space: nowrap\">邮件版订阅推送</div> <div class=\"l2\" data-v-03c3c235=\"\" style=\"white-space: nowrap\">\n",
       "            更省心的资讯获取方式\n",
       "          </div></div> <div class=\"subscribe-btn\" data-v-03c3c235=\"\" style=\"white-space: nowrap\">\n",
       "          立即订阅\n",
       "        </div></div></div></div> <div data-v-03c3c235=\"\"><!-- --></div></div> <div data-v-5c8b65e4=\"\" data-v-c131bd44=\"\"><div class=\"yymf_fixed_right\" data-v-c131bd44=\"\"><div class=\"round1\" data-v-c131bd44=\"\" id=\"nct_help\"><a class=\"ceil mf-text-center mf-relative\" data-v-c131bd44=\"\" href=\"https://support.qq.com/product/413758\" id=\"ra\" target=\"_blank\"><i class=\"iconfont icon-wentifankui mf-text-20px-important\" data-v-c131bd44=\"\"></i></a> <div class=\"mf-px-10px\" data-v-c131bd44=\"\"><div class=\"divider\" data-v-c131bd44=\"\"></div></div> <div class=\"ceil mf-text-center mf-relative\" data-v-c131bd44=\"\" id=\"rb\"><i class=\"iconfont icon-saoma mf-text-20px-important\" data-v-c131bd44=\"\"></i></div></div> <div class=\"round2 mf-mt-40px yymf_back\" data-v-c131bd44=\"\"><div class=\"ceil\" data-v-c131bd44=\"\"><i class=\"iconfont icon-backtop\" data-v-c131bd44=\"\"></i></div></div></div></div> <div data-v-5c8b65e4=\"\" style=\"display:none;\"><!-- --> <div class=\"img-list-bottom pointer-auto fadeOut\" style=\"display:none;\"></div></div> <!-- --></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T){B.isLogin=e;return {layout:\"DefaultLayout\",data:[{loginRes:B,wellknownIndustry:[[h,\"西南证券\",\"国金证券\"],[\"浙商证券\",\"华安证券\",\"安信证券\"],[\"湘财证券\",\"东吴证券\"]],industryConference:[[\"ESMO\",\"ASCO\",\"AACR\"],[\"CSCO\",\"SABCS\"]],hotCompany:[[\"罗氏\",\"诺华\",\"辉瑞\"],[\"默沙东\",\"阿斯利康\",\"强生\"],[\"赛诺菲\",\"BMS\",C],[\"吉利德\",\"礼来\",\"百济神州\"]],noCoverListPCList:[{fileName:\"中国新药月报-第24期-2024年7月刊\",esid:\"fc2e735bb74d477cb5e50b6fb44df2ce\",report_product:\"PharmaGO\",publish_date:1723651200000,publish_date_format:\"2024-08-15\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F新药 341723709756250.jpg\"},{fileName:\"全球医药交易月报-2024年7月刊\",esid:\"f291fe66050346c08ae3d0d0ca71e15c\",report_product:i,publish_date:1723564800000,publish_date_format:\"2024-08-14\",report_tags:s,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F7月1723614672702.jpg\"},{fileName:\"全球新药研发进展月报-第40期-2024年7月刊\",esid:\"9ce903ee817040e799110394eabcf239\",report_product:i,publish_date:1723392000000,publish_date_format:\"2024-08-12\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F7月长 341723458061966.jpg\"},{fileName:\"2024年H1 中国医药交易分析报告\",esid:\"7ff2d59d38944fddb6a23418fc42ca2b\",report_product:i,publish_date:1721232000000,publish_date_format:D,report_tags:s,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FH1 341721292897276.jpg\"},{fileName:\"专利调研报告——PARP抑制剂尼拉帕利（Niraparib）\",esid:\"2bba9764b5ad464aabf8c186e6fe09f7\",report_product:\"NextPat\",publish_date:1721145600000,publish_date_format:\"2024-07-17\",report_tags:\"专利洞察\",report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专利 341721207443873.jpg\"},{fileName:\"全球医药交易月报-2024年6月刊\",esid:\"33b2d49875604b24b23eca62681ee9bd\",report_product:i,publish_date:1721059200000,publish_date_format:\"2024-07-16\",report_tags:s,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F交易 341721096767430.jpg\"}],hasCoverListPCList:[{fileName:\"DeepMed临床指南-2024非小细胞肺癌临床指南洞察报告\",esid:\"fc63ee5b0a134e2d966962bd230d90a4\",report_product:t,publish_date:u,publish_date_format:v,report_tags:b,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F普通3_4封面 1 (1)1721009884109.png\"},{fileName:\"DeepMed临床指南-2024乳腺癌临床指南洞察报告\",esid:\"6ba8f4ef44524c21a4ded37ceb6e94db\",report_product:t,publish_date:u,publish_date_format:v,report_tags:b,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F普通3_4封面 1 (2)1721009964407.png\"},{fileName:\"DeepMed临床指南-2024淋巴瘤临床指南洞察报告\",esid:\"9d2660f2d5ff4d9da374ab34baf26370\",report_product:t,publish_date:u,publish_date_format:v,report_tags:b,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F普通3_4封面 11721009706951.png\"},{fileName:\"2024H1医疗健康领域投融资趋势盘点\",esid:\"704ad0dd8ede4a56af5972267a05ca14\",report_product:\"MedAlpha\",publish_date:1720627200000,publish_date_format:\"2024-07-11\",report_tags:E,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F深 (2)(1)1720700943099.jpg\"},{fileName:\"ADC投融资及研发趋势\",esid:\"a46007ee42d2474ca8a468829f2b4f88\",report_product:\"InvestGO\",publish_date:1719504000000,publish_date_format:\"2024-06-28\",report_tags:E,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F深 (2)(1)(1)1719561176565.jpg\"},{fileName:\"2024 ASCO 新药开发机会分析\",esid:\"9e5a43aef9324d0eb1f067be15825e01\",report_product:i,publish_date:1718208000000,publish_date_format:\"2024-06-13\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F深 (2)(1)1718270467948.jpg\"},{fileName:\"2024年中国创新药物研发趋势-附录\",esid:\"c5ff5cc1dbb64298a81b21886d7c68f4\",report_product:i,publish_date:F,publish_date_format:G,report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FChinese innovative drug R&D trends in 2024-附录_001722481601406.png\"},{fileName:\"2024年中国创新药物研发趋势\",esid:\"a94d0641436541ee9fd1557c4b5c6c02\",report_product:i,publish_date:F,publish_date_format:G,report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FChinese innovative drug R&D trends in 2024_001722481559582.png\"},{fileName:\"202310-INT J RHEUM DIS——FDA炎症性关节炎药物监管中种族影响因素研究\",esid:\"81525fd2d8304a81b553c8f4eea06e04\",report_product:i,publish_date:1698595200000,publish_date_format:\"2023-10-30\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F企业微信截图_169863715835311698637179245.png\"}],topicListPCList:[{updateTime:a,updateTimeStr:a,esid:\"d07e7e8477de48b68c9db80f6817fe0e\",topicGroupCover:a,title:\"医保支付方式（DRG\\u002FDIP）改革培训资料\",isTop:c,publishTime:1725417815717,publishTimeStr:H,label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FBD21725417720530.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-d07e7e8477de48b68c9db80f6817fe0e.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"054e1039a58b478fa0230794ffb2acc7\",topicGroupCover:a,title:\"WCLC 2024 研究报告及临床研究资讯合集\",isTop:c,publishTime:1725417278440,publishTimeStr:H,label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 81725417648751.png\",status:I,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-054e1039a58b478fa0230794ffb2acc7.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"a9d9db0e79ad458380ed9a66e048be7d\",topicGroupCover:a,title:\"CDE宣讲会课件资料汇总-ICH Q2(R2)\\u002FQ14指导原则\",isTop:c,publishTime:1725012584456,publishTimeStr:\"2024-08-30\",label:[J],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FCDE2 111725012528359.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-a9d9db0e79ad458380ed9a66e048be7d.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"1bba492189144db9a987c26527d37636\",topicGroupCover:a,title:\"CDE宣讲会课件资料汇总-抗肿瘤药物技术审评常见问题\",isTop:c,publishTime:1722590573222,publishTimeStr:\"2024-08-02\",label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FCDE2 11722590440294.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-1bba492189144db9a987c26527d37636.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"88905fb06453440e956af3b2914897bf\",topicGroupCover:a,title:\"2024年热门医药企业半年报合集\",isTop:c,publishTime:1721297909872,publishTimeStr:D,label:[\"企业财报\"],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 111721297863675.png\",status:I,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-88905fb06453440e956af3b2914897bf.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"22e95bbdbf364f678820d43e47159c4a\",topicGroupCover:a,title:\"CDE宣讲会课件资料汇总-药物临床研究基本考虑、试验设计\",isTop:c,publishTime:1720493036308,publishTimeStr:\"2024-07-09\",label:[J],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FCDE21720492942030.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-22e95bbdbf364f678820d43e47159c4a.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"9c2b1ffe196c44a4bc62f5a9c78d819c\",topicGroupCover:a,title:\"2024上半年35份医药行业 IPO 招股书汇总\",isTop:c,publishTime:1720075243831,publishTimeStr:\"2024-07-04\",label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 5 11720075042077.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-9c2b1ffe196c44a4bc62f5a9c78d819c.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"dbc58be8a1af43a185235777f7d59814\",topicGroupCover:a,title:\"2024上半年50份医药行业精选报告汇总\",isTop:c,publishTime:1719286910128,publishTimeStr:\"2024-06-25\",label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 4 11719287220313.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-dbc58be8a1af43a185235777f7d59814.jpg\"}],reportListPCList:[{fileName:\"医药行业周报：武田1类创新药拟纳入突破性治疗品种\",resource:K,publishDate:p,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-bbd1d34c596d4ece9403a1b1e3c3ff0a.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409091639788125_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:_KIUAf-GJaqmtiYCRtFdnCkL1Jc=\",previewFileName:\"H3_AP202409091639788125_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"bbd1d34c596d4ece9403a1b1e3c3ff0a\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"报告摘要\\u003Cbr\\u003E市场表现：\\u003Cbr\\u003E2024年9月6日，医药板块涨跌幅-1.93%，跑输沪深300指数1.12pct，涨跌幅居申万31个子行业第27名。各医药子行业中，线下药店(-1.26%)、血液制品(-1.40%)、医药流通（-1.42%）表现居前，医疗设备(-2.76%)、医疗研发外包(-2.73%)、疫苗(-2.13%)表现居后。个股方面，日涨幅榜前3位分别为康芝药业(+11.20%)、海南海药(+10.13%)、老百姓(+10.01%)；跌幅榜前3位为海辰药业(-8.34%)、乐心医疗(-7.86%)、纳微科技（-6.85%）。\\u003Cbr\\u003E行业要闻：\\u003Cbr\\u003E9月6日，CDE官网公示，武田（Takeda）的TAK-861片拟纳入突破性治疗品种，针对适应症为发作性睡病1型（NT1）。TAK-861是一种口服食欲素受体2（OX2R）激动剂，旨在通过选择性刺激食欲素受体来解决NT1中的食欲素缺乏问题。\\u003Cbr\\u003E（来源：CDE，太平洋证券研究院）\\u003Cbr\\u003E公司要闻：\\u003Cbr\\u003E卫信康（603676）：公司发布公告，子公司北京藏卫信康医药研发有限公司收到国家药品监督管理局核准签发的去氧胆酸注射液《药物临床试验批准通知书》，同意本品开展临床试验。\\u003Cbr\\u003E亚太药业（002370）：公司发布公告，近日收到国家药品监督管理局下发的关于阿替洛尔片一致性评价的受理通知书，标志着该品种一致性评价工作进入了审评阶段，如顺利通过一致性评价将增加其市场竞争力。\\u003Cbr\\u003E华森制药（002907）：公司发布公告，近日收到新加坡卫生科学局核准签发的中成药注册批文，批准公司产品甘桔冰梅片符合新加坡中成药标准注册，批准其在新加坡上市销售。\\u003Cbr\\u003E亚辉龙（688675）：公司发布公告，近日收到了由BSI Group TheNetherlands B.V.签发的关于公司产品乙型肝炎病毒e抗原检测试剂盒（化学发光法）的IVDR CE最高风险等级Class D认证证书，对于公司具有重要的里程碑意义。\\u003Cbr\\u003E风险提示：新药研发及上市不及预期；政策推进超预期；市场竞争加剧风险。\",report_format:g,report_pages:L,report_size:.36,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药行业周报：创新催化、政策鼓励支持，医药基本面持续向上复苏\",resource:\"民生证券\",publishDate:p,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-99938f6dd0c34db385840a0b00ac0834.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409091639787582_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:XTfrI1Rqtrzk0sRJ03ZJ865UKqM=\",previewFileName:\"H3_AP202409091639787582_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"99938f6dd0c34db385840a0b00ac0834\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"医药周观点：3季度开始，医药板块基本面持续向上，创新催化不断、政策持续鼓励支持，看好板块行情。继续重点关注医药创新（特别是GLP-1）、医疗设备、科学仪器、制剂出海等细分方向。\\u003Cbr\\u003E1）CXO：订单回暖趋势明显，Q2业绩环比改善，CXO板块H2业绩有望延续复苏状态，关注9月美国生物法案进展，建议关注ADC CDMO、临床CRO龙头和GLP-1产业链。2）创新药：司美格鲁肽在中国核心序列专利将在2026年3月20日到期，翰宇药业和丽珠集团均启动司美格鲁肽仿制药III期减重临床，预计2026年将迎来国产司美格鲁肽上市密集期，GLP-1领域研发进展不断，建议关注GLP-1产业链相关药物研发进展。3）中医药：建议关注特色中药与消费中药相关企业业绩持续稳健增长，关注呼吸类产品占比大的中药企业业绩拐点，关注销售费用率下降改善业绩的相关公司。4）疫苗血制品：持续看好静丙行业下半年及明年持续较快发展的弹性和确定性，其次关注下半年浆站数量变化驱动的行业份额变革中的潜在受益公司，疫苗方向关注相对稀缺的带疱疫苗放量为国内公司带来的潜在增量业绩，以及近期流感疫苗外资召回事件驱动的短期投资机会。5）医药上游供应链：创新药全产业链政策落地，伴随投融资底部回升，美国降息预期加强，国内竞争环境开始转好，叠加海外市场开拓，有望带动2024年生科链板块业绩+估值修复，重点关注制药工业端大订单落地以及出海节奏。6）医疗设备与IVD：国内以旧换新政策逐步落地，有望在24H2释放重大增量需求，关注迈瑞医疗、联影医疗、华大智造、山外山，其次重点关注消费型医疗设备的顺周期复苏反弹，如怡和嘉业、鱼跃医疗；IVD方面，关注国内的集采政策落地后具体情况推进和在海外市场的仪器铺货及单产情况。7）医疗服务：关注布局高线城市的刚需医疗服务板块，以及体外基金资产储备充足的相关标的，后续随着公司资金的充裕有望逐步将体外资产收入上市公司体内，提升整体业绩；此外建议重点关注与公立医院形成差异化竞争，或形成优势互补的医疗服务细分板块；8）线下药店：目前行业估值处于历史低位，后续建议重点关注相关上市公司，例如：益丰药房、老百姓、大参林以及一心堂等。9）高值耗材：\\u003Cbr\\u003E持续看好24H1业绩呈现较强景气度趋势的电生理、外周、神经介入领域的中长期成长空间及国产化率提升机遇。10)原料药：原料药企相继通过原料药+制剂\\u002FCDMO\\u002F合成生物学等进行高附加值业务布局，在传统业务利润释放预期渐明背景下，新兴业务有望成为第二增长极，打开公司成长天花板。建议关注华海药业、仙琚制药、川宁生物、奥翔药业等相关行业龙头。11）仪器设备：随着科学仪器需求端触底回暖，以及特别国债驱动的设备增量\\u002F换新订单的扶持，看好下半年及明年科学仪器行业的增速恢复，关注24H1业绩出现强拐点科学仪器龙头。\\u003Cbr\\u003E12）低值耗材：短期关注OEM模式下低耗龙头出海具有持续开拓能力和产品升级的公司，关注相关公司下半年增量客户变化，中长期持续看好GLP-1产业链相关包材、针头产品广阔市场潜力的兑现。\\u003Cbr\\u003E投资建议：建议关注泰格医药、恒瑞医药、百济神州、迈瑞医疗、三友医疗、爱康医疗、圣诺生物、和黄医药、博瑞医药、众生药业、聚光科技、健友股份、诺泰生物、微芯生物、怡和嘉业、康龙化成等。\\u003Cbr\\u003E风险提示：集采压力大于预期风险；产品研发进度不及预期风险；竞争加剧风险；政策监管环境变化风险；药物研发服务市场需求下降的风险。\",report_format:g,report_pages:20,report_size:1.13,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药行业周报：安进1类新药在华再获批临床\",resource:K,publishDate:p,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-61a06f9a125c4882a461c9c5975432ec.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409091639788122_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:lOP98C4XaIZ8WIqZxGmuT1OrsBc=\",previewFileName:\"H3_AP202409091639788122_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"61a06f9a125c4882a461c9c5975432ec\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"报告摘要\\u003Cbr\\u003E市场表现：\\u003Cbr\\u003E2024年9月4日，医药板块涨跌幅+0.16%，跑赢沪深300指数0.81pct，涨跌幅居申万31个子行业第3名。各医药子行业中，线下药店(+4.71%)、医药流通(+1.63%)、医疗研发外包（+1.47%）表现居前，疫苗(-1.36%)、其他生物制品(-0.04%)、医院(+0.09%)表现居后。个股方面，日涨幅榜前3位分别为漱玉平民(+19.98%)、人民同泰(+10.09%)、老百姓(+10.03%)；跌幅榜前3位为金石亚药(-5.62%)、普利制药(-5.09%)、东方海洋（-4.10%）。\\u003Cbr\\u003E行业要闻：\\u003Cbr\\u003E9月4，CDE官网公示，安进（Amgen）的1类新药AMG451一项新的临床申请获得批准，适应症为结节性痒疹。AMG451（Rocatinlimab）是一款全人源化抗OX40单克隆抗体在研新药，安进通过一项高达12.5亿美元的合作获得了共同开发和商业化该产品的权益。\\u003Cbr\\u003E（来源：CDE，太平洋证券研究院）\\u003Cbr\\u003E公司要闻：\\u003Cbr\\u003E灵康药业（603669）：公司发布公告，子公司海南灵康制药有限公司近日收到国家药品监督管理局核准签发的注射用头孢唑肟钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。\\u003Cbr\\u003E翰宇药业（300199）：公司发布公告，公司产品生长抑素原料药收到欧洲药品质量管理局签发的CEP证书，为进入欧盟市场开拓了准入通道，有利于公司原料药海外市场的拓展。\\u003Cbr\\u003E天宇股份（300702）：公司发布公告，子公司浙江诺得药业有限公司于近日收到国家药品监督管理局核准签发的关于尼可地尔片的《药品注册证书》，经审查，本品符合药品注册的有关要求，批准注册。\\u003Cbr\\u003E兴齐眼药（300573）：公司发布公告，公司研发的SQ-22031滴眼液于近日完成了“评估SQ-22031滴眼液在健康受试者中单次\\u002F多次给药的安全性、耐受性和药代动力学的单中心、随机、双盲、安慰剂对照I期临床试验”首例受试者入组，正式进入该临床试验。\\u003Cbr\\u003E风险提示：新药研发及上市不及预期；政策推进超预期；市场竞争加剧风险。\",report_format:g,report_pages:L,report_size:.37,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"WCLC 2024 摘要集\",resource:M,publishDate:p,publishDateLong:a,isRecommend:q,isTop:q,fileUrlFlag:w,primaryType:\"行业会议\",isVerify:a,secondaryType:b,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-ad8d10f28c934acd9a3c87c460cbfe18.jpg\",reportListCover:b,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FWCLC 2024 摘要集imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:9LTRe1mRubNpp5CYXyzKrrVZHbs=\",previewFileName:\"WCLC 2024 摘要集imgss0.jpg\",medicalReportTags:[M,\"WCLC 2024\"],chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"ad8d10f28c934acd9a3c87c460cbfe18\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:b,report_subtitle:b,report_format:g,report_pages:1627,report_size:35.68,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"新药周观点：Biotech 2024中报总结，商业化放量步入正轨、亏损持续改善\",resource:\"国投证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-95d65b44db8d475f8006495485005d37.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639786636_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:UqNOckR2JqIkac_tPaRNFnpziHk=\",previewFileName:\"H3_AP202409081639786636_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"95d65b44db8d475f8006495485005d37\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"本周新药行情回顾：\\u003Cbr\\u003E2024年9月2日-2024年9月6日，新药板块涨幅前5企业：圣诺医药（17.50%）、歌礼制药（14.12%）、云顶新耀（13.53%）、德琪医药（7.81%）、乐普生物（7.03%），跌幅前5企业：宜明昂科（-42.66%）、科济药业（-17.23%）、君圣泰（-17.02%）、欧康维视（-14.03%）、诺思兰德（-13.92%）。\\u003Cbr\\u003E本周新药行业重点分析：\\u003Cbr\\u003E根据最新披露的2024年中报，我们统计分析了65家A股、港股Biotech创新药公司2018年至2024H1的营业收入、归母净利润、研发费用、销售费用、货币资金的变化情况，总体来看目前国内Biotech创新药公司商业化已逐渐进入正轨，亏损开始收窄。\\u003Cbr\\u003E（1）营业收入：国内Biotech创新药企业商业化步入正轨，开始进入加速放量阶段。一方面已上市产品放量开始加速，2024H1年65家A股、港股Biotech创新药公司共实现441.8亿元的营业收入，同比增长35.6%；另一方面整体营收＞1亿元的公司数量也呈现持续增长态势，至2024H1年共有37家公司实现营收＞1亿元，数量同比增长16%。\\u003Cbr\\u003E（2）归母净利润：国内Biotech创新药企业亏损大幅收窄，开始逐年改善。2024H1年65家A股、港股Biotech创新药公司总体归母净利润为-61.6亿元，相对2023H1年的-139.3亿元实现大幅减亏。我们认为这一变化主要由三方面因素驱动，一是随商业化进入正轨带动总体营收的上升，二是研发投入端费用增长放缓，三是部分公司（如百利天恒）海外授权收入激增。预计随未来产品放量趋势的放大Biotech创新药公司的净利润将进一步改善。\\u003Cbr\\u003E（3）研发费用：国内Biotech创新药企业研发投入开始放缓。2024H1年65家A股、港股Biotech创新药公司总体研发费用为219.0亿元，同比减少1%，表明创新药领域研发投入放缓，我们认为这一变化主要受投融资环境的影响，以及研发费用基数本身较大所致。（4）销售费用：国内Biotech创新药企业销售费用随营收增长持续提升，但销售费用率有所下滑。2024H1年65家A股、港股Biotech创新药公司总体销售费用为227.8亿元，同期销售费用率达33%，相对2023年有所下滑。\\u003Cbr\\u003E（5）货币资金：国内Biotech创新药企业现金储备呈小幅下滑态势核心Biotech公司储备充足。2024H1年65家A股、港股Biotech创新药公司总体货币资金为938.7亿元，同比减少15%；整体来看，目\\u003Cbr\\u003E前Biotech创新药公司现金储备呈小幅下滑态势；截止0885438992024年6月30日，货币资金＞10亿元Biotech创新药公司共有28家，核心Biotech公司现金储备充足。\\u003Cbr\\u003E本周新药获批&受理情况：\\u003Cbr\\u003E本周国内17个新药获批IND，42个新药IND获受理，7个新药NDA获受理。\\u003Cbr\\u003E本周国内新药行业TOP3重点关注：\\u003Cbr\\u003E（1）9月5日，CDE官网公示恒瑞医药的口服高选择性JAK1抑制剂硫酸艾玛昔替尼片新适应症上市申请获得受理。\\u003Cbr\\u003E（2）9月4日，信达生物宣布其PD-1\\u002FIL-2α-bias双特异性抗体融合蛋白IBI363获得FDA授予快速通道资格。\\u003Cbr\\u003E（3）9月4日，岸迈生物与Vignette Bio公司宣布，双方就岸迈生物靶向BCMA的T细胞接合分子EMB-06达成了一项授权许可协议。\\u003Cbr\\u003E本周海外新药行业TOP3重点关注：\\u003Cbr\\u003E（1）9月7日，GSK宣布其靶向IL-5的“first-in-class”抗体疗法Nucala，在治疗成人慢性阻塞性肺病患者的3期临床试验MATINEE中获得积极结果。\\u003Cbr\\u003E（2）9月6日，礼来宣布了QWINT-1和QWINT-3两项3期临床试验的积极顶线结果。在这两项试验中，efsitora与每日基础胰岛素相比在降低糖化血红蛋白水平效果上达非劣效性。\\u003Cbr\\u003E（3）9月4日，默沙东宣布欧盟委员会已批准PD-1抑制剂Keytruda与安斯泰来和辉瑞旗下Seagen开发的抗体偶联药物Padcev联用，作为一线治疗不可切除或转移性尿路上皮癌成人患者的治疗方案。\\u003Cbr\\u003E风险提示：临床试验进度不及预期的风险，临床试验结果不及预期的风险，医药政策变动的风险，创新药专利纠纷的风险。\",report_format:g,report_pages:N,report_size:.93,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药魔方核心行业数据监测周报-09月09日\",resource:h,publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:w,primaryType:O,isVerify:a,secondaryType:b,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-1b0c24e8a9444dadaa37ee7793d5724c.jpg\",reportListCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FBydrug上传图片1725786222294.png\",isPharmcubeReport:x,previewFileUrl:a,previewFileName:a,medicalReportTags:[P],chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"1b0c24e8a9444dadaa37ee7793d5724c\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:b,report_subtitle:Q,report_format:g,report_pages:23,report_size:3.36,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药行业周报：Pharma创新成果显著，迈入商业化收获阶段\",resource:\"华源证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-3bb9f1c2c9484d07aca443c140648feb.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639787066_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:vbr8BMWxtNwxPEx3LXB0b27ahU4=\",previewFileName:\"H3_AP202409081639787066_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"3bb9f1c2c9484d07aca443c140648feb\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"投资要点：\\u003Cbr\\u003E本周医药市场表现分析：本周沪深300指数下跌（-2.70%），医药行业下滑(-2.05%)，整体板块缺少主线，个股涨幅方面，本周漱玉平民、老百姓等药店标的超跌反弹。近期医药整体行情表现疲软，短期建议关注：1）超跌、边际预期改善个股：在市场风格、医药政策等因素影响下，前期多个板块和个股跌幅显著如医疗设备（开立医疗、澳华内镜等），建议积极关注后续边际变化；2）院内资产：\\u003Cbr\\u003E从已公布的半年报来看，众多pharma的业绩已经触底反弹，展现了较强增长韧性，诊疗需求稳步提升，建议关注集采出清、新品放量的标的；3）创新药\\u002F械：顶层支持、产业趋势明确，创新品种正进入放量阶段，持续看好优质创新药\\u002F械个股；4）出海：全球市场容量更大，客户群体众多，长期对于公司丰富收入维度，规避局部风险较为重要，持续看好具有稳定出海能力的标的。\\u003Cbr\\u003E医药指数和各细分领域表现、涨跌幅：本周医药指数下滑（-2.05%），上涨个股数量97家，下跌个股数量392家。本周，医药商业（+1.8%）、化学制剂（-1.0%）相对表现较好，生物制品（-3.3%）、化学原料药（-3.0%）相对表现较差；年初以来，化学制剂（-14.3%）、化学原料药（-16.4%）和中药（-17.1%）相对表现较好，医疗服务（-41.5%）、生物制品（-35.9%）及医药生物（-25.1%）相对表现较差。\\u003Cbr\\u003E传统pharma和Biopharma中报业绩表现较好，创新转型成果显著。传统pharma和Biopharma中报业绩表现较好，创新转型成果显著。2018年至今仿制药集采已经过九批，对部分传统pharma业绩影响已显著消化，且随着创新药增长，该类公司收入结构已显著改善，创新药已经成为公司增长主要动力。中长期看，中国创新药已进入商业化快速兑现阶段，海外合作\\u002F销售加速，如康方生物卡度尼利2023首个上市完整年实现销售13.6亿元，艾力斯伏美替尼销售从2021年的2.36亿元到2023年19.8亿元，创新药商业化结果十分可观。此外，近些年部分Bioparma通过早期聚焦某一细分品种，借助产品优势在细分领域占据优势，产品快速商业化。整体来看：中国创新药已进入商业化兑现阶段，头部药企商业化优势显著，业绩兑现度高、速度快，看好传统Pharma和Biopharma。\\u003Cbr\\u003E投资观点及建议关注标的：年初以来医药指数下跌超25%，估值处于历史低位，基金持仓预计亦处于历史相对较低位置。2024年半年报已全部披露，展望三季度和四季度，医药基本面有望逐步企稳回升，业绩有望逐季度边际好转，结构性高增长的细分领域和个股值得期待。当前位置适合战略性布局建议关注以下方向：1）创新药械：建议关注恒瑞医药、和黄医药、科伦博泰、翰森制药、康方生物、信达生物、康诺亚、泽璟制药、信立泰、海思科、赛诺医疗等；2）出海：建议关注迈瑞医疗、联影医疗、三诺生物、美好医疗、福瑞股份、新产业、万孚生物、健友股份、科兴制药等；3？）老龄化及院外消费：建议关注鱼跃医疗、九典制药、可孚医疗、昆药集团、华润三九、太极集团、羚锐制药等；4）高壁垒行业：建议关注麻药（人福医药、恩华药业、国药股份等）、血制品（派林生物、天坛生物、博雅生物等）；5）国产替代：建议关注开立医疗、澳华内镜、惠泰医疗、微电生理等。6）小而美标的：建议关注百洋医药、普门科技、方盛制药、立方制药、麦澜德等。\\u003Cbr\\u003E本周投资组合：三诺生物、美好医疗、康方生物、派林生物、百洋医药。\\u003Cbr\\u003E本月投资组合：昆药集团、和黄医药、三诺生物、派林生物、美好医疗。\\u003Cbr\\u003E风险提示：行业竞争加剧风险，政策变化风险，行业需求不及预期风险。\",report_format:g,report_pages:14,report_size:1.39,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药生物行业周报：中药及商业板块整体略显承压，部分个股表现亮眼\",resource:\"开源证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-b65b7f0a0ed5475483fb2ef38048fc03.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639786701_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:KPpnHm0_k321H5bbL_c7BK6jN7M=\",previewFileName:\"H3_AP202409081639786701_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"b65b7f0a0ed5475483fb2ef38048fc03\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"中药及商业板块整体略显承压，部分个股表现亮眼\\u003Cbr\\u003E截至2024年8月31日，中药及商业板块公司公告2024上半年业绩，业绩表现整体略显承压。我们汇总了多数中药及商业企业的2024上半年业绩表现的影响因素及个股实现积极业绩的原因。\\u003Cbr\\u003E中药板块：（1）中药创新药企业：部分企业受2023H1高基数、产品集采降价等影响因而业绩承压，但如方盛制药在部分集采产品稳健销售的同时，渠道覆盖稳步推进，促使创新中药产品实现较快速的销售增长，实现营业收入9.10亿元，同比增长6.44%。（2）OTC及消费类企业：部分企业受2023H1高基数、比价政策、核心药品市场需求下降、消费疲软影响大健康业务等因素致使业绩承压，但如羚锐制药受益于人口老龄化长期发展逻辑，核心产品销售实现较高增长，实现营业收入19.06亿元，同比增长12.07%；佐力药业乌灵胶囊具备“医保+基药”双目录资质，叠加集采大规格替换进而快速放量，实现营业收入14.28亿元，同比增长41.21%；东阿阿胶深抓品牌效用，强化营销深挖客户群体，在消费疲软的当下仍实现业绩的快速增长，实现营业收入27.48亿元，同比增长26.80%。（3）国企改革：部分企业受经营战略调整、业务结构优化等因素影响致使业绩承压，但华润三九在业务结构与运营效率持续优化的过程中，核心CHC业务稳健拓展，带动业绩呈现较好增长，实现营业收入141.06亿元，同比增长7.30%。\\u003Cbr\\u003E商业板块：（1）零售药店企业：企业营业收入均实现不同程度增长，主要系原有门店的内生增长及新开、并购而新增门店的业绩贡献，但在毛利率承压、较为刚性的费用支出等影响下大部分企业利润端略显承压，但如益丰药房则凭借管理效益的提升缓解了费用端带来的经营压力，实现归母净利润7.98亿元，同比增长13.13%。（2）医药流通企业：由于流通企业面临药品、器械等多类产品的分销工作，因而面临来自药品季节性销售、药械集采等方面的影响而使业绩承压，但如百洋医药以核心的较高营收占比、高毛利的CSO业务为抓手，通过形成品牌矩阵，促使增长动能持续增强，实现归母净利润3.69亿元，同比增长21.89%。\\u003Cbr\\u003E推荐标的\\u003Cbr\\u003E推荐标的：制药及生物制品：泽璟制药、和黄医药、科伦博泰生物-B、恒瑞医药、人福医药、九典制药、恩华药业、康诺亚、智翔金泰、三生国健、艾迪药业、京新药业、健康元、丽珠集团、东诚药业；中药：悦康药业、方盛制药、羚锐制药、佐力药业、济川药业、昆药集团；医疗器械：奥泰生物、可孚医疗、迈瑞医疗、开立医疗、澳华内镜、海泰新光、戴维医疗、海尔生物、振德医疗、安杰思、三诺生物；原料药：华海药业、奥锐特、普洛药业、博瑞医药；CXO：诺泰生物、圣诺生物、药明合联、泰格医药；科研服务：皓元医药、毕得医药、昊帆生物、百普赛斯、奥浦迈、药康生物；医疗服务：海吉亚医疗、美年健康；零售药店：益丰药房、健之佳；疫苗：康泰生物。\\u003Cbr\\u003E风险提示：政策波动风险、市场震荡风险、竞争加剧风险等。\",report_format:g,report_pages:12,report_size:1.46,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药生物：关注ODAC，PD1双抗或将改变晚期胃癌免疫治疗认识\",resource:\"华福证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-356e990eb32e484196e5ff9fd1dc6ab0.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639786028_1imgss0.jpg?e=1725874164&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:tetUgPsTgnVNKImR8cNsCICajR8=\",previewFileName:\"H3_AP202409081639786028_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"356e990eb32e484196e5ff9fd1dc6ab0\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"投资要点：\\u003Cbr\\u003E行情回顾：本周（2024年9月2日-9月6日）中信医药指数下跌2.0%，跑赢沪深300指数0.7pct，在中信一级行业分类中排名第16位；2024年初至今中信医药生物板块指数下跌23.9%，跑输沪深300指数18.0pct，在中信行业分类中排名第26位。\\u003Cbr\\u003E关于月底ODAC会议：胃癌中PD-1单抗对不同PD-L1表达水平获益评估：目前获批的ICIs在胃癌中未限制PD-L1表达水平，2024年9月26日，FDA将召开肿瘤咨询委员会（ODAC）讨论会，主要讨论不同PD-L1表达水平人群的不同风险-获益评估，以及累积数据是否足以说明应根据PD-L1表达水平限制ICIs适应症人群。K药和O药的3期临床研究显示PD-L1低表达\\u002F阴性接受PD-1抗体免疫治疗的疗效普遍不佳（OS HR＞0.9），占比约50%低表达胃癌人群仍存在大量没有被满足的需求。康方生物的全球首创PD-1\\u002FCTLA-4双抗卡度尼利在PD-L1CPS＜5（PD-L1低表达）人群也具有良好抗肿瘤治疗作用，PFSHR=0.60，OSHR=0.70。卡度尼利解决了目前临床上单靶点免疫疗法不能解决的问题，很好地体现了“抗PD-1+抗CTLA-4”的双重免疫治疗协同增效的作用机制，成为胃癌免疫治疗差异化的“增量”，有望弥补当前晚期胃癌免疫治疗策略的不足，是晚期胃癌中潜在更优的免疫疗法，建议关注：康方生物。\\u003Cbr\\u003E本周市场复盘及中短期投资思考：本周A\\u002FH股医药指数均下跌，但均跑赢大盘，主要系大盘石油石化等权重板块跌幅较大所致，医药板块中药店板块涨幅明显，主要系跌幅带、估值低，叠加了“美好生活概念”，而创新药械和医疗服务板块跌幅较多，市场无明确主线。医药成交量占市场比例持续下行，周五占比仅6.4%。我们认为中报利空落地后医药有相对优势，Q3行业同比增速向上，接来下还有创新药产业链支持政策落地和医保谈判开始等催化，行业整体趋势向上。当前我们继续推荐Pharma、创新药以及大品种方向，及寻增量为最有前途，资金容纳量最大的方向，建议加大配置力度，24年下半年医药大概率有超额收益。\\u003Cbr\\u003E中长期配置思路：根据医药-供给，人口-需求、医保-支付、医疗-结构的分析框架，我们在《医药新常态，路在何方？——调存量、寻增量、抓变量》报告中提出在行业进入新常态的大背景下，调存量（老龄化+进口替代）、寻增量（出海+大品种+仿转创）和抓变量（国企改革）或成为中长期医药投资关键词。详细方向及标的见后文。\\u003Cbr\\u003E本周建议关注组合：恒瑞医药、康方生物、康哲药业、悦康药业、圣诺生物、三诺生物。\\u003Cbr\\u003E九月建议关注组合：恒瑞医药、康方生物、新诺威、美好医疗、诺泰生物、圣诺生物。\\u003Cbr\\u003E风险提示\\u003Cbr\\u003E行业需求不及预期；公司业绩不及预期；市场竞争加剧风险。\",report_format:g,report_pages:N,report_size:1.93,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药魔方核心行业数据监测周报EN-09月09日\",resource:h,publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:w,primaryType:O,isVerify:a,secondaryType:b,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-05f71a4840604c3baa6d7c259e96e48a.jpg\",reportListCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FBydrug上传图片1725786322369.png\",isPharmcubeReport:x,previewFileUrl:a,previewFileName:a,medicalReportTags:[P],chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"05f71a4840604c3baa6d7c259e96e48a\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:b,report_subtitle:Q,report_format:g,report_pages:33,report_size:2.54,report_language:a,report_playback:a,is_personal_information:a,tag:a}],newsPCList:[{abstracts:\"过去一年，尤其是2024年初产业里出现的一些变动，让业内感觉国产创新药正在出清，且有所加速了。 一方面，国内Biotech出现了破产清算的案例，随之而来的还有各类重组；另一方面， 具体到产品管线和产能建设上，来自CDE和医药魔方的数据显示，自2021年开始都出现了数量下滑趋势 。 产业出清：从管线到公司。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"51841ff780bf7f422270e48ea7213332\",title:\"融资建厂锐减超6成！创新药过剩产能加速出清\",resource:y,publishTime:\"2024-09-09 08:41\",tags:[h,\"创新药\"],logo:z,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:[{data_show_name:\"华泰创新药技术研究院\",data_execute_skip:c,data_esid:\"d7f14a9a1ea214c54c0b90a81d976002\"}]},{abstracts:\"9月8日，康方生物在2024世界肺癌大会（WCLC）上发布了PD-1\\u002FVEGF双抗依沃西单抗单药对比帕博利珠单抗（K药）单药一线治疗PD-L1表达阳性（PD-L1 TPS≥1%）的局部晚期或转移性非小细胞肺癌（NSCLC）的注册性III期临床研究（HARMONi-2\\u002FAK112-303）的重磅研究数据。 该 研究试验组与对照组入组人群基线均衡，其中 PD-L1 TPS≥50%患者的占比为42.2%，与真实世界人群分布一致。 结果显示，在意向治疗人群（ITT）中，依沃西单抗单药相较于K药单药显著延长了患者的无进展生存期（PFS），显著降低了患者的疾病进展或死亡风险（11.14 vs. 5.82个月，HR=0.51，P\\u003C0.0001）。\",isFullText:c,isRecommend:f,foldNewsCount:q,esid:\"c478b5698fcf7306423ef70059f962aa\",title:\"全球首个！依沃西单抗挑战K药III期研究取得积极结果\",resource:h,publishTime:A,tags:[\"PDL1\",\"K药\"],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"46775102224fc8bc48665c8f6b400f00\",drug_earth_title:\"依沃西单抗\"}],company_ids_bind_list:a},{abstracts:\"一个略冷的知识：公认的明星重磅炸弹药物贝伐珠单抗（anti-VEGF单抗），获批的适应症绝大多数都是联合用药，而并非广泛认为的单药。 根据医药魔方NextPharma®数据库，贝伐珠单抗自2004年首次以联用FOLFIR治疗结直肠癌获批在美国上市后，近20年间全球市场（美、欧、日、中）共获批9大癌种47项适应症。 还真未必，至少还有两款明星重磅炸弹也是联合用药的适应症作为主导。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"d0c46969a188e3d57621570bf3570ec3\",title:\"联合用药能否出爆款？从贝伐珠单抗说起\",resource:h,publishTime:A,tags:[h],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"7deca95e5f8930c89e46a68331c88ead\",drug_earth_title:\"贝伐珠单抗\"}],company_ids_bind_list:a},{abstracts:\"2024年欧洲肿瘤内科学会（ESMO）年会将于2024年9月13日至17日在西班牙巴塞罗那举行，科伦博泰生物（6990.HK）TROP2 ADC芦康沙妥珠单抗（sac-TMT）联合帕博利珠单抗（可瑞达®）用于复发或转移性宫颈癌（CC）患者的疗效及安全性数据摘要已在ESMO官网披露。 宫颈癌发病率居全球妇科三大恶性肿瘤之首，是导致女性癌症死亡的第四大原因。 据世界卫生组织（WHO）统计，2022年全球女性宫颈癌新发病例约66.2万例，占所有肿瘤的3.3%，位居第八，死亡人数约34.9万例，占所有肿瘤的3.6%，位居第九 。\",isFullText:c,isRecommend:f,foldNewsCount:q,esid:\"141fe4725cbb14c02162c103b03a0967\",title:\"科伦博泰Trop2 ADC芦康沙妥珠单抗宫颈癌临床数据亮相ESMO 2024！ADC+肿瘤免疫有望重新定义宫颈癌治疗标准\",resource:h,publishTime:A,tags:[\"科伦博泰\",\"宫颈癌\",\"Trop2\"],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"cf3f7121a8d0d5fbd82e427640170cd2\",drug_earth_title:\"帕博利珠单抗\"}],company_ids_bind_list:[{data_show_name:\"科伦博泰生物\",data_execute_skip:c,data_esid:\"9f44ad9e386cd6d9206802b5bbdc9961\"}]},{abstracts:\"近日，深交所发出一份《关于对信永中和会计师事务所（特殊普通合伙）、毕强、燕进的监管函》。 招股说明书（申报稿）显示，发行人聘请CSO推广服务商开展调研与咨询、学术推广、展览与宣传及会议会务等推 广活动，2020-2022年各期业务推广费分别为12,933.78万元、20,426.98万元、17,409.30万元，占营业收入比例分别为44.62%、46.72%、39.95%。 中国证监会现场检查发现，发行人业务推广相关内部控制存在薄弱环节，部分推广活动验收存在瑕疵。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"fe7f731d6e5fa8e2fcce51db150fc4ea\",title:\"信永中和被书面警示，涉及赛克赛斯IPO项目\",resource:y,publishTime:\"2024-09-08 10:06\",tags:[\"克赛\",\"信永中和\"],logo:z,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:a},{abstracts:\"近日，上交所官网显示， 纳微科技 和 保荐人中信证券股份有限公司申请撤回向不特定对象发行可转换公司债券，审核终止。 纳微科技原计划募集资金总额不超过6.7亿元，拟用于以下项目：。 纳微科技专门从事高性能纳米微球材料研发、规模化生产、销售及应用服务，为生物医药、平板显示、分析检测及体外诊断等领域客户提供核心微球材料及相关技术解决方案。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"0949ab354c20a4431e71a71d6dabd769\",title:\"纳微科技终止再融资，原计划募资6.7亿元\",resource:y,publishTime:\"2024-09-07 10:09\",tags:[\"纳微科技\"],logo:z,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:a},{abstracts:\"2024 年 8 月 27 日，传奇生物自主研发的 BCMA 靶向 CAR-T 细胞治疗产品卡卫荻®（西达基奥 仑 赛注射液）获得国家药品监督管理局批准上市，用于治疗复发或难治性多发性骨髓瘤成人患者，既往接受过至少三线治疗后进展（至少使用过一种蛋白酶体抑制剂及免疫调节剂）。 NextPharma全球新药数据库提供以下策略来帮助您解决这些问题。 策略1： 对目标所处赛道进行全面透视，纵览全球竞争格局。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"4c6c75b36db7964885619f744e353663\",title:\"新药获批上市，如何对其赛道进行竞争格局调研，确定产品价值 | 新药调研指南01\",resource:R,publishTime:\"2024-09-07 08:55\",tags:[\"BCMA\",i,\"多发性骨髓瘤\"],logo:S,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"0e9b81af3af7abcd1627b87e41f2eb24\",drug_earth_title:\"西达基奥仑赛\"}],company_ids_bind_list:[{data_show_name:\"传奇生物\",data_execute_skip:c,data_esid:\"d5482ac5ca989e2c3eb6830f8729a12b\"}]},{abstracts:\"9月6日，葛兰素史克（GSK）宣布 Nucala（ 美泊利珠单抗 ）治疗 慢性阻塞性肺病 （简称慢阻肺病， COPD）的III期 MATINEE研究取得了积极结果。 该研究是一项为期52-104周的多中心、随机、双盲、安慰剂对照临床试验（n=806），评估了 美泊利珠单抗（100mg，每4周1次，皮下注射）对比安慰剂作为疾病频繁恶化且血嗜酸性粒细胞水平升高的中度至重度COPD患者在维持治疗之外的附加治疗方案的有效性和安全性 。 结果显示， 治疗104周后， 美泊利珠单抗组患者的年恶化率低于安慰剂组，数据 具有统计学意义和临床意义 。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"a5d65db083b31901c57f6caa2adffded\",title:\"慢阻肺病再现突破！GSK美泊利珠单抗III期研究成功\",resource:h,publishTime:\"2024-09-07 08:29\",tags:[C,\"慢阻肺\",\"III期\"],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"07169db6e896dc8d8970fb59289e6508\",drug_earth_title:\"美泊利珠单抗\"}],company_ids_bind_list:[{data_show_name:\"葛兰素史克\",data_execute_skip:c,data_esid:\"f10a428fe5594a04fc9a1438e51144c3\"}]},{abstracts:\"阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病。 脑糖代谢受损是AD的一个病理特征。 有神经科学家认为，阿尔茨海默病可能会通过破坏葡萄糖代谢来剥夺大脑功能。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"dac03cf5730f16692bb830fe4f71b665\",title:\"Science：阿尔茨海默病新靶点——IDO1\",resource:\"医药魔方Pro\",publishTime:\"2024-09-06 21:51\",tags:[\"IDO1\",\"阿尔茨海默病\"],logo:\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F84fad3f676ebd639a89e7abb94b92856.png\",content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"e11eae5f4a0b03980e385cb3b2dec43d\",drug_earth_title:\"葡萄糖\"}],company_ids_bind_list:a},{abstracts:\"9月5日，石药聘任刘勇军为公司执行总裁和全球研发总裁。 据公开资料，今年8月，刘勇军从信达生物离职并退休。 他于2020年10月加入信达生物，被任命为公司总裁，负责信达生物全球研发、管线战略、商务合作及国际业务等工作。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"38ddeef684ef405b68246a240cb6927e\",title:\"信达前总裁入职石药！刘勇军担任石药执行总裁和全球研发总裁\",resource:R,publishTime:\"2024-09-06 14:38\",tags:[\"刘勇军\"],logo:S,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:[{data_show_name:\"石药集团\",data_execute_skip:c,data_esid:\"bd289c614873d90bf7607b7770487ca6\"}]}],hotNewsTags:[\"FDA\",\"恒瑞医药\",\"肿瘤\",\"PD1\",\"流感疫苗\"],bydrugURL:\"https:\\u002F\\u002Fbydrug.pharmcube.com\",baseURL:\"https:\\u002F\\u002Fpharmcube.com\"}],fetch:{},error:a,state:{isLogin:e,isVip:void 0,applyModalOpen:e,remainCount:d,userInfo:B,realPhone:b,secretPhone:b,memberId:b,downloadItem:{esid:b,fileUrlFlag:b},ts:b,chartPreviewOpen:e,chartPreviewList:[],chartPreviewItem:{},chartPreviewIndex:d,chartSignalPage:b,noticePreviewOpen:e,noticePreviewList:[],noticePreviewItem:{},noticePreviewIndex:d,noticeSignalPage:b,outLinkCheckShow:e,outLinkUrl:b,isCopyout:e,downloadCheckShow:e,report_params_cache:{\"报告分类\":b,\"报告分类二级\":b,\"发布时间\":b,\"报告页数\":b,\"报告格式\":b,\"报告语言\":b,\"搜索\":b,\"页码\":b},news_params_cache:{\"检索\":b,\"发布时间\":b,\"内容分类\":b,tab:b,\"页码\":b},chart_params_cache:{},paramCheckShow:e,userForm:{},formSetting:{},ShowLogin:e,drawerShow:e,drawerActiveEsid:b,mfNavDisapper:e,noticeCount:d},serverRendered:x,routePath:T,config:{_app:{basePath:T,assetsPath:\"\\u002F_nuxt\\u002F\",cdnURL:a}}}}(null,\"\",\"是\",0,false,\"否\",\"pdf\",\"医药魔方\",\"NextPharma\",\"05\",\"行业研究\",\"行业报告\",\"新药研发\",\"更新完成\",\"2024-09-08\",\"2024-09-09\",1,\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F271f5c568c58426e49cfff3684270676.png\",\"医药交易\",\"DeepMed\",1720972800000,\"2024-07-15\",\"01\",true,\"医药魔方Invest\",\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F21e09891ba976e69ffc0613a5e5e9eed.png\",\"2024-09-09 08:27\",{},\"GSK\",\"2024-07-18\",\"投融资\",1722355200000,\"2024-07-31\",\"2024-09-04\",\"更新中\",\"CDE培训\",\"太平洋\",3,\"WCLC\",15,\"魔方报告\",\"魔方周报\",\"\\u003Cp\\u003E感谢您关注魔方数据服务，上周行业动态重点事件如下，供您参考：\\r\\n1.一年长高11厘米！诺和诺德长效生长激素在华申报上市；\\r\\n2.国家药审中心关于公开征求《疫苗临床试验技术指导原则》意见的通知；\\r\\n3.赫吉亚生物宣布获数千万人民币A2轮融资。\\r\\n如想了解更多详情，敬请查阅本周新闻周报。\",\"医药魔方Info\",\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F6ad25aa68a7f2d9979385ef99131cad0.png\",\"\\u002F\"));</script><script defer=\"\" src=\"/_nuxt/906d100.js\"></script><script defer=\"\" src=\"/_nuxt/bc02015.js\"></script><script defer=\"\" src=\"/_nuxt/adf5c0e.js\"></script><script defer=\"\" src=\"/_nuxt/899bd2d.js\"></script><script defer=\"\" src=\"/_nuxt/d766ac1.js\"></script><script defer=\"\" src=\"/_nuxt/f5958aa.js\"></script><script defer=\"\" src=\"/_nuxt/0e8d870.js\"></script><script defer=\"\" src=\"/_nuxt/b325f63.js\"></script><script defer=\"\" src=\"/_nuxt/21c0bce.js\"></script><script defer=\"\" src=\"/_nuxt/0ffb51c.js\"></script>\n",
       "</body>\n",
       "</html>"
      ]
     },
     "execution_count": 1030,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "soup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1131,
   "id": "c0db912a-296f-4917-bf08-2f68b99d7190",
   "metadata": {},
   "outputs": [],
   "source": [
    "datas = soup.find_all('div', class_= 'mf-flex mf-items-center')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1133,
   "id": "f4c2e1bb-601e-4919-bb00-2d9f03b5b914",
   "metadata": {},
   "outputs": [],
   "source": [
    "datas = datas[1:11]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1135,
   "id": "b102752e-8f6c-40a1-a069-2c5d158e0864",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_tilte_and_url(item):\n",
    "    title = item.text.strip()\n",
    "    url = item.a['href']\n",
    "    return {\n",
    "        'title': title,\n",
    "        'url': url\n",
    "    }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1137,
   "id": "fdde8dd4-5839-43d4-845a-eb6b3ffbfea8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/bbd1d34c596d4ece9403a1b1e3c3ff0a\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：武田1类创新药拟纳入突破性治疗品种\n",
       "        </a> <!-- --></div>"
      ]
     },
     "execution_count": 1137,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "datas[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1139,
   "id": "a0534cd8-8961-4521-96fb-2782376d2e8c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'title': '医药行业周报：武田1类创新药拟纳入突破性治疗品种',\n",
       " 'url': 'https://bydrug.pharmcube.com/report/detail/bbd1d34c596d4ece9403a1b1e3c3ff0a'}"
      ]
     },
     "execution_count": 1139,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "get_tilte_and_url(datas[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1143,
   "id": "34cb1251-4754-4d8b-ad99-26124c07efeb",
   "metadata": {},
   "outputs": [],
   "source": [
    "res = list(map(get_tilte_and_url, datas))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1145,
   "id": "f1917d1a-231c-4931-8f8c-53c77f2f6497",
   "metadata": {},
   "outputs": [],
   "source": [
    "dates = [_.text for _ in soup.find_all('span', class_= 'text') if '-' in _.text]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1153,
   "id": "c2bdc22d-bb73-4ab6-8cd5-720e7853e220",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['2024-09-09',\n",
       " '2024-09-09',\n",
       " '2024-09-09',\n",
       " '2024-09-09',\n",
       " '2024-09-08',\n",
       " '2024-09-08',\n",
       " '2024-09-08',\n",
       " '2024-09-08',\n",
       " '2024-09-08',\n",
       " '2024-09-08']"
      ]
     },
     "execution_count": 1153,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dates"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1157,
   "id": "78529b61-5cba-4382-8d86-4b9dad19ab38",
   "metadata": {},
   "outputs": [],
   "source": [
    "for no, _ in enumerate(res):\n",
    "    _['date'] = dates[no]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "11f5146d-abc5-4898-9a2b-5889ff340f50",
   "metadata": {},
   "source": [
    "# https://news.yaozh.com/archivelist/24"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1162,
   "id": "e730b255-3a19-4226-9434-844fe372a3d2",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get('https://bydrug.pharmcube.com/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1164,
   "id": "68c5815f-3ea3-4d33-a9bb-6ee92531f66e",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup = BeautifulSoup(r.text, 'html.parser')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1166,
   "id": "a8220521-9cf3-417b-8a1c-ad7b266bbe52",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<!DOCTYPE html>\n",
       "\n",
       "<html data-n-head=\"%7B%22lang%22:%7B%22ssr%22:%22zh%22%7D%7D\" data-n-head-ssr=\"\" lang=\"zh\">\n",
       "<head>\n",
       "<meta charset=\"utf-8\" data-n-head=\"ssr\"/><meta content=\"width=device-width, initial-scale=1.0, minimum-scale=1, maximum-scale=1, user-scalable=no\" data-n-head=\"ssr\" name=\"viewport\"/><meta content=\"telephone=no\" data-n-head=\"ssr\" name=\"format-detection\"/><meta content=\"codeva-eL5dxvvOkL\" data-n-head=\"ssr\" name=\"baidu-site-verification\"/><meta content=\"strict-origin-when-cross-origin\" data-n-head=\"ssr\" name=\"referrer\"/><meta content=\"研究报告，医药魔方独家研究报告，海外研究报告，药企演讲ppt，药企财报，招股书，招股说明书，CDE培训咨询会议，FDA咨询会议，医药行业会议，药品获批新闻，医药新闻，医药魔方深度分析，热点研究，中国医疗器械，医疗器械上市数据，医疗器械注册数据，医疗器械注册审批信息，获批新药，license out，国家集采中标，医保谈判结果，ByDrug，掰药\" data-n-head=\"ssr\" name=\"keywords\"/><meta content=\"ByDrug掰药是一个专业的、覆盖医药行业药械相关信息资源和媒体资讯服务的共享中心。聚焦于药物和器械研发信息，面向医药行业从业人员提供医药行业优质研究报告、新闻报道、医药类专利和中国及海外医疗器械数据等。\" data-hid=\"description\" data-n-head=\"ssr\" name=\"description\"/><title>ByDrug-一站式医药资源共享中心-医药魔方</title><link data-n-head=\"ssr\" href=\"https://vcdn.pharmcube.com/1672301164623_logo-2.svg\" rel=\"icon\" type=\"image/x-icon\"/><script data-n-head=\"ssr\" src=\"https://hm.baidu.com/hm.js?aedff73bc4f02be835e11695a0b2066e\"></script><script data-n-head=\"ssr\" src=\"https://cdn.beschannels.com/js-sdk/collect-0.0.5.min.js\"></script><link as=\"script\" href=\"/_nuxt/906d100.js\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/b325f63.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/27bf4da.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/21c0bce.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/5c39864.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/0ffb51c.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/af88994.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/bc02015.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/c0b72af.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/adf5c0e.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/9fee54f.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/899bd2d.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/d26a049.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/d766ac1.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/64c1edb.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/f5958aa.js\" rel=\"preload\"/><link as=\"style\" href=\"/_nuxt/css/5528309.css\" rel=\"preload\"/><link as=\"script\" href=\"/_nuxt/0e8d870.js\" rel=\"preload\"/><link href=\"/_nuxt/css/27bf4da.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/5c39864.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/af88994.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/c0b72af.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/9fee54f.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/d26a049.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/64c1edb.css\" rel=\"stylesheet\"/><link href=\"/_nuxt/css/5528309.css\" rel=\"stylesheet\"/>\n",
       "</head>\n",
       "<body>\n",
       "<div data-server-rendered=\"true\" id=\"__nuxt\"><!-- --><div id=\"__layout\"><div class=\"nuxt-layout\"><img alt=\"\" src=\"https://vcdn.pharmcube.com/1672301164623_logo-2.svg\" style=\"width:64px;height:64px;visibility:hidden;position:fixed;\"/> <div class=\"cube-layout\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"cube-layout__nav web\" data-v-5c8b65e4=\"\"><div class=\"cube-nav\" data-v-3b232041=\"\" data-v-5c8b65e4=\"\" style=\"z-index:900;\"><div class=\"mf-gw-container mf-flex mf-justify-between mf-items-center\" data-v-3b232041=\"\"><a class=\"mf-flex mf-items-center\" data-v-3b232041=\"\" href=\"https://www.pharmcube.com\"><i class=\"iconfont icon-left\" data-v-3b232041=\"\"></i> <span data-v-3b232041=\"\">返回医药魔方首页</span></a> <a data-v-3b232041=\"\" href=\"https://www.pharmcube.com/product/about/index\" target=\"_blank\">关于医药魔方</a></div> <div class=\"cube-nav-inner cube-nav-inner__showdow\" data-v-3b232041=\"\"><div class=\"logo\" data-v-3b232041=\"\"><a data-v-3b232041=\"\" href=\"https://www.pharmcube.com\"><img alt=\"\" class=\"mofang\" data-v-3b232041=\"\" src=\"https://vcdn.pharmcube.com/drawbed/1710833114943_mofang.svg\"/></a> <div class=\"divider\" data-v-3b232041=\"\"></div> <a data-v-3b232041=\"\" href=\"/\"><img alt=\"\" class=\"bydrug\" data-v-3b232041=\"\" src=\"https://vcdn.pharmcube.com/drawbed/1710833114942_drug.svg\"/></a></div> <div class=\"menu\" data-v-3b232041=\"\"><ul class=\"cube-nav-menu\" data-v-3b232041=\"\" data-v-c534db4c=\"\"><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(0,146,188);--color-hover:rgb(0,146,188);\"><span class=\"menu-item menu-item--active\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(0,146,188);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">首页</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/report\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药报告</span> <!-- --> <!-- --></span></a> <span class=\"icon-arrow\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);\"><svg class=\"cube-slot-nav__nav-menu__svg\" data-v-c534db4c=\"\" height=\"16\" viewbox=\"0 0 1024 1024\" width=\"16\"><path d=\"M792.137143 338.139429a36.571429 36.571429 0 0 0-51.565714 3.584L513.462857 603.062857 283.282286 341.577143a36.425143 36.425143 0 1 0-54.784 48.201143L485.668571 683.300571l0.438858 0.292572a36.132571 36.132571 0 0 0 26.331428 11.264l0.512-0.146286 0.585143 0.146286a36.352 36.352 0 0 0 13.897143-2.925714 65.389714 65.389714 0 0 0 10.24-6.217143 36.571429 36.571429 0 0 0 3.364571-3.364572l254.537143-292.717714a36.571429 36.571429 0 0 0-3.510857-51.492571\" fill=\"currentColor\"></path></svg></span> <!-- --></span> <ul class=\"sub-menus\" data-v-c534db4c=\"\"><li data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/report\" style=\"width:100%;\"><span data-v-c534db4c=\"\">研究报告</span> <!-- --> <!-- --></a></li><li data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/report-device\" style=\"width:100%;\"><span data-v-c534db4c=\"\">医疗器械</span> <!-- --> <!-- --></a></li><li data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/chart\" style=\"width:100%;\"><span data-v-c534db4c=\"\">图表数据</span> <!-- --> <!-- --></a></li></ul></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/news\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药新闻</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/topic\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药专题</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data\" target=\"\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">数据查询</span> <!-- --> <!-- --></span></a> <!-- --> <span class=\"icon-arrow icon-no-rotate\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);\"><svg class=\"cube-slot-nav__nav-menu__svg\" data-v-c534db4c=\"\" height=\"16\" viewbox=\"0 0 1024 1024\" width=\"16\"><path d=\"M792.137143 338.139429a36.571429 36.571429 0 0 0-51.565714 3.584L513.462857 603.062857 283.282286 341.577143a36.425143 36.425143 0 1 0-54.784 48.201143L485.668571 683.300571l0.438858 0.292572a36.132571 36.132571 0 0 0 26.331428 11.264l0.512-0.146286 0.585143 0.146286a36.352 36.352 0 0 0 13.897143-2.925714 65.389714 65.389714 0 0 0 10.24-6.217143 36.571429 36.571429 0 0 0 3.364571-3.364572l254.537143-292.717714a36.571429 36.571429 0 0 0-3.510857-51.492571\" fill=\"currentColor\"></path></svg></span></span> <!-- --></li><li class=\"importantHover\" data-v-c534db4c=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);\"><span class=\"menu-item\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://go.pharmcube.com/medical_policy\" target=\"_blank\"><span data-v-c534db4c=\"\" style=\"font-size:0;color:rgb(52,55,56);\"><span data-v-c534db4c=\"\" style=\"font-size:14px;\">医药政策</span> <!-- --> <!-- --></span></a> <!-- --> <!-- --></span> <!-- --></li> <div class=\"databox-popover mf-flex mf-pl-200px\" data-v-c534db4c=\"\" style=\"display:none;\"><div data-v-c534db4c=\"\" style=\"width: 1200px; margin: 0 auto\"><div class=\"ant-row\" data-v-c534db4c=\"\"><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">药物研发</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/freePat\">医药专利</a></li></ul></div></div><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">中国器械</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceCNImported\">中国大陆上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceCNEvaluation\">中国大陆审评</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceHK\">中国香港上市</a></li></ul></div></div><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">全球器械</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceUS\">美国上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceJP\">日本上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceUK\">英国上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceSG\">新加坡上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/devicePT\">葡萄牙上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceRO\">罗马尼亚上市</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/deviceSA\">沙特上市</a></li></ul></div></div><div class=\"ant-col ant-col-6\" data-v-c534db4c=\"\" style=\"padding-left:16px;padding-right:16px;\"><div class=\"databox-popover-title\" data-v-c534db4c=\"\"><span data-v-c534db4c=\"\">专题数据</span></div> <div class=\"databox-popover-content mf-flex mf-justify-between\" data-v-c534db4c=\"\"><ul data-v-c534db4c=\"\"><li class=\"box-row\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectNewdrug\">全球获批新药</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectLicenseout\">License out</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectVbp\">国家集采结果</a></li><li class=\"box-row mf-mt-10px\" data-v-c534db4c=\"\"><a data-v-c534db4c=\"\" href=\"https://bydrug.pharmcube.com/data/list/subjectHealthcare\">医保谈判结果</a></li></ul></div></div></div></div></div></ul></div> <div class=\"right\" data-v-3b232041=\"\" style=\"color:rgb(52,55,56);\"> <!-- --> <div class=\"lang-text importantHover\" data-v-3b232041=\"\" style=\"color:rgb(52,55,56);--color-hover:rgb(0,146,188);display:none;\"><svg class=\"cube-slot-nav__nav-menu__svg\" data-v-3b232041=\"\" height=\"24\" version=\"1.1\" viewbox=\"0 0 1024 1024\" width=\"24\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M512 85.333333c235.648 0 426.666667 191.018667 426.666667 426.666667s-191.018667 426.666667-426.666667 426.666667S85.333333 747.648 85.333333 512 276.352 85.333333 512 85.333333z m0 42.666667a384 384 0 1 0 0 768 384 384 0 0 0 0-768z\" fill=\"currentColor\" p-id=\"4923\"></path> <path d=\"M469.333333 349.866667a25.6 25.6 0 1 1 0 51.2H332.757333v85.333333H469.333333a25.6 25.6 0 1 1 0 51.2H332.757333v85.333333H469.333333a25.6 25.6 0 0 1 0 51.2H307.2a25.6 25.6 0 0 1-25.6-25.6l0.085333-2.133333a25.941333 25.941333 0 0 1-0.085333-2.133333V375.466667a25.6 25.6 0 0 1 25.6-25.6H469.333333z m247.466667 0a25.6 25.6 0 0 1 25.6 25.6v273.066666a25.6 25.6 0 0 1-51.114667 1.877334l-0.085333 0.128-85.333333-171.690667V648.533333a25.6 25.6 0 0 1-51.2 0V375.466667a25.6 25.6 0 0 1 51.029333-2.944l0.170667-0.085334 85.290666 161.621334L691.2 375.466667a25.6 25.6 0 0 1 25.6-25.6z\" fill=\"currentColor\" p-id=\"4924\"></path></svg></div> <!-- --> <div data-v-3b232041=\"\"><span class=\"exit-text mf-relative\" data-v-3b232041=\"\">登录</span> <!-- --></div></div></div></div></div> <div class=\"cube-layout__nav h5\" data-v-5c8b65e4=\"\"><div class=\"h5-header mf-flex mf-items-center mf-justify-between\" data-v-5c8b65e4=\"\"><a data-v-5c8b65e4=\"\" href=\"https://pharmcube.com\"><i class=\"iconfont icon-logo-dantuxing\" data-v-5c8b65e4=\"\" style=\"color: #0092bc; font-size: 24px\"></i></a> <div class=\"title\" data-v-5c8b65e4=\"\">医药魔方ByDrug</div> <div class=\"mf-flex mf-items-center\" data-v-5c8b65e4=\"\"><i class=\"iconfont icon-menu\" data-v-5c8b65e4=\"\" style=\"color: #0092bc; font-size: 24px\"></i> <!-- --></div></div></div> <div class=\"cube-layout__content mf-relative\" data-v-5c8b65e4=\"\"><div class=\"nuxt-content-container\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"overflow-x:hidden;padding-top:36px;\"><div class=\"top-banner mf-relative mf-h-514px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"width:100vw;\"><div class=\"coverbg\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></div> <div class=\"home-center-layout mf-pt-24px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div class=\"bg\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></div> <div class=\"top-mfreport-container ant-row\" data-v-65ceef8e=\"\"><div class=\"ant-col ant-col-12 ant-col-xs-24 ant-col-md-24 ant-col-lg-12 ant-col-xl-12\" data-v-65ceef8e=\"\"><div class=\"title-container\" data-v-65ceef8e=\"\"><div class=\"mfreport-tags\" data-v-65ceef8e=\"\" style=\"margin-top:38px;height:26px;\"><!-- --></div> <h1 class=\"mfreport-fileName mf-line-clamp-3 mf-mt-16px\" data-v-65ceef8e=\"\">\n",
       "                DeepMed临床指南-2024非小细胞肺癌临床指南洞察报告\n",
       "              </h1> <button class=\"mfreport-btn ant-btn ant-btn-primary\" data-v-65ceef8e=\"\" type=\"button\"><span>立即查看</span></button></div></div> <div class=\"ant-col ant-col-12 ant-col-xs-24 ant-col-md-24 ant-col-lg-12 ant-col-xl-12\" data-v-65ceef8e=\"\"></div></div> <div class=\"hot-reports-layout hot-reports-container mf-flex mf-items-center mf-justify-start\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"left mf-w-120px mf-flex mf-items-center mf-justify-center mofangtuijian\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><img alt=\"魔方推荐报告\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683868574791_形状结合@2x.png\" style=\"width:64px;height:70px;\"/></div> <div class=\"right reports-swiper mf-relative\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"indicator\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><span class=\"active\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span> <span data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span></div> <div class=\"round left disable\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-left\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"round right\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"reports-container ant-row\" data-v-65ceef8e=\"\" style=\"overflow:hidden;width:1080px;padding:0px 20px;\"><div class=\"mf-w-2080px slider\" data-v-65ceef8e=\"\"><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        新药研发\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/fc2e735bb74d477cb5e50b6fb44df2ce\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        中国新药月报-第24期-2024年7月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">PharmaGO</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-08-15</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        医药交易\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/f291fe66050346c08ae3d0d0ca71e15c\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        全球医药交易月报-2024年7月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-08-14</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        新药研发\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/9ce903ee817040e799110394eabcf239\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        全球新药研发进展月报-第40期-2024年7月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-08-12</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        医药交易\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/7ff2d59d38944fddb6a23418fc42ca2b\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        2024年H1 中国医药交易分析报告\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-07-18</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        专利洞察\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/2bba9764b5ad464aabf8c186e6fe09f7\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        专利调研报告——PARP抑制剂尼拉帕利（Niraparib）\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPat</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-07-17</span></div></div></div><div class=\"ant-col ant-col-4\" data-v-65ceef8e=\"\"><div class=\"hot-report-item\" data-v-65ceef8e=\"\"><div class=\"mf-line-clamp-2 hot-report-title-height\" data-v-65ceef8e=\"\"><span class=\"hot-report-item-tag mf-mr-4px\" data-v-65ceef8e=\"\">\n",
       "                        医药交易\n",
       "                      </span> <a class=\"hot-report-item-title\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report/detail/33b2d49875604b24b23eca62681ee9bd\" style=\"max-width:300px;\" target=\"_blank\">\n",
       "                        全球医药交易月报-2024年6月刊\n",
       "                      </a></div> <div class=\"hot-report-item-desc\" data-v-65ceef8e=\"\"><span class=\"gray-text\" data-v-65ceef8e=\"\">NextPharma</span> <span class=\"divider\" data-v-65ceef8e=\"\"></span> <span class=\"gray-text\" data-v-65ceef8e=\"\">2024-07-16</span></div></div></div></div></div></div></div></div></div> <div class=\"home-center-layout mf-mt-26px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div class=\"mf-flex flex-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"left-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"report-container mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title-container mf-flex mf-items-end\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h2 data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"z-index:2;position:relative;\">研究报告</h2> <img alt=\"\" class=\"shape\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683869649817_形状结合@2x (1).png\"/></div> <div class=\"app-underline-switcher mf-ml-32px\" data-v-12f9d2f3=\"\" data-v-65ceef8e=\"\"><ul class=\"tabs\" data-v-12f9d2f3=\"\"><li class=\"tab active\" data-v-12f9d2f3=\"\">\n",
       "      最新\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li><li class=\"tab mf-ml-12px\" data-v-12f9d2f3=\"\">\n",
       "      药企PPT\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li><li class=\"tab mf-ml-12px\" data-v-12f9d2f3=\"\">\n",
       "      财报/招股书\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li></ul></div> <a class=\"lg-more alink mf-flex mf-items-center\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"https://bydrug.pharmcube.com/report\" target=\"_blank\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">更多</div> <i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></a></div> <div class=\"ant-spin-nested-loading\" data-v-65ceef8e=\"\"><div class=\"ant-spin-container\"><div class=\"reportCommon-container\" data-v-65ceef8e=\"\"><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/99938f6dd0c34db385840a0b00ac0834\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：创新催化、政策鼓励支持，医药基本面持续向上复苏\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E6%B0%91%E7%94%9F%E8%AF%81%E5%88%B8\" target=\"_blank\">民生证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.13M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">20页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/bbd1d34c596d4ece9403a1b1e3c3ff0a\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：武田1类创新药拟纳入突破性治疗品种\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%A4%AA%E5%B9%B3%E6%B4%8B\" target=\"_blank\">太平洋</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">0.36M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">3页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/61a06f9a125c4882a461c9c5975432ec\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：安进1类新药在华再获批临床\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%A4%AA%E5%B9%B3%E6%B4%8B\" target=\"_blank\">太平洋</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">0.37M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">3页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/ad8d10f28c934acd9a3c87c460cbfe18\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          WCLC 2024 摘要集\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/WCLC\" target=\"_blank\">WCLC</a></span><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/WCLC%202024\" target=\"_blank\">WCLC 2024</a></span></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/WCLC\" target=\"_blank\">WCLC</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-09</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">35.68M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">1627页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/1b0c24e8a9444dadaa37ee7793d5724c\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药魔方核心行业数据监测周报-09月09日\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/%E9%AD%94%E6%96%B9%E5%91%A8%E6%8A%A5\" target=\"_blank\">魔方周报</a></span></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\">医药魔方</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">3.36M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">23页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/95d65b44db8d475f8006495485005d37\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          新药周观点：Biotech 2024中报总结，商业化放量步入正轨、亏损持续改善\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%9B%BD%E6%8A%95%E8%AF%81%E5%88%B8\" target=\"_blank\">国投证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">0.93M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">15页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/3bb9f1c2c9484d07aca443c140648feb\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药行业周报：Pharma创新成果显著，迈入商业化收获阶段\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8D%8E%E6%BA%90%E8%AF%81%E5%88%B8\" target=\"_blank\">华源证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.39M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">14页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/356e990eb32e484196e5ff9fd1dc6ab0\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药生物：关注ODAC，PD1双抗或将改变晚期胃癌免疫治疗认识\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8D%8E%E7%A6%8F%E8%AF%81%E5%88%B8\" target=\"_blank\">华福证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.93M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">15页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/b65b7f0a0ed5475483fb2ef38048fc03\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药生物行业周报：中药及商业板块整体略显承压，部分个股表现亮眼\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%BC%80%E6%BA%90%E8%AF%81%E5%88%B8\" target=\"_blank\">开源证券</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">1.46M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">12页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:1;width:calc(100% - 32px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-report mf-px-16px mf-px-16px\" data-v-23503f46=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-justify-start\" data-v-23503f46=\"\" style=\"height: 100%\"><div class=\"report-cover nozoom mf-mr-20px mf-flex mf-justify-center mf-items-center\" data-v-23503f46=\"\"><img alt=\"\" data-v-23503f46=\"\" src=\"https://vcdn.pharmcube.com/1687162426639_logo-2 (2).svg\" style=\"display:block;width:36px;height:38px;\"/></div> <div data-v-23503f46=\"\"><div class=\"mf-flex mf-items-center\" data-v-23503f46=\"\"><a class=\"fileName\" data-v-23503f46=\"\" href=\"https://bydrug.pharmcube.com/report/detail/05f71a4840604c3baa6d7c259e96e48a\" style=\"max-width:1080px;\" target=\"_blank\">\n",
       "          医药魔方核心行业数据监测周报EN-09月09日\n",
       "        </a> <!-- --></div> <div class=\"mf-flex mf-justify-start mf-items-center mf-mt-12px tag-row\" data-v-23503f46=\"\" style=\"height: 20px\"><span class=\"mf-tag-primary mf-mr-8px\" data-v-23503f46=\"\"><a data-v-23503f46=\"\" href=\"/report/summary/tag/%E9%AD%94%E6%96%B9%E5%91%A8%E6%8A%A5\" target=\"_blank\">魔方周报</a></span></div> <div class=\"mf-flex mf-justify-between mf-items-center mf-mt-16px\" data-v-23503f46=\"\"><div class=\"desc mf-inline-flex mf-items-center\" data-v-23503f46=\"\"><span class=\"text\" data-v-23503f46=\"\"><a class=\"dark-link\" data-v-23503f46=\"\" href=\"/report/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\">医药魔方</a> <!-- --></span> <span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2024-09-08</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text\" data-v-23503f46=\"\">2.54M</span><span class=\"divider\" data-v-23503f46=\"\"></span> <span class=\"text mf-inline-flex mf-items-center report_format\" data-v-23503f46=\"\"><!-- --> <i class=\"iconfont icon-pdf\" data-v-23503f46=\"\" style=\"color: #f46d3e\"></i> <!-- --> <!-- --> <div class=\"mf-ml-4px\" data-v-23503f46=\"\">33页</div></span></div> </div></div></div> <!-- --> <div class=\"bottom-line\" data-v-23503f46=\"\" style=\"opacity:0;width:calc(100% - 32px);\"></div></div></div> <!-- --></div></div></div></div></div> <div class=\"right-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"box mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container zmjg\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">知名机构</h3> <i class=\"icon iconfont icon-zhimingjigou\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ant-row\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" style=\"white-space:nowrap;\" target=\"_blank\">医药魔方</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%A5%BF%E5%8D%97%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">西南证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%9B%BD%E9%87%91%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">国金证券</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E6%B5%99%E5%95%86%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">浙商证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%8D%8E%E5%AE%89%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">华安证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%AE%89%E4%BF%A1%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">安信证券</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E6%B9%98%E8%B4%A2%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">湘财证券</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E4%B8%9C%E5%90%B4%E8%AF%81%E5%88%B8\" style=\"white-space:nowrap;\" target=\"_blank\">东吴证券</a></div></div></div></div> <div class=\"box mf-bg-white mf-rounded-8px mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container hyhy\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">行业会议</h3> <i class=\"icon iconfont icon-hangyehuiyi1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ant-row\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/ESMO\" style=\"white-space:nowrap;\" target=\"_blank\">ESMO</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/ASCO\" style=\"white-space:nowrap;\" target=\"_blank\">ASCO</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/AACR\" style=\"white-space:nowrap;\" target=\"_blank\">AACR</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/CSCO\" style=\"white-space:nowrap;\" target=\"_blank\">CSCO</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/SABCS\" style=\"white-space:nowrap;\" target=\"_blank\">SABCS</a></div></div></div></div> <div class=\"box mf-bg-white mf-rounded-8px mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container rmgs\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">热门公司</h3> <i class=\"icon iconfont icon-remengongsi1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ant-row\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E7%BD%97%E6%B0%8F\" style=\"white-space:nowrap;\" target=\"_blank\">罗氏</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%AF%BA%E5%8D%8E\" style=\"white-space:nowrap;\" target=\"_blank\">诺华</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%BE%89%E7%91%9E\" style=\"white-space:nowrap;\" target=\"_blank\">辉瑞</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E9%BB%98%E6%B2%99%E4%B8%9C\" style=\"white-space:nowrap;\" target=\"_blank\">默沙东</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E9%98%BF%E6%96%AF%E5%88%A9%E5%BA%B7\" style=\"white-space:nowrap;\" target=\"_blank\">阿斯利康</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%BC%BA%E7%94%9F\" style=\"white-space:nowrap;\" target=\"_blank\">强生</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E8%B5%9B%E8%AF%BA%E8%8F%B2\" style=\"white-space:nowrap;\" target=\"_blank\">赛诺菲</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/BMS\" style=\"white-space:nowrap;\" target=\"_blank\">BMS</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/GSK\" style=\"white-space:nowrap;\" target=\"_blank\">GSK</a></div></div><div class=\"ant-row mf-mt-12px\" data-v-65ceef8e=\"\" style=\"margin-left:-18px;margin-right:-18px;\"><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E5%90%89%E5%88%A9%E5%BE%B7\" style=\"white-space:nowrap;\" target=\"_blank\">吉利德</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E7%A4%BC%E6%9D%A5\" style=\"white-space:nowrap;\" target=\"_blank\">礼来</a></div><div class=\"ant-col ant-col-8\" data-v-65ceef8e=\"\" style=\"padding-left:18px;padding-right:18px;\"><a class=\"mf-mr-12px alink\" data-v-65ceef8e=\"\" href=\"/report/summary/source/%E7%99%BE%E6%B5%8E%E7%A5%9E%E5%B7%9E\" style=\"white-space:nowrap;\" target=\"_blank\">百济神州</a></div></div></div></div> <div class=\"box mf-bg-white mf-rounded-8px mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container xzph mf-flex mf-items-center mf-justify-between\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">热门报告</h3> <i class=\"icon iconfont icon-xiazaipaihangbang\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i> <div class=\"app-tab-switcher mf- mf-mr-8px\" data-v-65ceef8e=\"\" data-v-874a1162=\"\" style=\"z-index:2;\"><div class=\"mf-flex mf-justify-start\" data-v-874a1162=\"\"><div class=\"mf-flex mf-justify-start mf-items-center mf-cursor-pointer tab active\" data-v-874a1162=\"\"><span data-v-874a1162=\"\">周榜</span></div><div class=\"mf-flex mf-justify-start mf-items-center mf-cursor-pointer tab mf-ml-8px\" data-v-874a1162=\"\"><span data-v-874a1162=\"\">月榜</span></div></div></div></div> <div class=\"mf-pt-8px mf-pb-20px ant-spin-nested-loading\" data-v-65ceef8e=\"\" style=\"padding-top:8px;\"><div class=\"ant-spin-container\"><div class=\"rankingList-container\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center mf-justify-between item-ranking mf-px-16px mf-pl-20px\" data-v-65ceef8e=\"\" style=\"position:relative;line-height:20px;\"><div class=\"left mf-flex mf-items-center mf-justify-start\" data-v-65ceef8e=\"\"><div class=\"rank-index\" data-v-65ceef8e=\"\" style=\"color:#999999;font-size:12px;position:relative;left:-3px;\">\n",
       "                      排行\n",
       "                    </div> <div data-v-65ceef8e=\"\" style=\"color:#999999;font-size:12px;margin-left:4px;\">\n",
       "                      名称\n",
       "                    </div></div> <div data-v-65ceef8e=\"\" style=\"color:#999999;font-size:12px;\">热度</div></div> <div class=\"empty-container mf-flex mf-justify-center mf-items-center\" data-v-65ceef8e=\"\" style=\"padding:16px;\"><div class=\"ui-empty mf-text-center small\" data-v-65ceef8e=\"\"><div class=\"mf-text-center\"><img alt=\"\" src=\"https://vcdn.pharmcube.com/1684832692952_空数据.png\"/></div> <div class=\"text cover-text\">\n",
       "    暂无数据\n",
       "  </div></div></div></div></div></div></div></div></div></div> <div class=\"home-center-layout mf-mt-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div class=\"news-container mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title-container mf-flex mf-items-end\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h2 data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"z-index:2;position:relative;\">医药专题</h2> <img alt=\"\" class=\"shape\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683869649817_形状结合@2x (1).png\"/></div> <a class=\"lg-more alink mf-flex mf-items-center\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/topic\" target=\"_blank\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">更多</div> <i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></a></div> <div class=\"topic-reports-container mf-relative\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"indicator\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><span class=\"active\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span><span data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></span></div> <div class=\"round left disable\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-left\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"round right\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"overflow:hidden;width:1200px;\"><div class=\"mf-flex mf-justify-start slider\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"width:2249px;transform:translateX(8.5px);transition:transform 0.5s ease-in-out;\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/d07e7e8477de48b68c9db80f6817fe0e\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">医保支付方式（DRG/DIP）改革培训资料</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/054e1039a58b478fa0230794ffb2acc7\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">WCLC 2024 研究报告及临床研究资讯合集</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/a9d9db0e79ad458380ed9a66e048be7d\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-ICH Q2(R2)/Q14指导原则</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/1bba492189144db9a987c26527d37636\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-抗肿瘤药物技术审评常见问题</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/88905fb06453440e956af3b2914897bf\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024年热门医药企业半年报合集</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/22e95bbdbf364f678820d43e47159c4a\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-药物临床研究基本考虑、试验设计</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/9c2b1ffe196c44a4bc62f5a9c78d819c\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年35份医药行业 IPO 招股书汇总</div></a></div><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/dbc58be8a1af43a185235777f7d59814\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年50份医药行业精选报告汇总</div></a></div></div></div></div> <div class=\"topic-reports-h5-container\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/d07e7e8477de48b68c9db80f6817fe0e\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">医保支付方式（DRG/DIP）改革培训资料</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/054e1039a58b478fa0230794ffb2acc7\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">WCLC 2024 研究报告及临床研究资讯合集</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/a9d9db0e79ad458380ed9a66e048be7d\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-ICH Q2(R2)/Q14指导原则</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/1bba492189144db9a987c26527d37636\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-抗肿瘤药物技术审评常见问题</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/88905fb06453440e956af3b2914897bf\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024年热门医药企业半年报合集</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/22e95bbdbf364f678820d43e47159c4a\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">CDE宣讲会课件资料汇总-药物临床研究基本考虑、试验设计</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/9c2b1ffe196c44a4bc62f5a9c78d819c\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年35份医药行业 IPO 招股书汇总</div></a></div><div class=\"mf-mt-12px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"topic-item mf-cursor-pointer topic-margin show\" data-v-65ceef8e=\"\" data-v-e3a053f2=\"\" href=\"/topic/detail/dbc58be8a1af43a185235777f7d59814\" target=\"_blank\"><div class=\"topic-img\" data-v-e3a053f2=\"\"><!-- --></div> <div class=\"topic-name mf-line-clamp-1\" data-v-e3a053f2=\"\">2024上半年50份医药行业精选报告汇总</div></a></div></div></div></div> <div class=\"home-center-layout mf-mt-20px mf-mb-20px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"margin-left:calc(50vw - 625px);\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" id=\"news\" style=\"position:relative;top:-92px;\"></div> <div class=\"mf-flex flex-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"left-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"news-container mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title-container mf-flex mf-items-end\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"lg-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h2 data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"z-index:2;position:relative;\">医药新闻</h2> <img alt=\"\" class=\"shape\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" src=\"https://vcdn.pharmcube.com/1683869649817_形状结合@2x (1).png\"/></div> <div class=\"app-underline-switcher mf-ml-32px\" data-v-12f9d2f3=\"\" data-v-65ceef8e=\"\"><ul class=\"tabs\" data-v-12f9d2f3=\"\"><li class=\"tab active\" data-v-12f9d2f3=\"\">\n",
       "      魔方原创\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li><li class=\"tab mf-ml-12px\" data-v-12f9d2f3=\"\">\n",
       "      1w+阅读\n",
       "\n",
       "      <em class=\"count\" data-v-12f9d2f3=\"\" style=\"display:none;\"></em> <span data-v-12f9d2f3=\"\"></span></li></ul></div> <a class=\"lg-more alink mf-flex mf-items-center\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?tab=%E9%AD%94%E6%96%B9%E5%8E%9F%E5%88%9B\" target=\"_blank\"><div data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">更多</div> <i class=\"iconfont icon-down1\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></a></div> <div class=\"ant-spin-nested-loading\" data-v-65ceef8e=\"\"><div class=\"ant-spin-container\"><div class=\"reportCommon-container\" data-v-65ceef8e=\"\"><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/51841ff780bf7f422270e48ea7213332\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">融资建厂锐减超6成！创新药过剩产能加速出清</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">过去一年，尤其是2024年初产业里出现的一些变动，让业内感觉国产创新药正在出清，且有所加速了。 一方面，国内Biotech出现了破产清算的案例，随之而来的还有各类重组；另一方面， 具体到产品管线和产能建设上，来自CDE和医药魔方的数据显示，自2021年开始都出现了数量下滑趋势 。 产业出清：从管线到公司。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Invest\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/21e09891ba976e69ffc0613a5e5e9eed.png\"/></div>\n",
       "\n",
       "          医药魔方Invest\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">7小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/d7f14a9a1ea214c54c0b90a81d976002\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>华泰创新药技术研究院</span></a></span></span></div> <!-- --></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/d0c46969a188e3d57621570bf3570ec3\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">联合用药能否出爆款？从贝伐珠单抗说起</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">一个略冷的知识：公认的明星重磅炸弹药物贝伐珠单抗（anti-VEGF单抗），获批的适应症绝大多数都是联合用药，而并非广泛认为的单药。 根据医药魔方NextPharma®数据库，贝伐珠单抗自2004年首次以联用FOLFIR治疗结直肠癌获批在美国上市后，近20年间全球市场（美、欧、日、中）共获批9大癌种47项适应症。 还真未必，至少还有两款明星重磅炸弹也是联合用药的适应症作为主导。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">8小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/7deca95e5f8930c89e46a68331c88ead\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>贝伐珠单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/141fe4725cbb14c02162c103b03a0967\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">科伦博泰Trop2 ADC芦康沙妥珠单抗宫颈癌临床数据亮相ESMO 2024！ADC+肿瘤免疫有望重新定义宫颈癌治疗标准</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">2024年欧洲肿瘤内科学会（ESMO）年会将于2024年9月13日至17日在西班牙巴塞罗那举行，科伦博泰生物（6990.HK）TROP2 ADC芦康沙妥珠单抗（sac-TMT）联合帕博利珠单抗（可瑞达®）用于复发或转移性宫颈癌（CC）患者的疗效及安全性数据摘要已在ESMO官网披露。 宫颈癌发病率居全球妇科三大恶性肿瘤之首，是导致女性癌症死亡的第四大原因。 据世界卫生组织（WHO）统计，2022年全球女性宫颈癌新发病例约66.2万例，占所有肿瘤的3.3%，位居第八，死亡人数约34.9万例，占所有肿瘤的3.6%，位居第九 。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">8小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <div class=\"similar\" data-v-12a4774d=\"\">\n",
       "      1篇相似报道\n",
       "    </div></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/9f44ad9e386cd6d9206802b5bbdc9961\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>科伦博泰生物</span></a></span></span></div> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/cf3f7121a8d0d5fbd82e427640170cd2\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>帕博利珠单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/c478b5698fcf7306423ef70059f962aa\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">全球首个！依沃西单抗挑战K药III期研究取得积极结果</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">9月8日，康方生物在2024世界肺癌大会（WCLC）上发布了PD-1/VEGF双抗依沃西单抗单药对比帕博利珠单抗（K药）单药一线治疗PD-L1表达阳性（PD-L1 TPS≥1%）的局部晚期或转移性非小细胞肺癌（NSCLC）的注册性III期临床研究（HARMONi-2/AK112-303）的重磅研究数据。 该 研究试验组与对照组入组人群基线均衡，其中 PD-L1 TPS≥50%患者的占比为42.2%，与真实世界人群分布一致。 结果显示，在意向治疗人群（ITT）中，依沃西单抗单药相较于K药单药显著延长了患者的无进展生存期（PFS），显著降低了患者的疾病进展或死亡风险（11.14 vs. 5.82个月，HR=0.51，P&lt;0.0001）。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">8小时前</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <div class=\"similar\" data-v-12a4774d=\"\">\n",
       "      1篇相似报道\n",
       "    </div></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/46775102224fc8bc48665c8f6b400f00\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>依沃西单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/fe7f731d6e5fa8e2fcce51db150fc4ea\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">信永中和被书面警示，涉及赛克赛斯IPO项目</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">近日，深交所发出一份《关于对信永中和会计师事务所（特殊普通合伙）、毕强、燕进的监管函》。 招股说明书（申报稿）显示，发行人聘请CSO推广服务商开展调研与咨询、学术推广、展览与宣传及会议会务等推 广活动，2020-2022年各期业务推广费分别为12,933.78万元、20,426.98万元、17,409.30万元，占营业收入比例分别为44.62%、46.72%、39.95%。 中国证监会现场检查发现，发行人业务推广相关内部控制存在薄弱环节，部分推广活动验收存在瑕疵。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Invest\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/21e09891ba976e69ffc0613a5e5e9eed.png\"/></div>\n",
       "\n",
       "          医药魔方Invest\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">昨天 10:06</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div data-v-12a4774d=\"\" data-v-299cff7f=\"\" style=\"height:4px;\"></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/0949ab354c20a4431e71a71d6dabd769\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">纳微科技终止再融资，原计划募资6.7亿元</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">近日，上交所官网显示， 纳微科技 和 保荐人中信证券股份有限公司申请撤回向不特定对象发行可转换公司债券，审核终止。 纳微科技原计划募集资金总额不超过6.7亿元，拟用于以下项目：。 纳微科技专门从事高性能纳米微球材料研发、规模化生产、销售及应用服务，为生物医药、平板显示、分析检测及体外诊断等领域客户提供核心微球材料及相关技术解决方案。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Invest\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/21e09891ba976e69ffc0613a5e5e9eed.png\"/></div>\n",
       "\n",
       "          医药魔方Invest\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">前天 10:09</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div data-v-12a4774d=\"\" data-v-299cff7f=\"\" style=\"height:4px;\"></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/4c6c75b36db7964885619f744e353663\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">新药获批上市，如何对其赛道进行竞争格局调研，确定产品价值 | 新药调研指南01</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">2024 年 8 月 27 日，传奇生物自主研发的 BCMA 靶向 CAR-T 细胞治疗产品卡卫荻®（西达基奥 仑 赛注射液）获得国家药品监督管理局批准上市，用于治疗复发或难治性多发性骨髓瘤成人患者，既往接受过至少三线治疗后进展（至少使用过一种蛋白酶体抑制剂及免疫调节剂）。 NextPharma全球新药数据库提供以下策略来帮助您解决这些问题。 策略1： 对目标所处赛道进行全面透视，纵览全球竞争格局。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Info\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/6ad25aa68a7f2d9979385ef99131cad0.png\"/></div>\n",
       "\n",
       "          医药魔方Info\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">前天 08:55</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/d5482ac5ca989e2c3eb6830f8729a12b\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>传奇生物</span></a></span></span></div> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/0e9b81af3af7abcd1627b87e41f2eb24\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>西达基奥仑赛</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/a5d65db083b31901c57f6caa2adffded\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">慢阻肺病再现突破！GSK美泊利珠单抗III期研究成功</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">9月6日，葛兰素史克（GSK）宣布 Nucala（ 美泊利珠单抗 ）治疗 慢性阻塞性肺病 （简称慢阻肺病， COPD）的III期 MATINEE研究取得了积极结果。 该研究是一项为期52-104周的多中心、随机、双盲、安慰剂对照临床试验（n=806），评估了 美泊利珠单抗（100mg，每4周1次，皮下注射）对比安慰剂作为疾病频繁恶化且血嗜酸性粒细胞水平升高的中度至重度COPD患者在维持治疗之外的附加治疗方案的有效性和安全性 。 结果显示， 治疗104周后， 美泊利珠单抗组患者的年恶化率低于安慰剂组，数据 具有统计学意义和临床意义 。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/271f5c568c58426e49cfff3684270676.png\"/></div>\n",
       "\n",
       "          医药魔方\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">前天 08:29</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><div class=\"drugs mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"drugs-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解企业：</span> <span class=\"drugs-list\" data-v-299cff7f=\"\"><span class=\"mf-tag-company mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\"><a class=\"inside link\" href=\"/investgo/company/detail/f10a428fe5594a04fc9a1438e51144c3\" target=\"_blank\"><img alt=\"\" class=\"company-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1711508728909_企业-彩色.svg\"/> <span>葛兰素史克</span></a></span></span></div> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/07169db6e896dc8d8970fb59289e6508\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>美泊利珠单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/dac03cf5730f16692bb830fe4f71b665\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">Science：阿尔茨海默病新靶点——IDO1</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病。 脑糖代谢受损是AD的一个病理特征。 有神经科学家认为，阿尔茨海默病可能会通过破坏葡萄糖代谢来剥夺大脑功能。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Pro\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/84fad3f676ebd639a89e7abb94b92856.png\"/></div>\n",
       "\n",
       "          医药魔方Pro\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">09-06 21:51</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/e11eae5f4a0b03980e385cb3b2dec43d\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>葡萄糖</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:1;width:calc(100% - 48px);\"></div></div></div><div data-v-65ceef8e=\"\"><div class=\"item-news mf-p-16px mf-pb-12px mf-relative\" data-v-12a4774d=\"\" data-v-65ceef8e=\"\"><div class=\"mf-flex mf-items-center\" data-v-12a4774d=\"\"><a class=\"mf-font-600 mf-text-18px alink news-title mf-block mf-leading-26px\" data-v-12a4774d=\"\" href=\"/news/detail/8e5d17bdebd8077957aac5b6bcf7b130\" target=\"_blank\"><span class=\"highlight-container\" data-v-12a4774d=\"\">康方AK112头对头K药III期数据即将WCLC揭晓，从什么维度来看数据？</span></a> <!-- --></div> <div class=\"subtitle mf-mt-8px mf-h-44px mf-line-clamp-2\" data-v-12a4774d=\"\"><span class=\"highlight-container\" data-v-12a4774d=\"\">9月8日，康方生物全球瞩目的PD-1/VEGF双抗依沃西头对头帕博利珠单抗的III期临床研究数据将正式披露。 为了赢下全球肿瘤免疫药王“K药”，全球众多制药公司做足了努力和探索，付出无数心血，多年来未取得实质性的成功。 依沃西vs K药的这项研究是依沃西（AK112）单药一线治疗PD-L1阳性的非小细胞肺癌的III期头对头临床研究（AK112-303研究或称为HARMONi-2研究）。</span></div> <div class=\"last-line mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><div class=\"mf-flex-wrap mf-flex mf-items-center mf-justify-between\" data-v-12a4774d=\"\"><span class=\"gray-text\" data-v-12a4774d=\"\"><a class=\"dark-link mf-flex mf-items-center mf-justify-start\" data-v-12a4774d=\"\" href=\"/news/summary/source/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9Info\" target=\"_blank\"><div class=\"mf-flex mf-items-center mf-justify-center mf-mr-4px\" data-v-12a4774d=\"\" style=\"\\n              width: 20px;\\n              height: 20px;\\n              border-radius: 50%;\\n              box-shadow: 0px 2px 16px 0px rgba(152, 194, 237, 0.3);\\n            \"><img alt=\"\" class=\"source-logo\" data-v-12a4774d=\"\" referrerpolicy=\"no-referrer\" src=\"https://pharmcube-pat.oss-cn-beijing.aliyuncs.com/wechat_mp_logo/6ad25aa68a7f2d9979385ef99131cad0.png\"/></div>\n",
       "\n",
       "          医药魔方Info\n",
       "          <span class=\"origin-tag mf-ml-4px\" data-v-12a4774d=\"\">\n",
       "            原创\n",
       "          </span></a></span> <span class=\"divider\" data-v-12a4774d=\"\"></span> <span class=\"gray-text\" data-v-12a4774d=\"\">09-06 14:38</span> <span class=\"mf-mr-16px\" data-v-12a4774d=\"\"></span></div> <!-- --></div> <div class=\"block-tags-container mf-mt-8px mf-flex mf-items-center mf-flex-wrap\" data-v-12a4774d=\"\" data-v-299cff7f=\"\"><!-- --> <div class=\"ents mf-inline-flex mf-items-start mf-mr-16px\" data-v-299cff7f=\"\"><span class=\"ents-title mf-my-2px mf-flex-shrink-0 mf-leading-22px\" data-v-299cff7f=\"\">了解药品：</span> <span class=\"ents-list\" data-v-299cff7f=\"\"><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/cf3f7121a8d0d5fbd82e427640170cd2\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>帕博利珠单抗</span></a><a class=\"mf-tag-drug mf-mr-16px mf-my-2px mf-leading-22px drug-nobg\" data-v-299cff7f=\"\" href=\"/nextpharma/drug/detail/46775102224fc8bc48665c8f6b400f00\" target=\"_blank\"><img alt=\"\" class=\"drug-icon\" src=\"https://vcdn.pharmcube.com/drawbed/1705283222635_药品-彩色.svg\"/> <span>依沃西单抗</span></a></span></div></div> <div class=\"bottom-line\" data-v-12a4774d=\"\" style=\"opacity:0;width:calc(100% - 48px);\"></div></div></div> <!-- --></div></div></div> <div class=\"mf-pt-8px mf-pb-20px mf-text-center load-more-container\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"ui-load-more mf-flex mf-items-center mf-justify-center\" data-v-65ceef8e=\"\"><div><button class=\"load-more ant-btn\" data-v-65ceef8e=\"\" type=\"button\"><span>加载更多</span></button></div></div></div></div></div> <div class=\"right-wrap\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"box mf-bg-white mf-rounded-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><div class=\"right-md-title-container rmbq\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><h3 class=\"right-md-title\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\">热门标签</h3> <i class=\"icon iconfont icon-remenbiaoqian\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"></i></div> <div class=\"children mf-p-16px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" style=\"padding-bottom:0.1px;\"><div class=\"mf-mb-8px\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\"><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=FDA\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">FDA</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=%E6%81%92%E7%91%9E%E5%8C%BB%E8%8D%AF\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">恒瑞医药</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=%E8%82%BF%E7%98%A4\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">肿瘤</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=PD1\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">PD1</a><a class=\"mf-mr-12px mf-mb-16px mf-tag-primary mf-inline-block\" data-v-5c8b65e4=\"\" data-v-65ceef8e=\"\" href=\"/news?searchKey=%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97\" style=\"word-break:keep-all;white-space:nowrap;\" target=\"_blank\">流感疫苗</a> <!-- --></div></div></div></div></div></div></div> <!-- --> <div class=\"mffooter\" data-v-5c8b65e4=\"\" data-v-a97d78d2=\"\"><div class=\"inner\" data-v-a97d78d2=\"\"><div class=\"left\" data-v-a97d78d2=\"\"><div class=\"ltop\" data-v-a97d78d2=\"\"><p data-v-a97d78d2=\"\">Copyright©2015-2024</p> <p data-v-a97d78d2=\"\">\n",
       "          备案号:\n",
       "          <a data-v-a97d78d2=\"\" href=\"https://beian.miit.gov.cn\" target=\"_blank\">沪ICP备2024080838号-7</a> <span data-v-a97d78d2=\"\"><img alt=\"备案图标\" data-v-a97d78d2=\"\" src=\"https://vcdn.pharmcube.com/images/common/ico_gongan.png\" style=\"\\n                display: inline-block;\\n                vertical-align: middle;\\n                margin: -1px 2px 0px 17px;\\n              \"/> <a data-v-a97d78d2=\"\" href=\"https://www.beian.gov.cn/portal/registerSystemInfo?recordcode=11010502052237\" target=\"_blank\">沪公网安备31011502401367号</a></span></p> <p data-v-a97d78d2=\"\">\n",
       "          互联网药品信息服务资格证书编号：(沪)-经营性-2024-0212\n",
       "        </p></div> <div class=\"ldown\" data-v-a97d78d2=\"\"><span class=\"iconf iconfont icon-weixin\" data-v-a97d78d2=\"\"><!-- --></span> <a class=\"iconf iconfont icon-weibo\" data-v-a97d78d2=\"\" href=\"https://weibo.com/yiyaomofang\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-zhihu\" data-v-a97d78d2=\"\" href=\"https://www.zhihu.com/org/yi-yao-mo-fang-6 \" target=\"_blank\"></a> <a class=\"iconf iconfont icon-linkedin-fill\" data-v-a97d78d2=\"\" href=\"https://www.linkedin.com/company/%E5%8C%BB%E8%8D%AF%E9%AD%94%E6%96%B9/?viewAsMember=true\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-twitter-fill\" data-v-a97d78d2=\"\" href=\"https://twitter.com/pharmcube\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-facebook-fill\" data-v-a97d78d2=\"\" href=\"https://www.facebook.com/PharmCubeGlobal\" target=\"_blank\"></a> <a class=\"iconf iconfont icon-youtubeyoutube7\" data-v-a97d78d2=\"\" href=\"https://www.youtube.com/channel/UCQReNOQAXp1tmg-YCkrMhfg\" target=\"_blank\"></a></div></div> <div class=\"right\" data-v-a97d78d2=\"\"><svg class=\"icon\" data-v-a97d78d2=\"\" p-id=\"4457\" t=\"1658893879302\" version=\"1.1\" viewbox=\"0 0 2925 1024\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M876.251429 377.173333l-248.685715 115.321905c-17.554286 8.289524-29.013333 25.84381-29.013333 45.348572v306.468571c0 18.529524 19.260952 30.96381 36.083809 23.161905l248.685715-115.321905c17.554286-8.289524 29.013333-25.84381 29.013333-45.348571V400.335238c0-18.529524-19.260952-30.96381-36.083809-23.161905z m-114.834286 291.596191c20.48-9.99619 33.401905-35.352381 33.401905-35.352381l8.045714 4.388571c1.462857 0.731429 1.706667 3.169524 0.487619 5.36381-10.24 18.041905-24.868571 33.401905-41.20381 40.96-30.47619 14.140952-55.344762-3.657143-55.344761-39.984762 0-36.08381 24.868571-77.04381 55.344761-91.184762 16.335238-7.558095 30.96381-5.851429 41.20381 2.681905 1.219048 0.975238 0.975238 3.657143-0.487619 5.851428l-7.070476 10.24s-9.264762-12.190476-31.451429-2.194285c-19.748571 9.020952-41.691429 40.472381-42.422857 67.535238-0.487619 26.331429 17.798095 42.422857 39.497143 31.695238zM633.660952 288.182857l-30.963809-14.628571-52.419048 24.624762 30.476191 14.140952c9.020952 4.144762 32.670476 6.826667 49.980952-1.219048 20.48-9.508571 10.48381-19.260952 2.925714-22.918095z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4458\"></path> <path d=\"M872.838095 333.04381c21.455238-9.99619 21.455238-40.472381 0-50.468572L616.594286 162.620952a90.209524 90.209524 0 0 0-76.068572 0l-256.243809 119.954286c-21.455238 9.99619-21.455238 40.472381 0 50.468572l256.243809 119.954285a90.209524 90.209524 0 0 0 76.068572 0l256.243809-119.954285z m-306.224762-14.140953l-30.47619-14.140952-44.617143 20.967619-19.748571-9.264762 120.685714-56.32a12.190476 12.190476 0 0 1 9.264762 0l45.348571 21.211428c11.946667 5.607619 34.864762 21.942857-0.975238 38.521905-28.038095 13.165714-64.853333 5.851429-79.481905-0.975238zM528.822857 492.495238l-248.685714-116.297143c-16.822857-8.045714-36.327619 4.388571-36.327619 22.918095v306.468572c0 19.504762 11.215238 37.059048 28.769524 45.348571l248.685714 116.297143c16.822857 7.801905 36.327619-4.388571 36.327619-23.161905V537.84381c0-19.504762-11.215238-37.302857-28.769524-45.348572z m-73.142857 218.209524l-16.579048-7.801905v-92.891428l-38.521904 40.228571-38.521905-76.312381v88.259048c0 2.438095-1.706667 3.657143-3.657143 2.681904l-12.921905-6.095238V536.380952c0-2.681905 1.706667-3.900952 3.900953-2.925714l10.483809 4.876191 40.472381 81.188571 39.740952-41.691429c0.731429-0.731429 1.950476-0.975238 3.169524-0.243809l12.434286 5.851428v127.268572z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4459\"></path> <path d=\"M2122.361905 289.889524h153.843809v-22.430476c0-3.169524-2.681905-5.851429-5.851428-5.851429h-147.992381v-9.264762a7.070476 7.070476 0 0 0-7.070476-7.070476h-41.691429v16.335238h-147.992381c-3.169524 0-5.851429 2.681905-5.851429 5.851429v225.523809c0 28.038095-5.851429 45.104762-24.868571 50.712381-2.438095 0.731429-4.144762 2.925714-4.144762 5.607619v27.550476c51.687619 0 72.167619-39.740952 72.167619-83.626666V290.133333H2122.361905z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4460\"></path> <path d=\"M1986.31619 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851429 5.851428h27.062857v-24.380952c0-3.169524-2.681905-5.851429-5.851428-5.851429h-27.062858zM2084.08381 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851428 5.851428h27.062857v-24.380952c0-3.169524-2.681905-5.851429-5.851428-5.851429h-27.062857z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4461\"></path> <path d=\"M2121.142857 310.857143c0-3.169524-2.681905-5.851429-5.851428-5.851429H2072.380952a7.68 7.68 0 0 0-7.558095-7.070476h-35.59619v7.070476h-42.910477c-3.169524 0-5.851429 2.681905-5.851428 5.851429v22.430476h48.761905V365.714286c0 3.413333 2.925714 6.339048 6.339047 6.339047H2072.380952v-39.009523h48.761905v-22.186667zM2274.255238 310.857143c0-3.169524-2.681905-5.851429-5.851428-5.851429h-42.910477a7.68 7.68 0 0 0-7.558095-7.070476h-35.59619v7.070476H2140.647619a7.070476 7.070476 0 0 0-7.070476 7.070476v21.211429h48.761905V365.714286c0 3.413333 2.925714 6.339048 6.339047 6.339047h37.059048v-39.009523h48.761905v-22.186667z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4462\"></path> <path d=\"M2137.478095 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851429 5.851428h27.062857v-24.380952c0-3.169524-2.681905-5.851429-5.851429-5.851429h-27.062857zM2236.464762 341.820952v24.380953c0 3.169524 2.681905 5.851429 5.851428 5.851428h27.062858v-24.380952c0-3.169524-2.681905-5.851429-5.851429-5.851429h-27.062857zM2087.984762 498.834286h30.72v62.902857c0 8.045714 6.582857 14.628571 14.628571 14.628571h135.801905c8.045714 0 14.628571-6.582857 14.628572-14.628571v-36.571429H2250.361905c-3.413333 0-6.095238 2.681905-6.095238 6.095238v11.702858h-76.556191c-3.169524 0-5.851429-2.681905-5.851428-5.851429v-38.278095h93.379047c8.045714 0 14.628571-6.582857 14.628572-14.628572v-88.259047c0-3.169524-2.681905-5.851429-5.851429-5.851429h-161.401905v-6.095238a7.070476 7.070476 0 0 0-7.070476-7.070476h-41.691428V390.095238h-62.415239c-3.169524 0-5.851429 2.681905-5.851428 5.851429v102.887619h57.051428c-3.657143 27.550476-39.009524 45.83619-64.365714 49.005714-2.681905 0.24381-4.87619 2.925714-4.87619 5.851429v24.137142c59.733333 2.194286 101.668571-31.207619 114.590476-78.994285z m61.19619-41.691429h80.944762v13.409524h-80.944762v-13.409524z m80.944762-24.868571h-80.944762v-14.140953h80.944762v14.140953z m-124.342857-13.897143v14.140952h-81.432381v-14.140952h81.432381z m-81.188571 52.175238v-13.409524h81.432381v13.409524h-81.432381z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4463\"></path> <path d=\"M2188.190476 506.148571c-5.851429 0-10.727619 3.900952-11.946666 9.508572l-0.975239 4.144762-3.900952 16.091428h62.171429c1.950476 0 3.413333-1.706667 3.169523-3.657143l-3.169523-17.554285h-22.674286l0.975238 5.12h-12.190476l3.900952-13.653334h-15.36zM1108.601905 576.609524h349.135238V551.009524c0-3.169524-2.681905-5.851429-5.851429-5.851429H1148.586667c-3.169524 0-5.851429-2.681905-5.851429-5.851428V288.914286h309.881905V263.314286c0-3.169524-2.681905-5.851429-5.851429-5.851429H1100.068571c-3.169524 0-5.851429 2.681905-5.851428 5.851429v298.910476c0 7.801905 6.339048 14.384762 14.384762 14.384762z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4464\"></path> <path d=\"M1438.72 403.504762c0-3.169524-2.681905-5.851429-5.851429-5.851429h-104.350476v-37.546666h102.64381v-25.84381c0-3.169524-2.681905-5.851429-5.851429-5.851428h-164.083809l8.289523-13.897143h-56.563809l-14.140952 23.405714c-3.169524 5.36381-9.020952 8.533333-15.116191 8.533333h-0.975238c-3.169524 0-5.851429 2.681905-5.851429 5.851429v22.430476h28.281905c13.409524 0 26.087619-5.36381 35.352381-14.628571h39.009524v37.546666H1175.161905c-3.169524 0-5.851429 2.681905-5.851429 5.851429v25.843809h108.251429c-6.339048 27.794286-30.232381 59.977143-102.4 61.68381-3.169524 0-5.851429 2.681905-5.851429 5.851429v23.161904c69.973333 0 111.420952-18.773333 134.339048-43.885714 22.918095 25.112381 64.609524 43.885714 134.339047 43.885714v-23.405714c0-3.169524-2.438095-5.607619-5.607619-5.607619-72.411429-1.706667-96.304762-33.889524-102.643809-61.68381h108.251428v-25.843809zM1503.329524 550.765714v26.575238l130.438095-13.897142c2.925714-0.24381 5.12-2.925714 5.12-5.851429v-26.575238l-130.438095 13.897143c-2.925714 0.24381-5.12 2.681905-5.12 5.851428zM1845.638095 562.224762v-214.796191c0-3.169524-2.681905-5.851429-5.851428-5.851428h-106.544762l7.558095-12.921905h-56.56381l-12.434285 20.72381c-3.169524 5.36381-9.020952 8.533333-15.116191 8.533333h-0.975238c-3.169524 0-5.851429 2.681905-5.851428 5.851429v22.430476h28.281904c12.678095 0 24.380952-4.87619 33.401905-12.921905h85.089524v172.129524h-101.668571c-3.169524 0-5.607619 2.438095-5.60762 5.607619v25.843809h141.409524c8.289524-0.24381 14.872381-6.826667 14.872381-14.628571z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4465\"></path> <path d=\"M1720.07619 501.76h41.935239L1731.047619 420.08381a5.827048 5.827048 0 0 0-5.363809-3.657143h-41.935239l30.96381 81.67619c0.731429 2.194286 2.925714 3.657143 5.363809 3.657143zM1545.020952 301.348571v8.777143c0 3.169524 2.681905 5.851429 5.851429 5.851429h42.910476v-14.628572h161.401905v8.777143c0 3.169524 2.681905 5.851429 5.851428 5.851429h42.910477v-14.628572h52.419047V275.504762c0-3.169524-2.681905-5.851429-5.851428-5.851429h-46.567619v-18.529523c0-3.169524-2.681905-5.851429-5.851429-5.851429h-42.910476v24.624762h-161.401905v-18.773333c0-3.169524-2.681905-5.851429-5.851428-5.851429h-42.910477v24.624762h-46.811428c-3.169524 0-5.607619 2.438095-5.607619 5.607619v25.843809h52.419047zM1634.742857 328.655238h-65.340952l-63.878095 70.948572c-1.462857 1.706667-2.194286 3.657143-2.194286 5.851428v24.868572h65.340952l-63.878095 71.19238c-0.975238 0.975238-1.462857 2.438095-1.462857 3.900953v16.335238l130.681905-13.897143c2.925714-0.24381 5.12-2.925714 5.12-5.851428V475.428571l-50.468572 5.36381 49.005714-54.369524c0.975238-0.975238 1.462857-2.438095 1.462858-3.900952v-20.48h-70.217143l65.828571-73.386667zM2674.834286 269.897143h-150.430476v-17.310476a7.070476 7.070476 0 0 0-7.070477-7.070477h-41.691428v24.624762h-150.430476a7.070476 7.070476 0 0 0-7.070477 7.070477v24.380952h100.205715l-39.497143 191.634286c-5.607619 27.550476-28.281905 47.542857-49.249524 50.224762-2.925714 0.487619-5.12 2.925714-5.12 5.607619v27.550476c51.687619 0 91.91619-26.575238 101.180952-70.460953l23.405715-113.127619h155.062857l-15.847619 151.893334h-63.634286c-3.169524 0-5.607619 2.438095-5.607619 5.607619l-0.24381 25.843809h104.594286c7.558095 0 13.897143-5.851429 14.384762-13.165714l16.822857-185.782857a14.482286 14.482286 0 0 0-14.384762-15.847619H2455.893333l12.434286-60.220953H2681.904762v-24.380952a7.070476 7.070476 0 0 0-7.070476-7.070476zM1139.809524 662.918095h-41.447619c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h17.798095V736.304762h27.794286c13.409524 0 37.302857-9.752381 37.302857-35.352381 0-32.670476-26.575238-38.034286-37.302857-38.034286z m0 60.708572h-27.794286v-47.786667h28.281905c6.826667 0 20.967619 4.87619 20.967619 23.893333 0 15.60381-13.409524 23.893333-21.455238 23.893334zM1337.539048 667.062857v43.885714h-50.956191v-48.274285h-13.897143c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h17.798096v-53.638095h50.95619v53.638095h17.798095v-114.102857h-13.653333c-2.194286 0.24381-3.900952 2.194286-3.900952 4.388571zM1509.424762 662.918095h-12.434286c-1.706667 0-3.169524 0.975238-3.900952 2.438095l-46.32381 111.664762h18.773334l12.921904-31.939047h46.567619l12.921905 31.939047h18.773334l-46.32381-111.664762-0.975238-2.438095z m-25.84381 69.485715l18.285715-45.836191 18.285714 45.592381-36.571429 0.24381zM1929.99619 664.624762l-42.910476 53.881905-43.885714-55.588572h-11.459048c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h13.897143c2.194286 0 4.144762-1.706667 4.144762-4.144762v-78.994285l41.691429 52.175238 41.447619-52.175238v83.139047h17.798095v-114.102857h-13.165714c-1.462857 0-2.681905 0.487619-3.413334 1.706667zM2313.020952 730.940952c0 8.533333-5.607619 31.695238-30.232381 31.695238-21.942857 0-30.232381-22.918095-30.232381-31.695238V663.161905h-18.041904V731.428571c0 12.921905 4.632381 24.137143 14.140952 33.401905 9.264762 9.264762 20.72381 13.897143 34.133333 13.897143 13.409524 0 24.624762-4.632381 34.133334-13.897143 9.264762-9.264762 14.140952-20.23619 14.140952-33.401905v-68.510476h-18.041905v68.022857zM2502.217143 725.820952c-1.462857-1.950476-3.169524-3.900952-5.12-5.607619-1.950476-1.706667-3.413333-2.681905-4.144762-3.169523a6.680381 6.680381 0 0 0-1.706667-0.975239l2.925715-2.194285c1.950476-1.462857 3.657143-4.144762 5.607619-8.045715 1.950476-3.900952 2.925714-8.045714 2.925714-12.678095 0-7.801905-5.851429-30.232381-33.401905-30.232381h-42.179047c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h48.761904c10.48381 0 19.260952-3.169524 26.087619-9.752381 7.070476-6.826667 10.727619-14.872381 10.48381-24.137142 0-3.900952-0.975238-7.558095-2.438095-10.971429-1.462857-2.681905-2.438095-4.632381-3.657143-6.339048z m-61.68381-50.224762h28.525715c4.388571 0 15.60381 2.438095 15.603809 17.310477 0 13.653333-10.971429 17.310476-15.603809 17.310476h-28.525715v-34.620953z m30.96381 88.746667h-28.525714a2.438095 2.438095 0 0 1-2.438096-2.438095V724.114286h30.96381c5.36381 0 18.773333 5.36381 18.773333 19.504762 0 16.335238-13.653333 20.72381-18.773333 20.723809zM2677.76 764.342857h-60.220952v-38.521905h57.051428v-9.020952c0-2.438095-1.950476-4.144762-4.144762-4.144762h-52.662857v-36.815238h62.902857v-8.533333c0-2.438095-1.950476-4.144762-4.144762-4.144762h-72.167619c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095H2681.904762v-8.533333c0-2.438095-1.950476-4.388571-4.144762-4.388572zM1731.291429 696.07619c-0.975238-25.112381-20.72381-33.158095-34.864762-33.158095h-43.885715c-2.438095 0-4.144762 1.950476-4.144762 4.144762v109.958095h17.798096V731.428571h26.087619l25.35619 45.592381h18.773334L1710.08 731.428571s22.186667-7.801905 21.211429-35.352381z m-35.108572 22.674286h-30.232381v-43.154286h29.013334c7.801905 0 19.748571 4.87619 19.748571 20.48 0.24381 15.36-9.752381 22.674286-18.529524 22.674286zM2133.577143 747.27619s-12.678095 17.310476-35.596191 17.310477c-23.893333 0-43.154286-20.967619-43.154285-44.373334 0-23.405714 19.260952-44.373333 43.154285-44.373333 22.918095 0 35.59619 17.310476 35.596191 17.310476l9.020952-7.558095c1.462857-1.219048 1.706667-3.657143 0.487619-5.12-10.971429-11.946667-27.550476-19.017143-45.104762-19.017143-32.914286 0-59.733333 26.331429-59.733333 58.758095s26.819048 58.758095 59.733333 58.758096c17.798095 0 34.133333-7.070476 45.104762-19.017143 1.219048-1.462857 0.975238-3.657143-0.487619-5.12l-9.020952-7.558096z\" data-v-a97d78d2=\"\" fill=\"#ffffff\" p-id=\"4466\"></path></svg></div> <!-- --></div></div></div> <!-- --> <div data-v-03c3c235=\"\" data-v-5c8b65e4=\"\"><div class=\"subscribe-float toggle-default\" data-v-03c3c235=\"\"><div class=\"ui-subscribe\" data-v-03c3c235=\"\">魔方智选</div> <div class=\"ui-subscribe-expand\" data-v-03c3c235=\"\"><img alt=\"\" class=\"mail\" data-v-03c3c235=\"\" src=\"https://vcdn.pharmcube.com/drawbed/1702970312257_邮件素材.png\"/> <div class=\"bg\" data-v-03c3c235=\"\"><div class=\"left\" data-v-03c3c235=\"\"><div class=\"l1\" data-v-03c3c235=\"\" style=\"white-space: nowrap\">邮件版订阅推送</div> <div class=\"l2\" data-v-03c3c235=\"\" style=\"white-space: nowrap\">\n",
       "            更省心的资讯获取方式\n",
       "          </div></div> <div class=\"subscribe-btn\" data-v-03c3c235=\"\" style=\"white-space: nowrap\">\n",
       "          立即订阅\n",
       "        </div></div></div></div> <div data-v-03c3c235=\"\"><!-- --></div></div> <div data-v-5c8b65e4=\"\" data-v-c131bd44=\"\"><div class=\"yymf_fixed_right\" data-v-c131bd44=\"\"><div class=\"round1\" data-v-c131bd44=\"\" id=\"nct_help\"><a class=\"ceil mf-text-center mf-relative\" data-v-c131bd44=\"\" href=\"https://support.qq.com/product/413758\" id=\"ra\" target=\"_blank\"><i class=\"iconfont icon-wentifankui mf-text-20px-important\" data-v-c131bd44=\"\"></i></a> <div class=\"mf-px-10px\" data-v-c131bd44=\"\"><div class=\"divider\" data-v-c131bd44=\"\"></div></div> <div class=\"ceil mf-text-center mf-relative\" data-v-c131bd44=\"\" id=\"rb\"><i class=\"iconfont icon-saoma mf-text-20px-important\" data-v-c131bd44=\"\"></i></div></div> <div class=\"round2 mf-mt-40px yymf_back\" data-v-c131bd44=\"\"><div class=\"ceil\" data-v-c131bd44=\"\"><i class=\"iconfont icon-backtop\" data-v-c131bd44=\"\"></i></div></div></div></div> <div data-v-5c8b65e4=\"\" style=\"display:none;\"><!-- --> <div class=\"img-list-bottom pointer-auto fadeOut\" style=\"display:none;\"></div></div> <!-- --></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y){B.isLogin=e;return {layout:\"DefaultLayout\",data:[{loginRes:B,wellknownIndustry:[[h,\"西南证券\",\"国金证券\"],[\"浙商证券\",\"华安证券\",\"安信证券\"],[\"湘财证券\",\"东吴证券\"]],industryConference:[[\"ESMO\",\"ASCO\",\"AACR\"],[\"CSCO\",\"SABCS\"]],hotCompany:[[\"罗氏\",\"诺华\",\"辉瑞\"],[\"默沙东\",\"阿斯利康\",\"强生\"],[\"赛诺菲\",\"BMS\",C],[\"吉利德\",\"礼来\",\"百济神州\"]],noCoverListPCList:[{fileName:\"中国新药月报-第24期-2024年7月刊\",esid:\"fc2e735bb74d477cb5e50b6fb44df2ce\",report_product:\"PharmaGO\",publish_date:1723651200000,publish_date_format:\"2024-08-15\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F新药 341723709756250.jpg\"},{fileName:\"全球医药交易月报-2024年7月刊\",esid:\"f291fe66050346c08ae3d0d0ca71e15c\",report_product:i,publish_date:1723564800000,publish_date_format:\"2024-08-14\",report_tags:s,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F7月1723614672702.jpg\"},{fileName:\"全球新药研发进展月报-第40期-2024年7月刊\",esid:\"9ce903ee817040e799110394eabcf239\",report_product:i,publish_date:1723392000000,publish_date_format:\"2024-08-12\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F7月长 341723458061966.jpg\"},{fileName:\"2024年H1 中国医药交易分析报告\",esid:\"7ff2d59d38944fddb6a23418fc42ca2b\",report_product:i,publish_date:1721232000000,publish_date_format:D,report_tags:s,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FH1 341721292897276.jpg\"},{fileName:\"专利调研报告——PARP抑制剂尼拉帕利（Niraparib）\",esid:\"2bba9764b5ad464aabf8c186e6fe09f7\",report_product:\"NextPat\",publish_date:1721145600000,publish_date_format:\"2024-07-17\",report_tags:\"专利洞察\",report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专利 341721207443873.jpg\"},{fileName:\"全球医药交易月报-2024年6月刊\",esid:\"33b2d49875604b24b23eca62681ee9bd\",report_product:i,publish_date:1721059200000,publish_date_format:\"2024-07-16\",report_tags:s,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F交易 341721096767430.jpg\"}],hasCoverListPCList:[{fileName:\"DeepMed临床指南-2024非小细胞肺癌临床指南洞察报告\",esid:\"fc63ee5b0a134e2d966962bd230d90a4\",report_product:t,publish_date:u,publish_date_format:v,report_tags:b,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F普通3_4封面 1 (1)1721009884109.png\"},{fileName:\"DeepMed临床指南-2024乳腺癌临床指南洞察报告\",esid:\"6ba8f4ef44524c21a4ded37ceb6e94db\",report_product:t,publish_date:u,publish_date_format:v,report_tags:b,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F普通3_4封面 1 (2)1721009964407.png\"},{fileName:\"DeepMed临床指南-2024淋巴瘤临床指南洞察报告\",esid:\"9d2660f2d5ff4d9da374ab34baf26370\",report_product:t,publish_date:u,publish_date_format:v,report_tags:b,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F普通3_4封面 11721009706951.png\"},{fileName:\"2024H1医疗健康领域投融资趋势盘点\",esid:\"704ad0dd8ede4a56af5972267a05ca14\",report_product:\"MedAlpha\",publish_date:1720627200000,publish_date_format:\"2024-07-11\",report_tags:E,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F深 (2)(1)1720700943099.jpg\"},{fileName:\"ADC投融资及研发趋势\",esid:\"a46007ee42d2474ca8a468829f2b4f88\",report_product:\"InvestGO\",publish_date:1719504000000,publish_date_format:\"2024-06-28\",report_tags:E,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F深 (2)(1)(1)1719561176565.jpg\"},{fileName:\"2024 ASCO 新药开发机会分析\",esid:\"9e5a43aef9324d0eb1f067be15825e01\",report_product:i,publish_date:1718208000000,publish_date_format:\"2024-06-13\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F深 (2)(1)1718270467948.jpg\"},{fileName:\"2024年中国创新药物研发趋势-附录\",esid:\"c5ff5cc1dbb64298a81b21886d7c68f4\",report_product:i,publish_date:F,publish_date_format:G,report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FChinese innovative drug R&D trends in 2024-附录_001722481601406.png\"},{fileName:\"2024年中国创新药物研发趋势\",esid:\"a94d0641436541ee9fd1557c4b5c6c02\",report_product:i,publish_date:F,publish_date_format:G,report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FChinese innovative drug R&D trends in 2024_001722481559582.png\"},{fileName:\"202310-INT J RHEUM DIS——FDA炎症性关节炎药物监管中种族影响因素研究\",esid:\"81525fd2d8304a81b553c8f4eea06e04\",report_product:i,publish_date:1698595200000,publish_date_format:\"2023-10-30\",report_tags:m,report_list_cover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F企业微信截图_169863715835311698637179245.png\"}],topicListPCList:[{updateTime:a,updateTimeStr:a,esid:\"d07e7e8477de48b68c9db80f6817fe0e\",topicGroupCover:a,title:\"医保支付方式（DRG\\u002FDIP）改革培训资料\",isTop:c,publishTime:1725417815717,publishTimeStr:H,label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FBD21725417720530.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-d07e7e8477de48b68c9db80f6817fe0e.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"054e1039a58b478fa0230794ffb2acc7\",topicGroupCover:a,title:\"WCLC 2024 研究报告及临床研究资讯合集\",isTop:c,publishTime:1725417278440,publishTimeStr:H,label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 81725417648751.png\",status:I,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-054e1039a58b478fa0230794ffb2acc7.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"a9d9db0e79ad458380ed9a66e048be7d\",topicGroupCover:a,title:\"CDE宣讲会课件资料汇总-ICH Q2(R2)\\u002FQ14指导原则\",isTop:c,publishTime:1725012584456,publishTimeStr:\"2024-08-30\",label:[J],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FCDE2 111725012528359.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-a9d9db0e79ad458380ed9a66e048be7d.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"1bba492189144db9a987c26527d37636\",topicGroupCover:a,title:\"CDE宣讲会课件资料汇总-抗肿瘤药物技术审评常见问题\",isTop:c,publishTime:1722590573222,publishTimeStr:\"2024-08-02\",label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FCDE2 11722590440294.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-1bba492189144db9a987c26527d37636.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"88905fb06453440e956af3b2914897bf\",topicGroupCover:a,title:\"2024年热门医药企业半年报合集\",isTop:c,publishTime:1721297909872,publishTimeStr:D,label:[\"企业财报\"],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 111721297863675.png\",status:I,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-88905fb06453440e956af3b2914897bf.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"22e95bbdbf364f678820d43e47159c4a\",topicGroupCover:a,title:\"CDE宣讲会课件资料汇总-药物临床研究基本考虑、试验设计\",isTop:c,publishTime:1720493036308,publishTimeStr:\"2024-07-09\",label:[J],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FCDE21720492942030.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-22e95bbdbf364f678820d43e47159c4a.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"9c2b1ffe196c44a4bc62f5a9c78d819c\",topicGroupCover:a,title:\"2024上半年35份医药行业 IPO 招股书汇总\",isTop:c,publishTime:1720075243831,publishTimeStr:\"2024-07-04\",label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 5 11720075042077.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-9c2b1ffe196c44a4bc62f5a9c78d819c.jpg\"},{updateTime:a,updateTimeStr:a,esid:\"dbc58be8a1af43a185235777f7d59814\",topicGroupCover:a,title:\"2024上半年50份医药行业精选报告汇总\",isTop:c,publishTime:1719286910128,publishTimeStr:\"2024-06-25\",label:[],homeCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002F专题2 4 11719287220313.png\",status:n,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002FspecialTopicNew-dbc58be8a1af43a185235777f7d59814.jpg\"}],reportListPCList:[{fileName:\"医药行业周报：创新催化、政策鼓励支持，医药基本面持续向上复苏\",resource:\"民生证券\",publishDate:p,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-99938f6dd0c34db385840a0b00ac0834.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409091639787582_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:vcrOltVpr774WWa3fkXRwsOJtFg=\",previewFileName:\"H3_AP202409091639787582_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"99938f6dd0c34db385840a0b00ac0834\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"医药周观点：3季度开始，医药板块基本面持续向上，创新催化不断、政策持续鼓励支持，看好板块行情。继续重点关注医药创新（特别是GLP-1）、医疗设备、科学仪器、制剂出海等细分方向。\\u003Cbr\\u003E1）CXO：订单回暖趋势明显，Q2业绩环比改善，CXO板块H2业绩有望延续复苏状态，关注9月美国生物法案进展，建议关注ADC CDMO、临床CRO龙头和GLP-1产业链。2）创新药：司美格鲁肽在中国核心序列专利将在2026年3月20日到期，翰宇药业和丽珠集团均启动司美格鲁肽仿制药III期减重临床，预计2026年将迎来国产司美格鲁肽上市密集期，GLP-1领域研发进展不断，建议关注GLP-1产业链相关药物研发进展。3）中医药：建议关注特色中药与消费中药相关企业业绩持续稳健增长，关注呼吸类产品占比大的中药企业业绩拐点，关注销售费用率下降改善业绩的相关公司。4）疫苗血制品：持续看好静丙行业下半年及明年持续较快发展的弹性和确定性，其次关注下半年浆站数量变化驱动的行业份额变革中的潜在受益公司，疫苗方向关注相对稀缺的带疱疫苗放量为国内公司带来的潜在增量业绩，以及近期流感疫苗外资召回事件驱动的短期投资机会。5）医药上游供应链：创新药全产业链政策落地，伴随投融资底部回升，美国降息预期加强，国内竞争环境开始转好，叠加海外市场开拓，有望带动2024年生科链板块业绩+估值修复，重点关注制药工业端大订单落地以及出海节奏。6）医疗设备与IVD：国内以旧换新政策逐步落地，有望在24H2释放重大增量需求，关注迈瑞医疗、联影医疗、华大智造、山外山，其次重点关注消费型医疗设备的顺周期复苏反弹，如怡和嘉业、鱼跃医疗；IVD方面，关注国内的集采政策落地后具体情况推进和在海外市场的仪器铺货及单产情况。7）医疗服务：关注布局高线城市的刚需医疗服务板块，以及体外基金资产储备充足的相关标的，后续随着公司资金的充裕有望逐步将体外资产收入上市公司体内，提升整体业绩；此外建议重点关注与公立医院形成差异化竞争，或形成优势互补的医疗服务细分板块；8）线下药店：目前行业估值处于历史低位，后续建议重点关注相关上市公司，例如：益丰药房、老百姓、大参林以及一心堂等。9）高值耗材：\\u003Cbr\\u003E持续看好24H1业绩呈现较强景气度趋势的电生理、外周、神经介入领域的中长期成长空间及国产化率提升机遇。10)原料药：原料药企相继通过原料药+制剂\\u002FCDMO\\u002F合成生物学等进行高附加值业务布局，在传统业务利润释放预期渐明背景下，新兴业务有望成为第二增长极，打开公司成长天花板。建议关注华海药业、仙琚制药、川宁生物、奥翔药业等相关行业龙头。11）仪器设备：随着科学仪器需求端触底回暖，以及特别国债驱动的设备增量\\u002F换新订单的扶持，看好下半年及明年科学仪器行业的增速恢复，关注24H1业绩出现强拐点科学仪器龙头。\\u003Cbr\\u003E12）低值耗材：短期关注OEM模式下低耗龙头出海具有持续开拓能力和产品升级的公司，关注相关公司下半年增量客户变化，中长期持续看好GLP-1产业链相关包材、针头产品广阔市场潜力的兑现。\\u003Cbr\\u003E投资建议：建议关注泰格医药、恒瑞医药、百济神州、迈瑞医疗、三友医疗、爱康医疗、圣诺生物、和黄医药、博瑞医药、众生药业、聚光科技、健友股份、诺泰生物、微芯生物、怡和嘉业、康龙化成等。\\u003Cbr\\u003E风险提示：集采压力大于预期风险；产品研发进度不及预期风险；竞争加剧风险；政策监管环境变化风险；药物研发服务市场需求下降的风险。\",report_format:g,report_pages:20,report_size:1.13,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药行业周报：武田1类创新药拟纳入突破性治疗品种\",resource:K,publishDate:p,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-bbd1d34c596d4ece9403a1b1e3c3ff0a.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409091639788125_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:0311VqHTjNWa1MO0wKGxqGjA9x0=\",previewFileName:\"H3_AP202409091639788125_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"bbd1d34c596d4ece9403a1b1e3c3ff0a\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"报告摘要\\u003Cbr\\u003E市场表现：\\u003Cbr\\u003E2024年9月6日，医药板块涨跌幅-1.93%，跑输沪深300指数1.12pct，涨跌幅居申万31个子行业第27名。各医药子行业中，线下药店(-1.26%)、血液制品(-1.40%)、医药流通（-1.42%）表现居前，医疗设备(-2.76%)、医疗研发外包(-2.73%)、疫苗(-2.13%)表现居后。个股方面，日涨幅榜前3位分别为康芝药业(+11.20%)、海南海药(+10.13%)、老百姓(+10.01%)；跌幅榜前3位为海辰药业(-8.34%)、乐心医疗(-7.86%)、纳微科技（-6.85%）。\\u003Cbr\\u003E行业要闻：\\u003Cbr\\u003E9月6日，CDE官网公示，武田（Takeda）的TAK-861片拟纳入突破性治疗品种，针对适应症为发作性睡病1型（NT1）。TAK-861是一种口服食欲素受体2（OX2R）激动剂，旨在通过选择性刺激食欲素受体来解决NT1中的食欲素缺乏问题。\\u003Cbr\\u003E（来源：CDE，太平洋证券研究院）\\u003Cbr\\u003E公司要闻：\\u003Cbr\\u003E卫信康（603676）：公司发布公告，子公司北京藏卫信康医药研发有限公司收到国家药品监督管理局核准签发的去氧胆酸注射液《药物临床试验批准通知书》，同意本品开展临床试验。\\u003Cbr\\u003E亚太药业（002370）：公司发布公告，近日收到国家药品监督管理局下发的关于阿替洛尔片一致性评价的受理通知书，标志着该品种一致性评价工作进入了审评阶段，如顺利通过一致性评价将增加其市场竞争力。\\u003Cbr\\u003E华森制药（002907）：公司发布公告，近日收到新加坡卫生科学局核准签发的中成药注册批文，批准公司产品甘桔冰梅片符合新加坡中成药标准注册，批准其在新加坡上市销售。\\u003Cbr\\u003E亚辉龙（688675）：公司发布公告，近日收到了由BSI Group TheNetherlands B.V.签发的关于公司产品乙型肝炎病毒e抗原检测试剂盒（化学发光法）的IVDR CE最高风险等级Class D认证证书，对于公司具有重要的里程碑意义。\\u003Cbr\\u003E风险提示：新药研发及上市不及预期；政策推进超预期；市场竞争加剧风险。\",report_format:g,report_pages:L,report_size:.36,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药行业周报：安进1类新药在华再获批临床\",resource:K,publishDate:p,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-61a06f9a125c4882a461c9c5975432ec.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409091639788122_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:eBY0BhCfM5jaZIZiyU3ctAsYKaY=\",previewFileName:\"H3_AP202409091639788122_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"61a06f9a125c4882a461c9c5975432ec\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"报告摘要\\u003Cbr\\u003E市场表现：\\u003Cbr\\u003E2024年9月4日，医药板块涨跌幅+0.16%，跑赢沪深300指数0.81pct，涨跌幅居申万31个子行业第3名。各医药子行业中，线下药店(+4.71%)、医药流通(+1.63%)、医疗研发外包（+1.47%）表现居前，疫苗(-1.36%)、其他生物制品(-0.04%)、医院(+0.09%)表现居后。个股方面，日涨幅榜前3位分别为漱玉平民(+19.98%)、人民同泰(+10.09%)、老百姓(+10.03%)；跌幅榜前3位为金石亚药(-5.62%)、普利制药(-5.09%)、东方海洋（-4.10%）。\\u003Cbr\\u003E行业要闻：\\u003Cbr\\u003E9月4，CDE官网公示，安进（Amgen）的1类新药AMG451一项新的临床申请获得批准，适应症为结节性痒疹。AMG451（Rocatinlimab）是一款全人源化抗OX40单克隆抗体在研新药，安进通过一项高达12.5亿美元的合作获得了共同开发和商业化该产品的权益。\\u003Cbr\\u003E（来源：CDE，太平洋证券研究院）\\u003Cbr\\u003E公司要闻：\\u003Cbr\\u003E灵康药业（603669）：公司发布公告，子公司海南灵康制药有限公司近日收到国家药品监督管理局核准签发的注射用头孢唑肟钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。\\u003Cbr\\u003E翰宇药业（300199）：公司发布公告，公司产品生长抑素原料药收到欧洲药品质量管理局签发的CEP证书，为进入欧盟市场开拓了准入通道，有利于公司原料药海外市场的拓展。\\u003Cbr\\u003E天宇股份（300702）：公司发布公告，子公司浙江诺得药业有限公司于近日收到国家药品监督管理局核准签发的关于尼可地尔片的《药品注册证书》，经审查，本品符合药品注册的有关要求，批准注册。\\u003Cbr\\u003E兴齐眼药（300573）：公司发布公告，公司研发的SQ-22031滴眼液于近日完成了“评估SQ-22031滴眼液在健康受试者中单次\\u002F多次给药的安全性、耐受性和药代动力学的单中心、随机、双盲、安慰剂对照I期临床试验”首例受试者入组，正式进入该临床试验。\\u003Cbr\\u003E风险提示：新药研发及上市不及预期；政策推进超预期；市场竞争加剧风险。\",report_format:g,report_pages:L,report_size:.37,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"WCLC 2024 摘要集\",resource:M,publishDate:p,publishDateLong:a,isRecommend:q,isTop:q,fileUrlFlag:w,primaryType:\"行业会议\",isVerify:a,secondaryType:b,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-ad8d10f28c934acd9a3c87c460cbfe18.jpg\",reportListCover:b,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FWCLC 2024 摘要集imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:btSS9kUpuTE7n0Rc56HNvoqe4qA=\",previewFileName:\"WCLC 2024 摘要集imgss0.jpg\",medicalReportTags:[M,N],chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"ad8d10f28c934acd9a3c87c460cbfe18\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:b,report_subtitle:b,report_format:g,report_pages:1627,report_size:35.68,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药魔方核心行业数据监测周报-09月09日\",resource:h,publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:w,primaryType:O,isVerify:a,secondaryType:b,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-1b0c24e8a9444dadaa37ee7793d5724c.jpg\",reportListCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FBydrug上传图片1725786222294.png\",isPharmcubeReport:x,previewFileUrl:a,previewFileName:a,medicalReportTags:[P],chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"1b0c24e8a9444dadaa37ee7793d5724c\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:b,report_subtitle:Q,report_format:g,report_pages:23,report_size:3.36,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"新药周观点：Biotech 2024中报总结，商业化放量步入正轨、亏损持续改善\",resource:\"国投证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-95d65b44db8d475f8006495485005d37.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639786636_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:fT2fTD0Vxa2Xaeysr9ZjnYixsbY=\",previewFileName:\"H3_AP202409081639786636_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"95d65b44db8d475f8006495485005d37\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"本周新药行情回顾：\\u003Cbr\\u003E2024年9月2日-2024年9月6日，新药板块涨幅前5企业：圣诺医药（17.50%）、歌礼制药（14.12%）、云顶新耀（13.53%）、德琪医药（7.81%）、乐普生物（7.03%），跌幅前5企业：宜明昂科（-42.66%）、科济药业（-17.23%）、君圣泰（-17.02%）、欧康维视（-14.03%）、诺思兰德（-13.92%）。\\u003Cbr\\u003E本周新药行业重点分析：\\u003Cbr\\u003E根据最新披露的2024年中报，我们统计分析了65家A股、港股Biotech创新药公司2018年至2024H1的营业收入、归母净利润、研发费用、销售费用、货币资金的变化情况，总体来看目前国内Biotech创新药公司商业化已逐渐进入正轨，亏损开始收窄。\\u003Cbr\\u003E（1）营业收入：国内Biotech创新药企业商业化步入正轨，开始进入加速放量阶段。一方面已上市产品放量开始加速，2024H1年65家A股、港股Biotech创新药公司共实现441.8亿元的营业收入，同比增长35.6%；另一方面整体营收＞1亿元的公司数量也呈现持续增长态势，至2024H1年共有37家公司实现营收＞1亿元，数量同比增长16%。\\u003Cbr\\u003E（2）归母净利润：国内Biotech创新药企业亏损大幅收窄，开始逐年改善。2024H1年65家A股、港股Biotech创新药公司总体归母净利润为-61.6亿元，相对2023H1年的-139.3亿元实现大幅减亏。我们认为这一变化主要由三方面因素驱动，一是随商业化进入正轨带动总体营收的上升，二是研发投入端费用增长放缓，三是部分公司（如百利天恒）海外授权收入激增。预计随未来产品放量趋势的放大Biotech创新药公司的净利润将进一步改善。\\u003Cbr\\u003E（3）研发费用：国内Biotech创新药企业研发投入开始放缓。2024H1年65家A股、港股Biotech创新药公司总体研发费用为219.0亿元，同比减少1%，表明创新药领域研发投入放缓，我们认为这一变化主要受投融资环境的影响，以及研发费用基数本身较大所致。（4）销售费用：国内Biotech创新药企业销售费用随营收增长持续提升，但销售费用率有所下滑。2024H1年65家A股、港股Biotech创新药公司总体销售费用为227.8亿元，同期销售费用率达33%，相对2023年有所下滑。\\u003Cbr\\u003E（5）货币资金：国内Biotech创新药企业现金储备呈小幅下滑态势核心Biotech公司储备充足。2024H1年65家A股、港股Biotech创新药公司总体货币资金为938.7亿元，同比减少15%；整体来看，目\\u003Cbr\\u003E前Biotech创新药公司现金储备呈小幅下滑态势；截止0885438992024年6月30日，货币资金＞10亿元Biotech创新药公司共有28家，核心Biotech公司现金储备充足。\\u003Cbr\\u003E本周新药获批&受理情况：\\u003Cbr\\u003E本周国内17个新药获批IND，42个新药IND获受理，7个新药NDA获受理。\\u003Cbr\\u003E本周国内新药行业TOP3重点关注：\\u003Cbr\\u003E（1）9月5日，CDE官网公示恒瑞医药的口服高选择性JAK1抑制剂硫酸艾玛昔替尼片新适应症上市申请获得受理。\\u003Cbr\\u003E（2）9月4日，信达生物宣布其PD-1\\u002FIL-2α-bias双特异性抗体融合蛋白IBI363获得FDA授予快速通道资格。\\u003Cbr\\u003E（3）9月4日，岸迈生物与Vignette Bio公司宣布，双方就岸迈生物靶向BCMA的T细胞接合分子EMB-06达成了一项授权许可协议。\\u003Cbr\\u003E本周海外新药行业TOP3重点关注：\\u003Cbr\\u003E（1）9月7日，GSK宣布其靶向IL-5的“first-in-class”抗体疗法Nucala，在治疗成人慢性阻塞性肺病患者的3期临床试验MATINEE中获得积极结果。\\u003Cbr\\u003E（2）9月6日，礼来宣布了QWINT-1和QWINT-3两项3期临床试验的积极顶线结果。在这两项试验中，efsitora与每日基础胰岛素相比在降低糖化血红蛋白水平效果上达非劣效性。\\u003Cbr\\u003E（3）9月4日，默沙东宣布欧盟委员会已批准PD-1抑制剂Keytruda与安斯泰来和辉瑞旗下Seagen开发的抗体偶联药物Padcev联用，作为一线治疗不可切除或转移性尿路上皮癌成人患者的治疗方案。\\u003Cbr\\u003E风险提示：临床试验进度不及预期的风险，临床试验结果不及预期的风险，医药政策变动的风险，创新药专利纠纷的风险。\",report_format:g,report_pages:R,report_size:.93,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药行业周报：Pharma创新成果显著，迈入商业化收获阶段\",resource:\"华源证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-3bb9f1c2c9484d07aca443c140648feb.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639787066_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:ky0hPeXymAMrMD2waW9eCGyZVDU=\",previewFileName:\"H3_AP202409081639787066_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"3bb9f1c2c9484d07aca443c140648feb\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"投资要点：\\u003Cbr\\u003E本周医药市场表现分析：本周沪深300指数下跌（-2.70%），医药行业下滑(-2.05%)，整体板块缺少主线，个股涨幅方面，本周漱玉平民、老百姓等药店标的超跌反弹。近期医药整体行情表现疲软，短期建议关注：1）超跌、边际预期改善个股：在市场风格、医药政策等因素影响下，前期多个板块和个股跌幅显著如医疗设备（开立医疗、澳华内镜等），建议积极关注后续边际变化；2）院内资产：\\u003Cbr\\u003E从已公布的半年报来看，众多pharma的业绩已经触底反弹，展现了较强增长韧性，诊疗需求稳步提升，建议关注集采出清、新品放量的标的；3）创新药\\u002F械：顶层支持、产业趋势明确，创新品种正进入放量阶段，持续看好优质创新药\\u002F械个股；4）出海：全球市场容量更大，客户群体众多，长期对于公司丰富收入维度，规避局部风险较为重要，持续看好具有稳定出海能力的标的。\\u003Cbr\\u003E医药指数和各细分领域表现、涨跌幅：本周医药指数下滑（-2.05%），上涨个股数量97家，下跌个股数量392家。本周，医药商业（+1.8%）、化学制剂（-1.0%）相对表现较好，生物制品（-3.3%）、化学原料药（-3.0%）相对表现较差；年初以来，化学制剂（-14.3%）、化学原料药（-16.4%）和中药（-17.1%）相对表现较好，医疗服务（-41.5%）、生物制品（-35.9%）及医药生物（-25.1%）相对表现较差。\\u003Cbr\\u003E传统pharma和Biopharma中报业绩表现较好，创新转型成果显著。传统pharma和Biopharma中报业绩表现较好，创新转型成果显著。2018年至今仿制药集采已经过九批，对部分传统pharma业绩影响已显著消化，且随着创新药增长，该类公司收入结构已显著改善，创新药已经成为公司增长主要动力。中长期看，中国创新药已进入商业化快速兑现阶段，海外合作\\u002F销售加速，如康方生物卡度尼利2023首个上市完整年实现销售13.6亿元，艾力斯伏美替尼销售从2021年的2.36亿元到2023年19.8亿元，创新药商业化结果十分可观。此外，近些年部分Bioparma通过早期聚焦某一细分品种，借助产品优势在细分领域占据优势，产品快速商业化。整体来看：中国创新药已进入商业化兑现阶段，头部药企商业化优势显著，业绩兑现度高、速度快，看好传统Pharma和Biopharma。\\u003Cbr\\u003E投资观点及建议关注标的：年初以来医药指数下跌超25%，估值处于历史低位，基金持仓预计亦处于历史相对较低位置。2024年半年报已全部披露，展望三季度和四季度，医药基本面有望逐步企稳回升，业绩有望逐季度边际好转，结构性高增长的细分领域和个股值得期待。当前位置适合战略性布局建议关注以下方向：1）创新药械：建议关注恒瑞医药、和黄医药、科伦博泰、翰森制药、康方生物、信达生物、康诺亚、泽璟制药、信立泰、海思科、赛诺医疗等；2）出海：建议关注迈瑞医疗、联影医疗、三诺生物、美好医疗、福瑞股份、新产业、万孚生物、健友股份、科兴制药等；3？）老龄化及院外消费：建议关注鱼跃医疗、九典制药、可孚医疗、昆药集团、华润三九、太极集团、羚锐制药等；4）高壁垒行业：建议关注麻药（人福医药、恩华药业、国药股份等）、血制品（派林生物、天坛生物、博雅生物等）；5）国产替代：建议关注开立医疗、澳华内镜、惠泰医疗、微电生理等。6）小而美标的：建议关注百洋医药、普门科技、方盛制药、立方制药、麦澜德等。\\u003Cbr\\u003E本周投资组合：三诺生物、美好医疗、康方生物、派林生物、百洋医药。\\u003Cbr\\u003E本月投资组合：昆药集团、和黄医药、三诺生物、派林生物、美好医疗。\\u003Cbr\\u003E风险提示：行业竞争加剧风险，政策变化风险，行业需求不及预期风险。\",report_format:g,report_pages:14,report_size:1.39,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药生物：关注ODAC，PD1双抗或将改变晚期胃癌免疫治疗认识\",resource:\"华福证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-356e990eb32e484196e5ff9fd1dc6ab0.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639786028_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:5Z7Knk1Cnw2B6sdQ-xFR8cpnG28=\",previewFileName:\"H3_AP202409081639786028_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"356e990eb32e484196e5ff9fd1dc6ab0\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"投资要点：\\u003Cbr\\u003E行情回顾：本周（2024年9月2日-9月6日）中信医药指数下跌2.0%，跑赢沪深300指数0.7pct，在中信一级行业分类中排名第16位；2024年初至今中信医药生物板块指数下跌23.9%，跑输沪深300指数18.0pct，在中信行业分类中排名第26位。\\u003Cbr\\u003E关于月底ODAC会议：胃癌中PD-1单抗对不同PD-L1表达水平获益评估：目前获批的ICIs在胃癌中未限制PD-L1表达水平，2024年9月26日，FDA将召开肿瘤咨询委员会（ODAC）讨论会，主要讨论不同PD-L1表达水平人群的不同风险-获益评估，以及累积数据是否足以说明应根据PD-L1表达水平限制ICIs适应症人群。K药和O药的3期临床研究显示PD-L1低表达\\u002F阴性接受PD-1抗体免疫治疗的疗效普遍不佳（OS HR＞0.9），占比约50%低表达胃癌人群仍存在大量没有被满足的需求。康方生物的全球首创PD-1\\u002FCTLA-4双抗卡度尼利在PD-L1CPS＜5（PD-L1低表达）人群也具有良好抗肿瘤治疗作用，PFSHR=0.60，OSHR=0.70。卡度尼利解决了目前临床上单靶点免疫疗法不能解决的问题，很好地体现了“抗PD-1+抗CTLA-4”的双重免疫治疗协同增效的作用机制，成为胃癌免疫治疗差异化的“增量”，有望弥补当前晚期胃癌免疫治疗策略的不足，是晚期胃癌中潜在更优的免疫疗法，建议关注：康方生物。\\u003Cbr\\u003E本周市场复盘及中短期投资思考：本周A\\u002FH股医药指数均下跌，但均跑赢大盘，主要系大盘石油石化等权重板块跌幅较大所致，医药板块中药店板块涨幅明显，主要系跌幅带、估值低，叠加了“美好生活概念”，而创新药械和医疗服务板块跌幅较多，市场无明确主线。医药成交量占市场比例持续下行，周五占比仅6.4%。我们认为中报利空落地后医药有相对优势，Q3行业同比增速向上，接来下还有创新药产业链支持政策落地和医保谈判开始等催化，行业整体趋势向上。当前我们继续推荐Pharma、创新药以及大品种方向，及寻增量为最有前途，资金容纳量最大的方向，建议加大配置力度，24年下半年医药大概率有超额收益。\\u003Cbr\\u003E中长期配置思路：根据医药-供给，人口-需求、医保-支付、医疗-结构的分析框架，我们在《医药新常态，路在何方？——调存量、寻增量、抓变量》报告中提出在行业进入新常态的大背景下，调存量（老龄化+进口替代）、寻增量（出海+大品种+仿转创）和抓变量（国企改革）或成为中长期医药投资关键词。详细方向及标的见后文。\\u003Cbr\\u003E本周建议关注组合：恒瑞医药、康方生物、康哲药业、悦康药业、圣诺生物、三诺生物。\\u003Cbr\\u003E九月建议关注组合：恒瑞医药、康方生物、新诺威、美好医疗、诺泰生物、圣诺生物。\\u003Cbr\\u003E风险提示\\u003Cbr\\u003E行业需求不及预期；公司业绩不及预期；市场竞争加剧风险。\",report_format:g,report_pages:R,report_size:1.93,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药生物行业周报：中药及商业板块整体略显承压，部分个股表现亮眼\",resource:\"开源证券\",publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:j,primaryType:k,isVerify:a,secondaryType:l,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-b65b7f0a0ed5475483fb2ef38048fc03.jpg\",reportListCover:a,isPharmcubeReport:e,previewFileUrl:\"https:\\u002F\\u002Fshare.pharmcube.com\\u002FH3_AP202409081639786701_1imgss0.jpg?e=1725875436&token=IJD70koyeaTSy1xsgdJ-GQMlQg0-PmIgWJ7oskyr:4urt9K38t9CQiD05TshJsJ2EPGA=\",previewFileName:\"H3_AP202409081639786701_1imgss0.jpg\",medicalReportTags:a,chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"b65b7f0a0ed5475483fb2ef38048fc03\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:a,report_subtitle:\"中药及商业板块整体略显承压，部分个股表现亮眼\\u003Cbr\\u003E截至2024年8月31日，中药及商业板块公司公告2024上半年业绩，业绩表现整体略显承压。我们汇总了多数中药及商业企业的2024上半年业绩表现的影响因素及个股实现积极业绩的原因。\\u003Cbr\\u003E中药板块：（1）中药创新药企业：部分企业受2023H1高基数、产品集采降价等影响因而业绩承压，但如方盛制药在部分集采产品稳健销售的同时，渠道覆盖稳步推进，促使创新中药产品实现较快速的销售增长，实现营业收入9.10亿元，同比增长6.44%。（2）OTC及消费类企业：部分企业受2023H1高基数、比价政策、核心药品市场需求下降、消费疲软影响大健康业务等因素致使业绩承压，但如羚锐制药受益于人口老龄化长期发展逻辑，核心产品销售实现较高增长，实现营业收入19.06亿元，同比增长12.07%；佐力药业乌灵胶囊具备“医保+基药”双目录资质，叠加集采大规格替换进而快速放量，实现营业收入14.28亿元，同比增长41.21%；东阿阿胶深抓品牌效用，强化营销深挖客户群体，在消费疲软的当下仍实现业绩的快速增长，实现营业收入27.48亿元，同比增长26.80%。（3）国企改革：部分企业受经营战略调整、业务结构优化等因素影响致使业绩承压，但华润三九在业务结构与运营效率持续优化的过程中，核心CHC业务稳健拓展，带动业绩呈现较好增长，实现营业收入141.06亿元，同比增长7.30%。\\u003Cbr\\u003E商业板块：（1）零售药店企业：企业营业收入均实现不同程度增长，主要系原有门店的内生增长及新开、并购而新增门店的业绩贡献，但在毛利率承压、较为刚性的费用支出等影响下大部分企业利润端略显承压，但如益丰药房则凭借管理效益的提升缓解了费用端带来的经营压力，实现归母净利润7.98亿元，同比增长13.13%。（2）医药流通企业：由于流通企业面临药品、器械等多类产品的分销工作，因而面临来自药品季节性销售、药械集采等方面的影响而使业绩承压，但如百洋医药以核心的较高营收占比、高毛利的CSO业务为抓手，通过形成品牌矩阵，促使增长动能持续增强，实现归母净利润3.69亿元，同比增长21.89%。\\u003Cbr\\u003E推荐标的\\u003Cbr\\u003E推荐标的：制药及生物制品：泽璟制药、和黄医药、科伦博泰生物-B、恒瑞医药、人福医药、九典制药、恩华药业、康诺亚、智翔金泰、三生国健、艾迪药业、京新药业、健康元、丽珠集团、东诚药业；中药：悦康药业、方盛制药、羚锐制药、佐力药业、济川药业、昆药集团；医疗器械：奥泰生物、可孚医疗、迈瑞医疗、开立医疗、澳华内镜、海泰新光、戴维医疗、海尔生物、振德医疗、安杰思、三诺生物；原料药：华海药业、奥锐特、普洛药业、博瑞医药；CXO：诺泰生物、圣诺生物、药明合联、泰格医药；科研服务：皓元医药、毕得医药、昊帆生物、百普赛斯、奥浦迈、药康生物；医疗服务：海吉亚医疗、美年健康；零售药店：益丰药房、健之佳；疫苗：康泰生物。\\u003Cbr\\u003E风险提示：政策波动风险、市场震荡风险、竞争加剧风险等。\",report_format:g,report_pages:12,report_size:1.46,report_language:a,report_playback:a,is_personal_information:a,tag:a},{fileName:\"医药魔方核心行业数据监测周报EN-09月09日\",resource:h,publishDate:o,publishDateLong:a,isRecommend:d,isTop:a,fileUrlFlag:w,primaryType:O,isVerify:a,secondaryType:b,previewFilePages:a,previewFile:a,qrcodeUrl:\"https:\\u002F\\u002Fwx.pharmcube.com\\u002Fqrcode-05f71a4840604c3baa6d7c259e96e48a.jpg\",reportListCover:\"https:\\u002F\\u002Fdoc.pharmcube.com\\u002FBydrug上传图片1725786322369.png\",isPharmcubeReport:x,previewFileUrl:a,previewFileName:a,medicalReportTags:[P],chartDataList:a,chartDataCount:a,isYymfFile:a,recommendCount:a,relateProducts:a,esid:\"05f71a4840604c3baa6d7c259e96e48a\",relate_newslibrary:a,relate_resource:a,relate_list:a,report_detail_cover:a,report_share_cover:a,report_product:a,report_tags:b,report_subtitle:Q,report_format:g,report_pages:33,report_size:2.54,report_language:a,report_playback:a,is_personal_information:a,tag:a}],newsPCList:[{abstracts:\"过去一年，尤其是2024年初产业里出现的一些变动，让业内感觉国产创新药正在出清，且有所加速了。 一方面，国内Biotech出现了破产清算的案例，随之而来的还有各类重组；另一方面， 具体到产品管线和产能建设上，来自CDE和医药魔方的数据显示，自2021年开始都出现了数量下滑趋势 。 产业出清：从管线到公司。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"51841ff780bf7f422270e48ea7213332\",title:\"融资建厂锐减超6成！创新药过剩产能加速出清\",resource:y,publishTime:\"2024-09-09 08:41\",tags:[h,\"创新药\"],logo:z,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:[{data_show_name:\"华泰创新药技术研究院\",data_execute_skip:c,data_esid:\"d7f14a9a1ea214c54c0b90a81d976002\"}]},{abstracts:\"一个略冷的知识：公认的明星重磅炸弹药物贝伐珠单抗（anti-VEGF单抗），获批的适应症绝大多数都是联合用药，而并非广泛认为的单药。 根据医药魔方NextPharma®数据库，贝伐珠单抗自2004年首次以联用FOLFIR治疗结直肠癌获批在美国上市后，近20年间全球市场（美、欧、日、中）共获批9大癌种47项适应症。 还真未必，至少还有两款明星重磅炸弹也是联合用药的适应症作为主导。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"d0c46969a188e3d57621570bf3570ec3\",title:\"联合用药能否出爆款？从贝伐珠单抗说起\",resource:h,publishTime:A,tags:[h],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"7deca95e5f8930c89e46a68331c88ead\",drug_earth_title:\"贝伐珠单抗\"}],company_ids_bind_list:a},{abstracts:\"2024年欧洲肿瘤内科学会（ESMO）年会将于2024年9月13日至17日在西班牙巴塞罗那举行，科伦博泰生物（6990.HK）TROP2 ADC芦康沙妥珠单抗（sac-TMT）联合帕博利珠单抗（可瑞达®）用于复发或转移性宫颈癌（CC）患者的疗效及安全性数据摘要已在ESMO官网披露。 宫颈癌发病率居全球妇科三大恶性肿瘤之首，是导致女性癌症死亡的第四大原因。 据世界卫生组织（WHO）统计，2022年全球女性宫颈癌新发病例约66.2万例，占所有肿瘤的3.3%，位居第八，死亡人数约34.9万例，占所有肿瘤的3.6%，位居第九 。\",isFullText:c,isRecommend:f,foldNewsCount:q,esid:\"141fe4725cbb14c02162c103b03a0967\",title:\"科伦博泰Trop2 ADC芦康沙妥珠单抗宫颈癌临床数据亮相ESMO 2024！ADC+肿瘤免疫有望重新定义宫颈癌治疗标准\",resource:h,publishTime:A,tags:[\"科伦博泰\",\"宫颈癌\",\"Trop2\"],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:S,drug_earth_title:T}],company_ids_bind_list:[{data_show_name:\"科伦博泰生物\",data_execute_skip:c,data_esid:\"9f44ad9e386cd6d9206802b5bbdc9961\"}]},{abstracts:\"9月8日，康方生物在2024世界肺癌大会（WCLC）上发布了PD-1\\u002FVEGF双抗依沃西单抗单药对比帕博利珠单抗（K药）单药一线治疗PD-L1表达阳性（PD-L1 TPS≥1%）的局部晚期或转移性非小细胞肺癌（NSCLC）的注册性III期临床研究（HARMONi-2\\u002FAK112-303）的重磅研究数据。 该 研究试验组与对照组入组人群基线均衡，其中 PD-L1 TPS≥50%患者的占比为42.2%，与真实世界人群分布一致。 结果显示，在意向治疗人群（ITT）中，依沃西单抗单药相较于K药单药显著延长了患者的无进展生存期（PFS），显著降低了患者的疾病进展或死亡风险（11.14 vs. 5.82个月，HR=0.51，P\\u003C0.0001）。\",isFullText:c,isRecommend:f,foldNewsCount:q,esid:\"c478b5698fcf7306423ef70059f962aa\",title:\"全球首个！依沃西单抗挑战K药III期研究取得积极结果\",resource:h,publishTime:A,tags:[\"PDL1\",\"K药\"],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:U,drug_earth_title:V}],company_ids_bind_list:a},{abstracts:\"近日，深交所发出一份《关于对信永中和会计师事务所（特殊普通合伙）、毕强、燕进的监管函》。 招股说明书（申报稿）显示，发行人聘请CSO推广服务商开展调研与咨询、学术推广、展览与宣传及会议会务等推 广活动，2020-2022年各期业务推广费分别为12,933.78万元、20,426.98万元、17,409.30万元，占营业收入比例分别为44.62%、46.72%、39.95%。 中国证监会现场检查发现，发行人业务推广相关内部控制存在薄弱环节，部分推广活动验收存在瑕疵。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"fe7f731d6e5fa8e2fcce51db150fc4ea\",title:\"信永中和被书面警示，涉及赛克赛斯IPO项目\",resource:y,publishTime:\"2024-09-08 10:06\",tags:[\"克赛\",\"信永中和\"],logo:z,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:a},{abstracts:\"近日，上交所官网显示， 纳微科技 和 保荐人中信证券股份有限公司申请撤回向不特定对象发行可转换公司债券，审核终止。 纳微科技原计划募集资金总额不超过6.7亿元，拟用于以下项目：。 纳微科技专门从事高性能纳米微球材料研发、规模化生产、销售及应用服务，为生物医药、平板显示、分析检测及体外诊断等领域客户提供核心微球材料及相关技术解决方案。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"0949ab354c20a4431e71a71d6dabd769\",title:\"纳微科技终止再融资，原计划募资6.7亿元\",resource:y,publishTime:\"2024-09-07 10:09\",tags:[\"纳微科技\"],logo:z,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[],company_ids_bind_list:a},{abstracts:\"2024 年 8 月 27 日，传奇生物自主研发的 BCMA 靶向 CAR-T 细胞治疗产品卡卫荻®（西达基奥 仑 赛注射液）获得国家药品监督管理局批准上市，用于治疗复发或难治性多发性骨髓瘤成人患者，既往接受过至少三线治疗后进展（至少使用过一种蛋白酶体抑制剂及免疫调节剂）。 NextPharma全球新药数据库提供以下策略来帮助您解决这些问题。 策略1： 对目标所处赛道进行全面透视，纵览全球竞争格局。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"4c6c75b36db7964885619f744e353663\",title:\"新药获批上市，如何对其赛道进行竞争格局调研，确定产品价值 | 新药调研指南01\",resource:W,publishTime:\"2024-09-07 08:55\",tags:[\"BCMA\",i,\"多发性骨髓瘤\"],logo:X,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"0e9b81af3af7abcd1627b87e41f2eb24\",drug_earth_title:\"西达基奥仑赛\"}],company_ids_bind_list:[{data_show_name:\"传奇生物\",data_execute_skip:c,data_esid:\"d5482ac5ca989e2c3eb6830f8729a12b\"}]},{abstracts:\"9月6日，葛兰素史克（GSK）宣布 Nucala（ 美泊利珠单抗 ）治疗 慢性阻塞性肺病 （简称慢阻肺病， COPD）的III期 MATINEE研究取得了积极结果。 该研究是一项为期52-104周的多中心、随机、双盲、安慰剂对照临床试验（n=806），评估了 美泊利珠单抗（100mg，每4周1次，皮下注射）对比安慰剂作为疾病频繁恶化且血嗜酸性粒细胞水平升高的中度至重度COPD患者在维持治疗之外的附加治疗方案的有效性和安全性 。 结果显示， 治疗104周后， 美泊利珠单抗组患者的年恶化率低于安慰剂组，数据 具有统计学意义和临床意义 。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"a5d65db083b31901c57f6caa2adffded\",title:\"慢阻肺病再现突破！GSK美泊利珠单抗III期研究成功\",resource:h,publishTime:\"2024-09-07 08:29\",tags:[C,\"慢阻肺\",\"III期\"],logo:r,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"07169db6e896dc8d8970fb59289e6508\",drug_earth_title:\"美泊利珠单抗\"}],company_ids_bind_list:[{data_show_name:\"葛兰素史克\",data_execute_skip:c,data_esid:\"f10a428fe5594a04fc9a1438e51144c3\"}]},{abstracts:\"阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病。 脑糖代谢受损是AD的一个病理特征。 有神经科学家认为，阿尔茨海默病可能会通过破坏葡萄糖代谢来剥夺大脑功能。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"dac03cf5730f16692bb830fe4f71b665\",title:\"Science：阿尔茨海默病新靶点——IDO1\",resource:\"医药魔方Pro\",publishTime:\"2024-09-06 21:51\",tags:[\"IDO1\",\"阿尔茨海默病\"],logo:\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F84fad3f676ebd639a89e7abb94b92856.png\",content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:\"e11eae5f4a0b03980e385cb3b2dec43d\",drug_earth_title:\"葡萄糖\"}],company_ids_bind_list:a},{abstracts:\"9月8日，康方生物全球瞩目的PD-1\\u002FVEGF双抗依沃西头对头帕博利珠单抗的III期临床研究数据将正式披露。 为了赢下全球肿瘤免疫药王“K药”，全球众多制药公司做足了努力和探索，付出无数心血，多年来未取得实质性的成功。 依沃西vs K药的这项研究是依沃西（AK112）单药一线治疗PD-L1阳性的非小细胞肺癌的III期头对头临床研究（AK112-303研究或称为HARMONi-2研究）。\",isFullText:c,isRecommend:f,foldNewsCount:d,esid:\"8e5d17bdebd8077957aac5b6bcf7b130\",title:\"康方AK112头对头K药III期数据即将WCLC揭晓，从什么维度来看数据？\",resource:W,publishTime:\"2024-09-06 14:38\",tags:[N],logo:X,content:a,is_top:f,is_yymf_original:c,earth_ids_bind_list:[{drug_earth_esid:S,drug_earth_title:T},{drug_earth_esid:U,drug_earth_title:V}],company_ids_bind_list:a}],hotNewsTags:[\"FDA\",\"恒瑞医药\",\"肿瘤\",\"PD1\",\"流感疫苗\"],bydrugURL:\"https:\\u002F\\u002Fbydrug.pharmcube.com\",baseURL:\"https:\\u002F\\u002Fpharmcube.com\"}],fetch:{},error:a,state:{isLogin:e,isVip:void 0,applyModalOpen:e,remainCount:d,userInfo:B,realPhone:b,secretPhone:b,memberId:b,downloadItem:{esid:b,fileUrlFlag:b},ts:b,chartPreviewOpen:e,chartPreviewList:[],chartPreviewItem:{},chartPreviewIndex:d,chartSignalPage:b,noticePreviewOpen:e,noticePreviewList:[],noticePreviewItem:{},noticePreviewIndex:d,noticeSignalPage:b,outLinkCheckShow:e,outLinkUrl:b,isCopyout:e,downloadCheckShow:e,report_params_cache:{\"报告分类\":b,\"报告分类二级\":b,\"发布时间\":b,\"报告页数\":b,\"报告格式\":b,\"报告语言\":b,\"搜索\":b,\"页码\":b},news_params_cache:{\"检索\":b,\"发布时间\":b,\"内容分类\":b,tab:b,\"页码\":b},chart_params_cache:{},paramCheckShow:e,userForm:{},formSetting:{},ShowLogin:e,drawerShow:e,drawerActiveEsid:b,mfNavDisapper:e,noticeCount:d},serverRendered:x,routePath:Y,config:{_app:{basePath:Y,assetsPath:\"\\u002F_nuxt\\u002F\",cdnURL:a}}}}(null,\"\",\"是\",0,false,\"否\",\"pdf\",\"医药魔方\",\"NextPharma\",\"05\",\"行业研究\",\"行业报告\",\"新药研发\",\"更新完成\",\"2024-09-08\",\"2024-09-09\",1,\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F271f5c568c58426e49cfff3684270676.png\",\"医药交易\",\"DeepMed\",1720972800000,\"2024-07-15\",\"01\",true,\"医药魔方Invest\",\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F21e09891ba976e69ffc0613a5e5e9eed.png\",\"2024-09-09 08:27\",{},\"GSK\",\"2024-07-18\",\"投融资\",1722355200000,\"2024-07-31\",\"2024-09-04\",\"更新中\",\"CDE培训\",\"太平洋\",3,\"WCLC\",\"WCLC 2024\",\"魔方报告\",\"魔方周报\",\"\\u003Cp\\u003E感谢您关注魔方数据服务，上周行业动态重点事件如下，供您参考：\\r\\n1.一年长高11厘米！诺和诺德长效生长激素在华申报上市；\\r\\n2.国家药审中心关于公开征求《疫苗临床试验技术指导原则》意见的通知；\\r\\n3.赫吉亚生物宣布获数千万人民币A2轮融资。\\r\\n如想了解更多详情，敬请查阅本周新闻周报。\",15,\"cf3f7121a8d0d5fbd82e427640170cd2\",\"帕博利珠单抗\",\"46775102224fc8bc48665c8f6b400f00\",\"依沃西单抗\",\"医药魔方Info\",\"https:\\u002F\\u002Fpharmcube-pat.oss-cn-beijing.aliyuncs.com\\u002Fwechat_mp_logo\\u002F6ad25aa68a7f2d9979385ef99131cad0.png\",\"\\u002F\"));</script><script defer=\"\" src=\"/_nuxt/906d100.js\"></script><script defer=\"\" src=\"/_nuxt/bc02015.js\"></script><script defer=\"\" src=\"/_nuxt/adf5c0e.js\"></script><script defer=\"\" src=\"/_nuxt/899bd2d.js\"></script><script defer=\"\" src=\"/_nuxt/d766ac1.js\"></script><script defer=\"\" src=\"/_nuxt/f5958aa.js\"></script><script defer=\"\" src=\"/_nuxt/0e8d870.js\"></script><script defer=\"\" src=\"/_nuxt/b325f63.js\"></script><script defer=\"\" src=\"/_nuxt/21c0bce.js\"></script><script defer=\"\" src=\"/_nuxt/0ffb51c.js\"></script>\n",
       "</body>\n",
       "</html>"
      ]
     },
     "execution_count": 1166,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "soup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6ec1ec60-f58e-4def-96da-7b0ac9db0a4a",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  },
  "widgets": {
   "application/vnd.jupyter.widget-state+json": {
    "state": {},
    "version_major": 2,
    "version_minor": 0
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
